data_1fjd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fjd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.675 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 126' ' ' MET . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.475 ' CD2' HD13 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 72' ' ' SER . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.594 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.488 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.56 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.528 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.549 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 65' ' ' ASN . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.516 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 6.9 tptp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 82' ' ' LEU . 58.0 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.165 0.507 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 42' ' ' HIS . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.418 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.476 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.543 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.476 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 127' ' ' VAL . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 98' ' ' ALA . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.519 ' HG2' ' CG2' ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 127' ' ' VAL . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 109' ' ' PRO . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.521 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' N ' ' HE2' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.689 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.689 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.524 ' N ' ' HB2' ' A' ' 104' ' ' SER . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.623 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.655 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.494 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' CG2' ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.408 ' O ' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.498 HG13 HG23 ' A' ' 43' ' ' ILE . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.554 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.515 HG23 ' CB ' ' A' ' 98' ' ' ALA . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.675 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.541 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.8 t-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.146 0.498 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 127' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 126' ' ' MET . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HG2' ' OD2' ' A' ' 81' ' ' ASP . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.515 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.561 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.561 ' N ' ' HE3' ' A' ' 52' ' ' MET . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.499 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.569 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 71' ' ' TYR . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 82' ' ' LEU . 5.6 t70 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.28 0.562 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 42' ' ' HIS . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.523 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.543 HG23 ' CG1' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.626 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.553 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.577 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.619 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.626 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' PRO . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 112' ' ' THR . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.488 ' CG2' ' CD1' ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.587 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.518 ' CB ' HG23 ' A' ' 43' ' ' ILE . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.532 HG13 ' CE1' ' A' ' 123' ' ' HIS . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.561 ' O ' ' CG ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 104' ' ' SER . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.152 0.501 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.588 ' CE1' ' OD2' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 ' CG1' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.709 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.709 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 48' ' ' HIS . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 55' ' ' MET . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.608 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.608 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' HE2' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.513 ' SD ' ' CE ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.571 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.563 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.556 ' OG ' ' CG1' ' A' ' 43' ' ' ILE . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 70' ' ' GLN . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.993 0.425 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.51 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.497 ' HB3' ' NE2' ' A' ' 95' ' ' GLN . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.516 ' HB2' ' CA ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.566 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.529 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.604 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 113' ' ' ASP . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.562 ' CG2' ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.522 ' HG2' ' CA ' ' A' ' 105' ' ' GLY . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.455 0.645 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 94' ' ' PHE . 14.3 m-70 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.541 ' N ' ' HA ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 51' ' ' ILE . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 48' ' ' HIS . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' ' HE3' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.521 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.533 ' HE1' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' N ' ' HE1' ' A' ' 52' ' ' MET . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CB ' ' HE3' ' A' ' 106' ' ' MET . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.467 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.616 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.522 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.616 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.039 0.447 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 42' ' ' HIS . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE3' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CA ' HD13 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' PHE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.58 ' HE2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.608 ' CG2' ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.636 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.636 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.494 ' CG2' ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.574 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 126' ' ' MET . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.604 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 124' ' ' ILE . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.54 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 ' HB ' ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.53 ' CA ' ' HE1' ' A' ' 52' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.51 ' HE1' ' CG ' ' A' ' 115' ' ' PRO . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HD2' ' CG1' ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.481 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.602 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' OD1' ' OE1' ' A' ' 66' ' ' GLU . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.577 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HG2' ' OD2' ' A' ' 74' ' ' ASP . 56.2 mmtt . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' LEU . 14.1 t70 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.983 0.421 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.604 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.45 ' C ' ' O ' ' A' ' 83' ' ' GLY . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE1' HD12 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 101' ' ' LEU . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 105' ' ' GLY . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' HG3' ' A' ' 106' ' ' MET . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' N ' HG11 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.573 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.573 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.499 ' O ' ' O ' ' A' ' 114' ' ' PRO . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.473 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.307 0.575 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' CB ' ' HB2' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' CG ' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.473 ' NE2' HG11 ' A' ' 40' ' ' VAL . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 115' ' ' PRO . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.559 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.541 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.577 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HG ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.577 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.532 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.594 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.594 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.235 0.54 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' O ' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 96' ' ' GLU . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 118' ' ' THR . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HG2' ' HA ' ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASP . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.537 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.437 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.574 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.586 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.466 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.541 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.512 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.434 ' C ' HG23 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 127' ' ' VAL . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.601 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' A' ' 55' ' ' MET . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 54' ' ' ALA . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.522 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.472 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.664 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.538 ' HB2' ' CG1' ' A' ' 43' ' ' ILE . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.644 ' CG ' ' CE1' ' A' ' 42' ' ' HIS . 3.2 mptt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 31.0 t0 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CZ3' ' O ' ' A' ' 37' ' ' ALA . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.413 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 90' ' ' MET . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' HG11 ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.497 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' N ' HG12 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' LEU . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.645 ' O ' ' O ' ' A' ' 123' ' ' HIS . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.61 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.521 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.543 HG11 ' CG1' ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.56 ' C ' ' CH2' ' A' ' 84' ' ' TRP . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.539 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.57 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.413 0.625 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 37' ' ' ALA . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 43' ' ' ILE . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.747 ' CD1' ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.747 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.551 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HG2' ' HE2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.536 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.635 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.555 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 43.4 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.014 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CD1' ' A' ' 99' ' ' PHE . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 98' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.562 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.545 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 116' ' ' VAL . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.6 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 113' ' ' ASP . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.515 ' CG1' HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.519 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 86' ' ' THR . 16.8 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.37 0.605 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' MET . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CE1' ' CZ ' ' A' ' 94' ' ' PHE . 4.4 m-70 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.498 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.58 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.611 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 64' ' ' PHE . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.476 ' OG ' ' SD ' ' A' ' 62' ' ' MET . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.545 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CD1' HD21 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.544 ' HB2' ' CD ' ' A' ' 63' ' ' ARG . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.568 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.8 t0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.153 0.502 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.509 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.509 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.512 ' CD2' HG23 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 104' ' ' SER . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.512 ' N ' HG13 ' A' ' 103' ' ' VAL . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.593 ' CE ' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.593 ' N ' ' CE ' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.685 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 111' ' ' PHE . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.531 ' C ' ' O ' ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.483 ' CG2' HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' O ' HG11 ' A' ' 116' ' ' VAL . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.603 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 113' ' ' ASP . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' ND1' ' HB2' ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.51 HG21 ' CB ' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.595 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.373 0.606 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.524 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.622 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.702 ' CE1' ' CB ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.658 HG22 ' CG ' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.552 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.564 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.564 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.6 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' ' NE2' ' A' ' 70' ' ' GLN . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.637 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.595 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.412 ' HB2' HG21 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.527 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 94' ' ' PHE . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 102' ' ' PRO . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 104' ' ' SER . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 110' ' ' VAL . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.502 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.569 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.526 HG13 ' HA2' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.554 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.571 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.582 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 103' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.507 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.715 0.769 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.597 ' ND1' ' CE2' ' A' ' 94' ' ' PHE . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.526 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.521 ' HG3' ' CG ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.59 ' CG1' ' CD ' ' A' ' 57' ' ' LYS . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.586 ' CD2' ' HB ' ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.566 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' GLN . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 44.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.352 0.596 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.557 ' CD1' ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.536 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.496 ' CB ' ' O ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' ND1' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 101' ' ' LEU . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 98' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.545 ' HE3' ' N ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' N ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.669 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.565 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.634 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.634 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 93' ' ' PRO . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.451 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' CG2' ' A' ' 40' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.616 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.579 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' THR . 4.0 m120 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.545 0.688 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' O ' ' CA ' ' A' ' 130' ' ' ARG . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.591 ' CE1' ' CG ' ' A' ' 122' ' ' TYR . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.536 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.527 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.537 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.513 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 2.8 tmtm? . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' CG ' ' NZ ' ' A' ' 39' ' ' LYS . 4.8 t0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 123' ' ' HIS . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' VAL . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' ' 111' ' ' PHE . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.539 ' N ' HG11 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 111' ' ' PHE . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.609 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.504 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 94' ' ' PHE . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.566 HG12 ' CE1' ' A' ' 123' ' ' HIS . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 104' ' ' SER . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.514 ' CA ' ' O ' ' A' ' 37' ' ' ALA . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.209 0.528 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.534 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.593 ' CD2' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.596 ' CA ' ' HB2' ' A' ' 72' ' ' SER . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 123' ' ' HIS . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.653 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.64 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.64 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 57' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.556 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.571 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.589 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' NE2' ' A' ' 70' ' ' GLN . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.596 ' HB2' ' CA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.572 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 39.0 t0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.011 0.434 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.593 HD12 ' CD2' ' A' ' 42' ' ' HIS . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.561 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.517 ' CD2' ' HB ' ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.517 ' HB ' ' CD2' ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.629 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 113' ' ' ASP . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.646 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.581 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.735 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.628 0.728 . . . . 0.0 109.806 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.782 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 126' ' ' MET . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' CG ' ' HG2' ' A' ' 126' ' ' MET . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 94' ' ' PHE . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.571 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' CB ' ' HG2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' HE1' ' A' ' 62' ' ' MET . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.647 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.65 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.463 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 74' ' ' ASP . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 8.5 tptt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.442 ' CG ' ' HG2' ' A' ' 41' ' ' ARG . 5.4 t0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.524 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.593 ' CD1' ' CG1' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.533 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 108' ' ' LYS . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 116' ' ' VAL . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.614 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.549 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.596 ' CE1' ' CE1' ' A' ' 94' ' ' PHE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 116' ' ' VAL . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.572 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.657 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 130' ' ' ARG . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 86' ' ' THR . 40.0 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.128 0.489 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' CB ' ' A' ' 130' ' ' ARG . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' HB3' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.54 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' CD2' ' HA ' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 45' ' ' CYS . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 115' ' ' PRO . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.537 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.527 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.591 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 t-20 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.591 ' HG2' ' CD ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.682 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 120.729 0.299 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.522 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.524 ' HB2' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.423 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 104' ' ' SER . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.404 ' HB ' HD13 ' A' ' 101' ' ' LEU . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.597 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.597 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.471 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.501 ' HG2' ' HA3' ' A' ' 105' ' ' GLY . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.464 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.296 0.569 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 130' ' ' ARG . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' C ' ' CD ' ' A' ' 41' ' ' ARG . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CD1' ' HB1' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.528 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.486 ' HE2' ' CD ' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.545 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.545 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.541 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.552 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 1.1 mm-40 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' HG11 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.418 HD13 ' CD2' ' A' ' 42' ' ' HIS . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.426 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 110' ' ' VAL . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.579 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.575 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.613 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 113' ' ' ASP . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' N ' HG23 ' A' ' 112' ' ' THR . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.576 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 44' ' ' LEU . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.523 ' O ' ' O ' ' A' ' 114' ' ' PRO . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.509 ' CG1' ' CD1' ' A' ' 51' ' ' ILE . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.633 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.649 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.429 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.52 ' O ' ' CG2' ' A' ' 86' ' ' THR . 91.0 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.353 0.597 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 126' ' ' MET . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NH2' ' HG3' ' A' ' 128' ' ' GLU . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 1.4 p80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.573 ' O ' ' C ' ' A' ' 72' ' ' SER . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.623 ' CE1' ' HB2' ' A' ' 122' ' ' TYR . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.522 HG12 ' CD2' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.526 ' HE2' ' CD ' ' A' ' 115' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.53 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.567 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 65' ' ' ASN . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.757 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 37.3 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.095 0.474 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 92' ' ' GLY . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 91' ' ' VAL . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CZ ' HD12 ' A' ' 125' ' ' ILE . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.54 HD23 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 104' ' ' SER . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.599 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.54 ' CG2' HD23 ' A' ' 101' ' ' LEU . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.527 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.434 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.595 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.591 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' CG2' ' A' ' 86' ' ' THR . 20.7 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.347 0.594 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.546 ' CG1' ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD3' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.657 ' O ' ' O ' ' A' ' 71' ' ' TYR . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' ND1' ' A' ' 48' ' ' HIS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.534 ' ND1' ' SG ' ' A' ' 45' ' ' CYS . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.528 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 115' ' ' PRO . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.528 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.542 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.624 ' N ' ' HE3' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.538 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.624 ' HE3' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.612 HG13 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 70' ' ' GLN . 7.5 tp60 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 44' ' ' LEU . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 13.3 tptt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 27.9 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.035 0.445 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG2' ' HB ' ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.529 ' O ' ' CG ' ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.529 ' CG ' ' O ' ' A' ' 97' ' ' ALA . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.542 ' HE3' ' N ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.542 ' N ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.681 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.51 ' OG1' HG11 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.513 HG22 ' NE2' ' A' ' 123' ' ' HIS . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.604 ' CA ' HD22 ' A' ' 44' ' ' LEU . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 114' ' ' PRO . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG13 ' CE1' ' A' ' 123' ' ' HIS . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.573 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.566 ' CG ' ' N ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.742 0.782 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 130' ' ' ARG . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 126' ' ' MET . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' A' ' 128' ' ' GLU . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 72' ' ' SER . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.581 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 124' ' ' ILE . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 64' ' ' PHE . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.647 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 58' ' ' LEU . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.569 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.532 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.562 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.226 0.536 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.552 ' CD1' ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 92' ' ' GLY . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.552 ' N ' ' CG1' ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 125' ' ' ILE . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 112' ' ' THR . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 104' ' ' SER . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.59 HG23 ' CD2' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 110' ' ' VAL . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.598 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.598 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 125' ' ' ILE . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.427 ' O ' HD13 ' A' ' 44' ' ' LEU . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 54' ' ' ALA . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.56 HD13 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.563 ' O ' ' CG ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.509 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.28 0.562 . . . . 2.94 110.605 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 1.36 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 1.48 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 2.24 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 2.06 113.074 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' CD ' ' HG2' ' A' ' 126' ' ' MET . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 2.43 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.636 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 2.3 p80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 4.12 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.51 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 1.54 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 2.24 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 2.11 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.53 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.72 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 2.37 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.472 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 1.57 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.55 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.54 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 1.19 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 1.43 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.93 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.538 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.82 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 64' ' ' PHE . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 1.63 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.52 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.05 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 1.36 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.538 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.75 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 2.42 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.57 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.82 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 2.4 110.56 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.39 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 1.28 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 1.26 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 1.23 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.636 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.28 113.556 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.52 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 73' ' ' GLU . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.59 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.94 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.53 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.48 111.016 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 83' ' ' GLY . 18.4 t0 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.631 -0.137 . . . . 2.11 110.631 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 2.16 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 1.3 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.503 ' CZ3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 1.11 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 2.2 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.93 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 3.31 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.83 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.71 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.86 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 2.3 109.632 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 1.4 109.697 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 94' ' ' PHE . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 1.27 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 2.42 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' CG ' ' A' ' 87' ' ' ARG . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.42 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.61 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 1.23 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 1.35 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 87' ' ' ARG . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 2.7 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.61 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 2.35 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' A' ' 101' ' ' LEU . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.61 110.872 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 2.16 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.83 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.73 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.498 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 2.14 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.89 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.65 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 3.17 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.526 HG11 ' N ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.89 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' N ' HG11 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 2.65 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 1.44 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.31 109.589 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.602 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 1.19 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 1.25 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 1.23 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.62 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.531 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.88 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.49 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 3.54 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 1.36 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 2.49 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 3.77 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.524 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 1.18 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 125' ' ' ILE . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 1.48 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.494 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.74 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.61 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.3 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.17 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.65 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HD3' ' CB ' ' A' ' 37' ' ' ALA . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 4.2 110.221 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 p -128.02 66.54 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 152.59 28.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.73 90.37 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.69 1.363 . . . . 0.0 110.643 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -133.54 107.72 8.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.24 35.44 0.83 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.06 -70.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 68.1 76.65 0.41 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.1 OUTLIER -125.55 -5.76 7.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -1.174 . . . . 0.0 110.319 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.675 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 126' ' ' MET . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' CB ' ' HG3' ' A' ' 77' ' ' ARG . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.475 ' CD2' HD13 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' CG1' ' HB2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.594 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.488 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.56 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.528 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.549 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.55 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.536 ' HG2' ' CB ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 65' ' ' ASN . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.516 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 6.9 tptp -57.09 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 75' ' ' LYS . . . 167.64 152.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.178 -0.951 . . . . 0.0 110.518 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' NH2' ' CG2' ' A' ' 124' ' ' ILE . 5.4 ttt-85 -94.04 -65.76 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.55 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 2.7 mp0 -60.18 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.744 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.13 -27.32 45.6 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.516 ' HA3' ' CB ' ' A' ' 76' ' ' ALA . . . -84.4 -1.95 89.2 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 58.0 t0 -41.22 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 110.177 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 80' ' ' GLY . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.418 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.476 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HG2' ' OG1' ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.476 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 127' ' ' VAL . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 98' ' ' ALA . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.519 ' HG2' ' CG2' ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 127' ' ' VAL . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.528 ' HB2' ' CA ' ' A' ' 109' ' ' PRO . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.521 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' N ' ' HE2' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.689 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.689 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.524 ' N ' ' HB2' ' A' ' 104' ' ' SER . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.623 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.655 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.494 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' ' CG2' ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.408 ' O ' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.602 ' CG2' ' NH2' ' A' ' 77' ' ' ARG . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.554 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.515 HG23 ' CB ' ' A' ' 98' ' ' ALA . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.675 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.545 ' HB2' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' SER . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -43.71 118.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.145 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.64 177.55 16.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.56 96.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.828 1.436 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 78.21 1.3 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.27 -139.01 20.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -124.27 -117.92 2.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA2' ' OXT' ' A' ' 131' ' ' LYS . . . -144.56 96.79 0.19 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.8 t-20 -116.06 -20.81 9.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -1.101 . . . . 0.0 110.256 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' A' ' 127' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 126' ' ' MET . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.515 ' CD2' HD11 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.561 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.561 ' N ' ' HE3' ' A' ' 52' ' ' MET . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.499 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.526 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.569 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.557 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' CE2' ' A' ' 71' ' ' TYR . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.544 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.574 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 4.0 ttpt -130.38 1.84 4.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 68' ' ' ALA . . . 68.14 148.48 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 111.311 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.542 ' HD3' ' CE ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -100.67 -61.45 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.858 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.82 -17.98 44.72 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . -94.71 -3.06 62.72 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.6 t70 -38.35 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.957 . . . . 0.0 110.309 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 80' ' ' GLY . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.523 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.543 HG23 ' CG1' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.626 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.553 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.577 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.619 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.626 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 109' ' ' PRO . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 112' ' ' THR . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 ' CG2' ' CD1' ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.473 ' O ' HG13 ' A' ' 116' ' ' VAL . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.587 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.519 HG21 ' NH2' ' A' ' 77' ' ' ARG . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.532 HG13 ' CE1' ' A' ' 123' ' ' HIS . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.561 ' O ' ' CG ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 104' ' ' SER . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.703 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.437 ' OXT' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 t -173.25 145.7 1.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.83 -170.75 22.97 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 100.74 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.827 1.435 . . . . 0.0 110.512 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.91 157.57 18.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.222 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.78 138.07 3.46 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -129.23 49.73 0.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 36' ' ' ASN . . . 47.03 -117.43 3.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' THR . 6.3 t-20 63.38 15.23 8.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -1.147 . . . . 0.0 110.217 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.588 ' CE1' ' OD2' ' A' ' 74' ' ' ASP . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' CG1' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.709 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.709 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 48' ' ' HIS . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 55' ' ' MET . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.608 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.608 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' CG ' ' HE2' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' HG ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.513 ' SD ' ' CE ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.571 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' CG2' ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.563 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 70' ' ' GLN . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -68.31 -5.85 20.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . 73.47 149.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 111.379 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.571 ' NH1' ' CE ' ' A' ' 126' ' ' MET . 2.0 ptp180 -108.63 -168.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.259 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.46 ' NE2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER 45.14 -91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.223 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -57.51 -25.05 54.46 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -91.85 -53.29 2.11 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 31.76 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.02 -0.694 . . . . 0.0 111.083 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.51 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.497 ' HB3' ' NE2' ' A' ' 95' ' ' GLN . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.537 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.516 ' HB2' ' CA ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.566 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.529 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.604 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 113' ' ' ASP . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.562 ' CG2' ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.571 ' CE ' ' NH1' ' A' ' 77' ' ' ARG . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 m 48.83 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.252 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.86 151.87 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.65 -60.13 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.764 1.402 . . . . 0.0 110.588 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.74 19.65 7.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 161.42 32.77 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.97 -136.45 13.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.17 -161.43 32.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.81 -71.59 0.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -1.184 . . . . 0.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.687 ' CE1' ' CE2' ' A' ' 94' ' ' PHE . 14.3 m-70 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.541 ' N ' ' HA ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 51' ' ' ILE . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 48' ' ' HIS . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' ' HE3' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.533 ' HE1' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' N ' ' HE1' ' A' ' 52' ' ' MET . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' CB ' ' HE3' ' A' ' 106' ' ' MET . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.467 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.616 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.543 ' O ' ' O ' ' A' ' 78' ' ' GLN . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.616 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.515 ' CA ' ' HB1' ' A' ' 76' ' ' ALA . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -56.54 122.05 11.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' CA ' ' A' ' 69' ' ' ALA . . . -96.18 -92.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.001 -1.062 . . . . 0.0 111.325 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 49.44 90.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.951 -1.093 . . . . 0.0 108.841 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 64' ' ' PHE . 1.7 tm0? 60.02 -75.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 109.469 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -166.0 47.97 0.27 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.525 ' O ' ' CD2' ' A' ' 82' ' ' LEU . . . 80.07 41.91 11.56 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -75.06 78.35 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -1.132 . . . . 0.0 110.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' CD2' ' A' ' 42' ' ' HIS . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE3' ' CD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CA ' HD13 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 99' ' ' PHE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.557 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.58 ' HE2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.608 ' CG2' ' CG2' ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.608 ' CG2' ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.636 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.636 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.494 ' CG2' ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.574 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -83.75 92.67 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 173.44 53.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.22 -31.19 92.72 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.689 1.363 . . . . 0.0 110.506 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -138.82 142.16 38.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.128 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.98 64.01 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.94 -134.38 5.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . 87.45 -135.09 12.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 60.34 13.13 3.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 126' ' ' MET . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.604 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 HD13 ' NE2' ' A' ' 78' ' ' GLN . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.54 ' O ' ' CE1' ' A' ' 48' ' ' HIS . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 ' HB ' ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.53 ' CA ' ' HE1' ' A' ' 52' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.51 ' HE1' ' CG ' ' A' ' 115' ' ' PRO . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HD2' ' CG1' ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.481 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.602 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 77' ' ' ARG . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 56.2 mmtt -53.57 -18.84 3.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 75' ' ' LYS . . . 78.44 -153.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.102 0.953 . . . . 0.0 112.34 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.619 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 36.8 ptt180 -55.96 154.48 7.38 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.902 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.653 ' CB ' ' CE1' ' A' ' 64' ' ' PHE . 2.2 mm100 -52.89 -23.37 6.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -44.6 -30.26 2.13 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 106.269 -2.733 . . . . 0.0 106.269 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -56.75 -50.01 66.45 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' GLN . 14.1 t70 26.29 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.319 -0.518 . . . . 0.0 111.709 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.604 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.45 ' C ' ' O ' ' A' ' 83' ' ' GLY . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.574 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE1' HD12 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.541 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 101' ' ' LEU . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.522 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.511 ' C ' ' O ' ' A' ' 105' ' ' GLY . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' HG3' ' A' ' 106' ' ' MET . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 101' ' ' LEU . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' N ' HG11 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.573 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.573 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.499 ' O ' ' O ' ' A' ' 114' ' ' PRO . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.473 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.549 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -105.81 117.33 33.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -1.09 . . . . 0.0 110.17 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.21 -85.58 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.22 147.67 94.98 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.666 1.35 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -177.14 161.94 1.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.053 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.39 143.37 17.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.75 -151.02 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA3' ' OXT' ' A' ' 131' ' ' LYS . . . -132.16 -43.38 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 55.2 17.61 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 110.191 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' CB ' ' HB2' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HD2' ' CG ' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' NE2' HG11 ' A' ' 40' ' ' VAL . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.647 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.548 ' CG1' ' HB3' ' A' ' 115' ' ' PRO . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.559 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.541 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.577 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HG ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.577 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.565 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.532 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.594 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.594 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm -54.92 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . . . -171.0 -135.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.766 -1.209 . . . . 0.0 110.925 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 68.46 105.64 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 -179.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.559 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 1.3 tm0? 64.7 -34.57 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.629 -0.669 . . . . 0.0 111.959 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 68' ' ' ALA . . . 159.2 -51.31 0.39 Allowed Glycine 0 N--CA 1.481 1.676 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . -167.23 20.58 0.1 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 13.1 p30 -60.16 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.957 -1.319 . . . . 0.0 109.728 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' O ' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 96' ' ' GLU . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HG2' ' OG1' ' A' ' 118' ' ' THR . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' CB ' HG22 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HG2' ' HA ' ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.458 ' O ' ' HB2' ' A' ' 107' ' ' ASP . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.537 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.437 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.574 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.586 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.466 ' O ' ' HA3' ' A' ' 105' ' ' GLY . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.556 ' HE1' ' NE2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.497 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.512 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -90.96 -7.12 52.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.167 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -163.25 21.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.14 -154.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.616 1.324 . . . . 0.0 110.422 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 tttm 49.75 178.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.46 84.67 0.27 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.53 -140.45 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 131' ' ' LYS . . . 97.4 -160.32 21.25 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.434 ' C ' HG23 ' A' ' 86' ' ' THR . 0.2 OUTLIER 52.89 25.33 3.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -1.205 . . . . 0.0 110.304 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 99' ' ' PHE . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 127' ' ' VAL . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.57 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.644 ' CE1' ' CG ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 76' ' ' ALA . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.601 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' A' ' 55' ' ' MET . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.55 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' CD2' ' NH2' ' A' ' 77' ' ' ARG . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.522 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.472 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.664 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' CG ' ' CE1' ' A' ' 42' ' ' HIS . 3.2 mptt -45.66 -93.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 77' ' ' ARG . . . 168.24 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER 143.6 -80.47 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.492 ' OE1' ' CE ' ' A' ' 126' ' ' MET . 3.8 mp0 -61.81 -91.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.544 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.22 -19.09 30.71 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 76' ' ' ALA . . . -93.06 3.4 73.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 80' ' ' GLY . 31.0 t0 -29.21 112.65 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.025 -0.691 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.596 HD11 ' CG ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CZ3' ' O ' ' A' ' 37' ' ' ALA . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.533 HG23 ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.413 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 90' ' ' MET . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.58 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' HG11 ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.497 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' N ' HG12 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.439 HG22 HD11 ' A' ' 101' ' ' LEU . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.645 ' O ' ' O ' ' A' ' 123' ' ' HIS . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.61 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.557 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.521 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.543 HG11 ' CG1' ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.56 ' C ' ' CH2' ' A' ' 84' ' ' TRP . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.539 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.57 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.81 74.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -1.155 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.31 153.87 16.99 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.52 -157.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.702 1.37 . . . . 0.0 110.562 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.81 130.95 25.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.25 59.6 10.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.07 42.85 1.18 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' OXT' ' A' ' 131' ' ' LYS . . . 78.7 -163.39 49.76 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' THR . 0.3 OUTLIER 63.04 17.42 10.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.143 -1.21 . . . . 0.0 110.031 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 37' ' ' ALA . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.627 ' CD2' ' CD2' ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 43' ' ' ILE . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.747 ' CD1' ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.747 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.551 ' N ' ' CG2' ' A' ' 51' ' ' ILE . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.462 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 77' ' ' ARG . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HG2' ' HE2' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.536 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.537 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.635 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.555 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER 68.58 76.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . -44.15 176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.681 0.753 . . . . 0.0 112.33 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.538 ' CZ ' HD23 ' A' ' 58' ' ' LEU . 13.8 ttp180 -87.4 -75.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.761 -0.587 . . . . 0.0 110.295 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HG3' ' HB3' ' A' ' 64' ' ' PHE . 22.5 mm-40 -81.73 -49.78 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.11 57.79 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' ' NE2' ' A' ' 42' ' ' HIS . . . -121.22 -10.19 6.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 43.4 p-10 -40.68 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -1.113 . . . . 0.0 110.625 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.459 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.565 ' SD ' ' CD1' ' A' ' 99' ' ' PHE . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 98' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.562 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.552 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.468 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.545 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 116' ' ' VAL . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.6 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 113' ' ' ASP . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.434 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.515 ' CG1' HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.524 ' HE3' ' CZ ' ' A' ' 77' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.562 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 p -83.72 -48.99 9.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.149 . . . . 0.0 110.227 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.16 -76.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.45 92.25 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.728 1.383 . . . . 0.0 110.638 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -118.17 -13.88 9.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.8 -86.33 0.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.14 -24.3 0.46 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.03 65.19 0.1 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 86' ' ' THR . 16.8 t-20 -82.22 -72.99 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 126' ' ' MET . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CE1' ' CZ ' ' A' ' 94' ' ' PHE . 4.4 m-70 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.498 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.58 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.611 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' N ' ' SG ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 52' ' ' MET . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 64' ' ' PHE . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.476 ' OG ' ' SD ' ' A' ' 62' ' ' MET . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.545 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.557 ' CD1' HD21 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.544 ' HB2' ' CD ' ' A' ' 63' ' ' ARG . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.593 ' CB ' ' HA ' ' A' ' 77' ' ' ARG . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -69.75 -16.22 63.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 75' ' ' LYS . . . 75.8 -154.55 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.96 0.886 . . . . 0.0 111.92 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.593 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -44.14 157.35 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.846 -0.534 . . . . 0.0 109.889 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' N ' ' CB ' ' A' ' 68' ' ' ALA . 36.5 mm-40 -52.46 -23.99 7.11 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -49.54 -27.06 8.05 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -65.05 -11.44 51.45 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' C ' ' O ' ' A' ' 80' ' ' GLY . 26.8 t0 -32.56 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.839 -0.801 . . . . 0.0 111.025 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.576 HD13 ' CE1' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.497 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.509 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.509 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.512 ' CD2' HG23 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 104' ' ' SER . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.512 ' N ' HG13 ' A' ' 103' ' ' VAL . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.593 ' CE ' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.593 ' N ' ' CE ' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.685 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.685 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.531 ' O ' ' C ' ' A' ' 111' ' ' PHE . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.531 ' C ' ' O ' ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.483 ' CG2' HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' O ' HG11 ' A' ' 116' ' ' VAL . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.603 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.603 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 113' ' ' ASP . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' ND1' ' HB2' ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.51 HG21 ' CB ' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.595 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.89 -162.02 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.165 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.57 -168.64 12.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.21 98.27 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.737 1.388 . . . . 0.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 1.2 tttt -102.73 -5.73 23.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.322 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.68 -44.7 0.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.8 -80.32 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.73 -144.51 16.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.32 -48.57 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.524 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.622 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.702 ' CE1' ' CB ' ' A' ' 122' ' ' TYR . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.658 HG22 ' CG ' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.552 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.491 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.564 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.564 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.6 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.601 ' CB ' ' N ' ' A' ' 78' ' ' GLN . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.623 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' ' NE2' ' A' ' 70' ' ' GLN . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.637 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.595 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -56.32 151.02 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . . . -144.23 -109.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER 66.97 3.98 3.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.923 -1.111 . . . . 0.0 111.689 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.601 ' N ' ' CB ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 169.8 -40.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.021 -1.05 . . . . 0.0 109.673 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' ' CB ' ' A' ' 68' ' ' ALA . . . 166.54 38.01 0.02 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 91.1 19.59 42.12 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 -55.89 81.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -1.101 . . . . 0.0 110.666 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.412 ' HB2' HG21 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.527 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 94' ' ' PHE . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 102' ' ' PRO . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 104' ' ' SER . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 110' ' ' VAL . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.502 ' O ' ' HB3' ' A' ' 107' ' ' ASP . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.569 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.526 HG13 ' HA2' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.554 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.571 ' CB ' ' CD ' ' A' ' 115' ' ' PRO . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.582 ' CB ' ' NE2' ' A' ' 48' ' ' HIS . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 103' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.507 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -119.13 41.96 2.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -1.127 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.75 -77.68 1.38 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.28 -29.43 86.21 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.65 1.342 . . . . 0.0 110.607 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER 65.4 164.92 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.075 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.32 40.41 0.23 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.83 125.05 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.53 -178.45 32.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 54.39 95.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.366 -1.079 . . . . 0.0 110.135 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HA ' ' O ' ' A' ' 129' ' ' GLY . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HG2' ' OE1' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.597 ' ND1' ' CE2' ' A' ' 94' ' ' PHE . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.483 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.526 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.521 ' HG3' ' CG ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.59 ' CG1' ' CD ' ' A' ' 57' ' ' LYS . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.586 ' CD2' ' HB ' ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.566 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 70' ' ' GLN . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER 66.81 143.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 69' ' ' ALA . . . -124.42 -106.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.018 . . . . 0.0 110.647 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 47.98 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.889 -1.132 . . . . 0.0 109.858 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' NE2' ' CA ' ' A' ' 79' ' ' GLY . 2.3 tm0? 60.84 -69.75 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.486 0.66 . . . . 0.0 109.419 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -176.72 51.08 0.11 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 78.5 34.64 35.15 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 44.0 p-10 -58.73 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -1.081 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.557 ' CD1' ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.536 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.496 ' CB ' ' O ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' ND1' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 101' ' ' LEU . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 98' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.545 ' HE3' ' N ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' N ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.669 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.565 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.634 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.634 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 93' ' ' PRO . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.451 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.52 HG21 ' CG2' ' A' ' 40' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.616 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.579 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -107.05 167.62 9.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -1.149 . . . . 0.0 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.58 -178.94 51.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.719 1.378 . . . . 0.0 110.496 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.79 82.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.6 89.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.38 -163.29 35.59 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.18 177.75 46.34 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' THR . 4.0 m120 55.42 94.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.991 . . . . 0.0 110.372 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' O ' ' CA ' ' A' ' 130' ' ' ARG . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CD1' ' HG2' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CD2' ' HB3' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.591 ' CE1' ' CG ' ' A' ' 122' ' ' TYR . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.536 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.527 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.537 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.51 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.649 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.8 tmtm? -112.72 20.12 16.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . 53.77 170.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.626 -1.296 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.602 ' CD ' ' CE ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -123.53 -27.46 4.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.427 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.601 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mt-30 -92.89 -79.37 0.4 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.29 -19.2 45.71 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -90.02 -40.08 5.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 80' ' ' GLY . 4.8 t0 27.53 94.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.335 -0.509 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.514 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 123' ' ' HIS . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 87' ' ' ARG . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 127' ' ' VAL . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' ' 111' ' ' PHE . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.539 ' N ' HG11 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 111' ' ' PHE . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.609 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.623 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.504 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 94' ' ' PHE . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.566 HG12 ' CE1' ' A' ' 123' ' ' HIS . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.602 ' CE ' ' CD ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 104' ' ' SER . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.514 ' CA ' ' O ' ' A' ' 37' ' ' ALA . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 30' ' ' GLY . 1.1 p 51.28 -150.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.487 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -116.04 -79.99 0.81 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.2 Cg_exo -61.09 -150.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.76 1.4 . . . . 0.0 110.533 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 2.1 tptt 68.61 162.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 110.152 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.5 -89.98 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.67 -41.23 0.75 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 131' ' ' LYS . . . 75.24 161.63 9.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 -109.89 -43.9 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -1.193 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.534 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.593 ' CD2' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.596 ' CA ' ' HB2' ' A' ' 72' ' ' SER . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 123' ' ' HIS . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.653 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.64 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.64 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HD2' ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 57' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.556 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.571 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.589 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.571 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 72' ' ' SER . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' O ' ' NE2' ' A' ' 70' ' ' GLN . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.596 ' HB2' ' CA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.572 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' CG ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -42.61 118.0 1.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB3' ' CA ' ' A' ' 69' ' ' ALA . . . -105.4 -13.8 15.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.081 -1.012 . . . . 0.0 110.387 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' GLY . 2.5 ttp180 -40.92 105.57 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 109.833 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.539 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.59 -60.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.45 0.643 . . . . 0.0 109.748 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -171.94 33.71 0.14 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 82.67 33.91 23.56 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.474 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 39.0 t0 -52.55 81.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.934 . . . . 0.0 111.416 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.593 HD12 ' CD2' ' A' ' 42' ' ' HIS . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.549 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.561 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.517 ' CD2' ' HB ' ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.504 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.536 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.48 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.517 ' HB ' ' CD2' ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.629 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.629 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 113' ' ' ASP . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.646 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.581 HG12 ' CZ ' ' A' ' 94' ' ' PHE . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.735 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -54.02 141.34 28.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.279 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.54 -158.97 24.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.17 -172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.706 1.371 . . . . 0.0 110.617 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -71.59 117.42 13.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.203 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.64 -50.1 2.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.86 -40.93 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' CA ' ' HE3' ' A' ' 131' ' ' LYS . . . -103.4 174.23 22.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER 61.96 37.11 15.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.806 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.782 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 130' ' ' ARG . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 126' ' ' MET . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' CG ' ' HG2' ' A' ' 126' ' ' MET . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 94' ' ' PHE . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.532 HD11 ' CZ ' ' A' ' 77' ' ' ARG . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.571 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 45' ' ' CYS . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.543 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.561 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' CB ' ' HG2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' HE1' ' A' ' 62' ' ' MET . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.647 ' HG2' ' CB ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.65 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CG ' ' OE1' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.476 ' OD1' ' HA3' ' A' ' 79' ' ' GLY . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 74' ' ' ASP . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 8.5 tptt 55.79 -101.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' A' ' 75' ' ' LYS . . . 166.21 149.97 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.115 -0.991 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.553 ' NH2' ' NE2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.97 -66.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.689 179.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 1.1 mt-30 -71.14 -67.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.83 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.476 ' HA3' ' OD1' ' A' ' 65' ' ' ASN . . . -61.43 -29.65 72.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 76' ' ' ALA . . . -97.45 5.38 62.57 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.4 t0 -39.59 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -1.049 . . . . 0.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 95' ' ' GLN . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 94' ' ' PHE . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.524 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.593 ' CD1' ' CG1' ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.533 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 108' ' ' LYS . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.596 ' CG1' ' N ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' N ' ' CG1' ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 116' ' ' VAL . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.614 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.549 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.596 ' CE1' ' CE1' ' A' ' 94' ' ' PHE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 116' ' ' VAL . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.572 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.657 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 130' ' ' ARG . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.782 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -119.92 138.96 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -1.164 . . . . 0.0 110.096 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.73 -173.0 23.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.37 139.03 80.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.809 1.426 . . . . 0.0 110.673 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.43 -8.25 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.7 45.44 1.65 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 50.22 -169.74 0.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . 107.98 -111.62 3.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 86' ' ' THR . 40.0 m-20 60.46 12.95 3.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 110.517 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' CB ' ' A' ' 130' ' ' ARG . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.609 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.54 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.611 ' CD2' ' HA ' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 45' ' ' CYS . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.555 ' CG1' ' HB3' ' A' ' 115' ' ' PRO . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.551 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.537 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.527 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.591 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.3 t-20 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.591 ' HG2' ' CD ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.661 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.558 ' O ' ' CB ' ' A' ' 76' ' ' ALA . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.682 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -40.88 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 68' ' ' ALA . . . -52.65 175.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 111.369 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.697 ' HD2' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -95.7 -59.37 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.697 ' NE2' ' HD2' ' A' ' 77' ' ' ARG . 20.5 mm-40 -58.47 -92.03 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.765 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.59 -13.75 59.19 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.556 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -88.54 -30.58 15.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' ARG . 8.9 t0 22.32 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.42 -0.459 . . . . 0.0 111.524 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.522 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.524 ' HB2' ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.423 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 104' ' ' SER . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.404 ' HB ' HD13 ' A' ' 101' ' ' LEU . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.597 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.597 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.471 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.541 ' CE ' ' HG3' ' A' ' 77' ' ' ARG . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.464 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -174.9 5.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.78 166.69 22.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.75 131.06 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.679 1.357 . . . . 0.0 110.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -74.08 -176.63 2.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 110.177 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.88 -170.45 14.4 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.58 11.17 71.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.63 96.55 2.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 -113.92 -25.19 8.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -1.151 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 130' ' ' ARG . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' C ' ' CD ' ' A' ' 41' ' ' ARG . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 79' ' ' GLY . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CD1' ' HB1' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.486 ' HE2' ' CD ' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.541 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.545 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.665 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.541 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' CB ' ' HA2' ' A' ' 79' ' ' GLY . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 1.1 mm-40 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' CE2' HG11 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -61.38 156.82 18.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 69' ' ' ALA . . . -152.36 -113.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.999 -1.063 . . . . 0.0 110.602 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' GLY . 6.5 tpp180 52.39 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.801 -1.187 . . . . 0.0 108.909 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.22 -70.14 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -172.91 61.63 0.14 Allowed Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 58.91 41.9 96.47 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 -60.66 72.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -1.083 . . . . 0.0 110.977 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 80' ' ' GLY . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.426 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 94' ' ' PHE . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 96' ' ' GLU . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.515 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 110' ' ' VAL . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.579 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.575 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.613 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 113' ' ' ASP . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' N ' HG23 ' A' ' 112' ' ' THR . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.576 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.521 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' O ' HD12 ' A' ' 44' ' ' LEU . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.523 ' O ' ' O ' ' A' ' 114' ' ' PRO . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.509 ' CG1' ' CD1' ' A' ' 51' ' ' ILE . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.633 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 103' ' ' VAL . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.649 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 t -122.23 -30.36 4.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 0.0 110.308 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.07 70.38 0.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -42.44 30.12 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.681 1.358 . . . . 0.0 110.37 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.31 82.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.48 34.93 3.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.72 93.84 0.36 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 179.45 53.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.52 ' O ' ' CG2' ' A' ' 86' ' ' THR . 91.0 m-20 -140.08 -47.5 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -1.154 . . . . 0.0 110.028 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 126' ' ' MET . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NH2' ' HG3' ' A' ' 128' ' ' GLU . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' GLY . 1.4 p80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CD1' ' HB3' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.573 ' O ' ' C ' ' A' ' 72' ' ' SER . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.623 ' CE1' ' HB2' ' A' ' 122' ' ' TYR . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.522 HG12 ' CD2' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.526 ' HE2' ' CD ' ' A' ' 115' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.53 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.567 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' CB ' ' HA2' ' A' ' 79' ' ' GLY . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 65' ' ' ASN . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.757 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.627 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 37.3 tptt -55.04 157.1 3.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -161.29 -119.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.8 . . . . 0.0 109.796 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 1.7 ttt180 70.27 3.35 4.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.902 -1.124 . . . . 0.0 110.879 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.551 ' NE2' ' HA3' ' A' ' 79' ' ' GLY . 2.6 tm0? 159.59 -53.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 68' ' ' ALA . . . 174.96 35.32 0.04 OUTLIER Glycine 0 C--N 1.298 -1.549 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 76.17 40.72 28.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 -60.11 76.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -1.115 . . . . 0.0 110.577 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 80' ' ' GLY . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 92' ' ' GLY . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 91' ' ' VAL . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CZ ' HD12 ' A' ' 125' ' ' ILE . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.54 HD23 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 104' ' ' SER . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.599 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.54 ' CG2' HD23 ' A' ' 101' ' ' LEU . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.527 ' CE2' ' HG3' ' A' ' 102' ' ' PRO . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.434 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.595 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.595 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.591 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.487 ' CG1' ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -75.3 -71.45 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -1.172 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.98 75.24 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -63.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.74 1.389 . . . . 0.0 110.427 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 44.5 -150.28 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.324 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.07 -171.02 5.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.34 -2.85 29.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . -108.78 166.71 12.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.547 ' O ' ' CG2' ' A' ' 86' ' ' THR . 20.7 t30 178.51 -45.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -1.123 . . . . 0.0 110.008 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.546 ' CG2' ' CG1' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.546 ' CG1' ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.844 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.657 ' O ' ' O ' ' A' ' 71' ' ' TYR . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.534 ' SG ' ' ND1' ' A' ' 48' ' ' HIS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.534 ' ND1' ' SG ' ' A' ' 45' ' ' CYS . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.528 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 115' ' ' PRO . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.528 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.542 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.624 ' N ' ' HE3' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.538 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.624 ' HE3' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 78' ' ' GLN . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 63' ' ' ARG . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG13 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' SER . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 70' ' ' GLN . 7.5 tp60 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 44' ' ' LEU . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 13.3 tptt -130.54 -98.33 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.594 ' N ' ' CB ' ' A' ' 72' ' ' SER . . . 177.11 127.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.07 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' CZ ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.86 -33.01 65.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.373 -1.455 . . . . 0.0 109.51 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 38.8 mm-40 -100.84 -54.57 2.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.901 -1.124 . . . . 0.0 108.77 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.99 -24.02 75.91 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.554 ' CA ' ' O ' ' A' ' 76' ' ' ALA . . . -103.64 5.66 47.97 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 27.9 t0 -37.99 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.682 -0.893 . . . . 0.0 110.024 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.456 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.412 ' SD ' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.493 ' N ' ' CG2' ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG2' ' HB ' ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.529 ' O ' ' CG ' ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.529 ' CG ' ' O ' ' A' ' 97' ' ' ALA . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 104' ' ' SER . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.542 ' HE3' ' N ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.542 ' N ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.681 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.51 ' OG1' HG11 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.57 HG23 ' CD2' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.513 HG22 ' NE2' ' A' ' 123' ' ' HIS . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.604 ' CA ' HD22 ' A' ' 44' ' ' LEU . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 114' ' ' PRO . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG13 ' CE1' ' A' ' 123' ' ' HIS . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.573 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.566 ' CG ' ' N ' ' A' ' 131' ' ' LYS . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 m 47.95 74.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -1.153 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 76.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 2.9 Cg_endo -62.14 -163.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.634 1.334 . . . . 0.0 110.543 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 63.97 117.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.27 -125.41 1.49 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 27.14 8.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.35 32.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 55.32 95.86 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG12 ' CG ' ' A' ' 130' ' ' ARG . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 126' ' ' MET . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' HG2' ' A' ' 77' ' ' ARG . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' NE2' ' CD1' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 72' ' ' SER . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.581 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' A' ' 124' ' ' ILE . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.558 HD13 ' NE ' ' A' ' 77' ' ' ARG . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.647 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 58' ' ' LEU . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 63' ' ' ARG . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' CB ' ' OE1' ' A' ' 78' ' ' GLN . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.532 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.65 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.562 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt -126.51 -132.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.486 ' HA ' ' OG ' ' A' ' 72' ' ' SER . . . -167.13 140.15 3.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.981 -1.074 . . . . 0.0 110.296 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.569 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -65.63 -31.26 72.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.25 -0.906 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.575 ' OE1' ' CB ' ' A' ' 68' ' ' ALA . 4.7 mp0 -117.1 -64.99 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 108.749 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.45 -16.85 37.69 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' N ' ' HB1' ' A' ' 76' ' ' ALA . . . -121.01 2.4 11.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 -41.2 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.552 ' CD1' ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 92' ' ' GLY . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.552 ' N ' ' CG1' ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 125' ' ' ILE . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.449 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 112' ' ' THR . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 104' ' ' SER . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.59 HG23 ' CD2' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.59 ' CD2' HG23 ' A' ' 110' ' ' VAL . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.598 ' CD ' ' HD2' ' A' ' 115' ' ' PRO . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.598 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 125' ' ' ILE . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.427 ' O ' HD13 ' A' ' 44' ' ' LEU . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 54' ' ' ALA . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.56 HD13 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.563 ' O ' ' CG ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.509 ' O ' ' HB ' ' A' ' 103' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' CA ' ' HD3' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.467 -1.453 . . . . 15.49 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.498 ' N ' ' HD3' ' A' ' 32' ' ' LYS . 84.8 p -74.29 66.0 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -1.128 . . . . 14.41 110.163 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 79.57 -157.34 42.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.384 -1.486 . . . . 12.77 109.384 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.25 112.95 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.707 1.372 . . . . 12.6 110.227 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -170.67 -43.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.219 -0.926 . . . . 12.38 110.375 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HE3' ' A' ' 32' ' ' LYS . . . 72.36 95.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.901 -1.279 . . . . 8.03 109.901 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' NZ ' ' A' ' 32' ' ' LYS . . . 58.25 152.84 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.874 -1.291 . . . . 6.38 109.874 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 36' ' ' ASN . . . -53.05 137.61 36.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.46 -1.456 . . . . 4.53 109.46 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 -143.71 -41.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 2.94 110.605 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 1.36 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 1.48 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 2.24 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 2.06 113.074 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.59 ' HB3' ' NH2' ' A' ' 77' ' ' ARG . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 2.43 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.636 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 2.3 p80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 4.12 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.676 ' HB ' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 1.54 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 2.24 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 2.11 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.53 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.72 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 2.37 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.472 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 1.57 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.55 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.54 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 1.19 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 1.43 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.93 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.538 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.82 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 64' ' ' PHE . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 1.63 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.52 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.05 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 1.36 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.538 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.75 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' O ' ' CG2' ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 2.42 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.57 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.82 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 2.4 110.56 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.39 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 1.28 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 76' ' ' ALA . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 1.26 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 1.23 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.636 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.28 113.556 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.52 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 73' ' ' GLU . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.59 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.94 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.53 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt 39.48 36.22 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.48 111.016 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 68' ' ' ALA . . . 40.73 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 2.11 110.244 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.676 ' HD2' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -139.23 -94.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.821 -1.175 . . . . 8.86 111.742 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.637 ' NE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -51.98 -55.39 20.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.837 -1.789 . . . . 2.83 108.606 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.35 -24.5 16.64 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 106.68 -2.568 . . . . 3.69 106.68 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -86.53 -49.35 4.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.043 -1.223 . . . . 2.3 110.043 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.663 ' N ' ' O ' ' A' ' 77' ' ' ARG . 18.4 t0 33.84 82.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.829 -0.806 . . . . 2.11 110.631 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 2.16 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 1.3 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.503 ' CZ3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 1.11 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 2.2 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.93 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 3.31 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.83 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.71 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.86 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 2.3 109.632 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 1.4 109.697 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 94' ' ' PHE . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 1.27 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 2.42 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HG3' ' CG ' ' A' ' 87' ' ' ARG . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.42 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.61 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 1.23 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 1.35 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 87' ' ' ARG . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 2.7 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.61 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 2.35 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' A' ' 101' ' ' LEU . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.61 110.872 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 2.16 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.83 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.73 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.498 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 2.14 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.89 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.65 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 3.17 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.526 HG11 ' N ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.89 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' N ' HG11 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 2.65 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 1.44 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.31 109.589 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.602 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 1.19 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 1.25 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 1.23 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.493 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.62 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.531 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.88 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.49 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 3.54 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 1.36 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 2.49 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 3.77 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.524 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 1.18 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 125' ' ' ILE . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 1.48 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.494 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.74 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.61 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.3 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.17 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.65 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 4.2 110.221 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.986 ' O ' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 131' ' ' LYS . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.896 ' HB ' HG13 ' A' ' 127' ' ' VAL . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.705 ' NE2' HD22 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.693 HG21 HD12 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.033 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 115' ' ' PRO . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.56 ' CE ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.538 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.715 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.684 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.532 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 6.9 tptp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 58.0 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.165 0.507 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.705 HD22 ' NE2' ' A' ' 42' ' ' HIS . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.59 ' C ' HG12 ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.807 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.615 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 110' ' ' VAL . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 1.018 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 104' ' ' SER . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 110' ' ' VAL . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.528 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' H ' ' HE3' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.018 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.665 ' H ' HG22 ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 110' ' ' VAL . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.935 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.617 HG22 ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.586 ' N ' HG23 ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.935 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.878 HG21 ' HB2' ' A' ' 98' ' ' ALA . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.738 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.991 ' O ' HG22 ' A' ' 86' ' ' THR . 1.8 t-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.146 0.498 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 40' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG13 HG23 ' A' ' 38' ' ' VAL . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CD2' HD13 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 124' ' ' ILE . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.816 ' N ' HD12 ' A' ' 44' ' ' LEU . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 71' ' ' TYR . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.5 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.533 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.81 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.795 HG23 ' H ' ' A' ' 68' ' ' ALA . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.795 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 72' ' ' SER . 2.2 mm-40 -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' CB ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.0 ttpt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 82' ' ' LEU . 5.6 t70 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.28 0.562 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 42' ' ' HIS . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.991 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.892 HD13 ' CG2' ' A' ' 110' ' ' VAL . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.904 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.647 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.609 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.642 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.647 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.892 ' CG2' HD13 ' A' ' 101' ' ' LEU . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.63 ' H ' HG22 ' A' ' 110' ' ' VAL . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.758 ' HB ' HD11 ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.051 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.051 HG23 ' CB ' ' A' ' 114' ' ' PRO . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.904 ' C ' HG22 ' A' ' 103' ' ' VAL . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.967 ' O ' HG22 ' A' ' 86' ' ' THR . 6.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.152 0.501 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 127' ' ' VAL . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.74 HG13 HD23 ' A' ' 82' ' ' LEU . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.877 ' HB3' HD21 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.993 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.993 ' N ' HD12 ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.53 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' HIS . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.606 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.622 ' HD2' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 54' ' ' ALA . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.686 HG23 ' N ' ' A' ' 68' ' ' ALA . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.556 ' OG ' ' CG1' ' A' ' 43' ' ' ILE . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.993 0.425 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.877 HD21 ' HB3' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.967 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 85' ' ' MET . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.555 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.534 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.736 ' HD2' HD23 ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.486 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.586 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.802 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.802 ' N ' HG13 ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.101 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.725 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.101 HG23 ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.712 HG13 ' HB ' ' A' ' 38' ' ' VAL . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.455 0.645 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' ND1' HD23 ' A' ' 82' ' ' LEU . 7.3 m80 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' LYS . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.724 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.724 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.595 ' HE2' ' HG3' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.626 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.68 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 68' ' ' ALA . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 72' ' ' SER . 0.2 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.82 ' HB3' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.039 0.447 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.431 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.935 HG12 ' HD2' ' A' ' 93' ' ' PRO . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.935 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.539 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.699 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 97' ' ' ALA . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.71 HG22 HG12 ' A' ' 127' ' ' VAL . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.752 ' HE1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.752 ' N ' ' HE1' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.912 HG22 ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' THR . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.014 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.658 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.602 HG22 ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.014 HG23 ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.589 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.71 HG12 HG22 ' A' ' 103' ' ' VAL . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG2' HG23 ' A' ' 125' ' ' ILE . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.088 ' CD2' HD13 ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 124' ' ' ILE . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.036 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.036 ' N ' HD12 ' A' ' 44' ' ' LEU . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.645 HD13 ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.58 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.614 HD21 ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.611 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' OD1' ' OE1' ' A' ' 66' ' ' GLU . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.906 HG23 ' H ' ' A' ' 68' ' ' ALA . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.906 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.603 ' HA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.844 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 82' ' ' LEU . 56.2 mmtt . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' LEU . 14.1 t70 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.983 0.421 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.088 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.658 ' HE3' ' HB1' ' A' ' 37' ' ' ALA . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.55 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' C ' ' A' ' 90' ' ' MET . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.828 ' CE1' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.541 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' CG ' ' A' ' 59' ' ' LYS . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 111' ' ' PHE . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.723 ' H ' HG22 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.446 HG21 HD13 ' A' ' 101' ' ' LEU . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.991 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' PHE . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.507 ' ND1' HD13 ' A' ' 44' ' ' LEU . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.828 HD11 ' CE1' ' A' ' 94' ' ' PHE . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 58' ' ' LEU . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 103' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.307 0.575 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' CG ' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HD2' ' CG ' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HD2' HD23 ' A' ' 82' ' ' LEU . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.694 HD12 ' CB ' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HE2' HE22 ' A' ' 70' ' ' GLN . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.601 ' HE2' ' H ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.822 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.701 HD23 ' HE1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.598 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.701 ' HE1' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 57' ' ' LYS . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.554 HE22 ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.604 ' CE2' HG12 ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.694 ' CB ' HD12 ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.235 0.54 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 108' ' ' LYS . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.56 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.717 ' N ' HG13 ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.463 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.092 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.855 HG23 ' NE2' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.596 ' C ' HG22 ' A' ' 118' ' ' THR . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.855 ' NE2' HG23 ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.781 HD11 ' HE1' ' A' ' 123' ' ' HIS . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.574 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.504 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG2' ' CG ' ' A' ' 81' ' ' ASP . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.764 ' CD2' ' CD1' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 51' ' ' ILE . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 48' ' ' HIS . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 67' ' ' VAL . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' SD ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.537 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.706 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG23 ' H ' ' A' ' 68' ' ' ALA . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.9 mm-40 -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.544 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD2' HD12 ' A' ' 44' ' ' LEU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.738 ' HG2' ' CD2' ' A' ' 42' ' ' HIS . 3.2 mptt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' HG2' ' A' ' 41' ' ' ARG . 31.0 t0 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.764 ' CD1' ' CD2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.59 ' CZ3' ' HD2' ' A' ' 131' ' ' LYS . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 1.03 HG23 ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 87' ' ' ARG . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.43 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.963 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.687 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.653 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.963 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.67 HG12 ' CG1' ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.748 ' H ' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 112' ' ' THR . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.989 ' HB2' HG23 ' A' ' 124' ' ' ILE . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 114' ' ' PRO . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' C ' ' A' ' 117' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.989 HG23 ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.67 ' CG1' HG12 ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.59 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.413 0.625 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.89 ' CD2' HD22 ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 124' ' ' ILE . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.161 HD12 ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.161 ' N ' HD12 ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.776 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 54' ' ' ALA . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.561 ' HG2' ' HE3' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.543 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.953 HG12 ' CE2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.8 mm-40 -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.953 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.611 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 43.4 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.014 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.472 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.666 ' O ' HG13 ' A' ' 91' ' ' VAL . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.737 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 97' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.571 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.561 ' HE3' ' HG2' ' A' ' 59' ' ' LYS . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.787 ' CB ' HG23 ' A' ' 124' ' ' ILE . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.612 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.706 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 98' ' ' ALA . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.576 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.816 ' O ' HG22 ' A' ' 86' ' ' THR . 16.8 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.37 0.605 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.919 ' HB ' HG13 ' A' ' 127' ' ' VAL . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.7 HG13 HG23 ' A' ' 38' ' ' VAL . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 1.121 ' CE1' HD13 ' A' ' 82' ' ' LEU . 1.8 m80 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.045 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.531 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 54' ' ' ALA . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.562 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.794 ' N ' HG22 ' A' ' 67' ' ' VAL . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.8 t0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.153 0.502 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.121 HD13 ' CE1' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 92' ' ' GLY . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.759 ' CZ ' ' CD2' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.738 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.961 HD22 HG21 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 128' ' ' GLU . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.845 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.845 ' N ' ' HE2' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 112' ' ' THR . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' N ' HG22 ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.017 ' HB2' HG23 ' A' ' 124' ' ' ILE . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.936 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.836 HG21 ' HB2' ' A' ' 98' ' ' ALA . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.62 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.921 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.373 0.606 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 130' ' ' ARG . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.081 ' CG2' HG23 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD22 ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.861 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.861 HG21 ' CD2' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.597 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.651 HG23 ' N ' ' A' ' 68' ' ' ALA . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' NE2' ' A' ' 70' ' ' GLN . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.606 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.727 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 43' ' ' ILE . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.587 ' N ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 110' ' ' VAL . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.73 HG22 ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.481 ' CA ' ' HG2' ' A' ' 126' ' ' MET . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' PRO . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.545 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.464 HG22 HD22 ' A' ' 101' ' ' LEU . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.973 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.601 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 93' ' ' PRO . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.729 ' HE1' HD11 ' A' ' 125' ' ' ILE . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.973 HG23 ' CB ' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.081 HG23 ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 ' HB ' ' A' ' 38' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.512 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.715 0.769 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.779 ' HB ' HG23 ' A' ' 127' ' ' VAL . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.955 ' NE2' HD12 ' A' ' 82' ' ' LEU . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.658 HG23 ' CA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.109 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.109 ' N ' HD12 ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.579 ' HE3' ' CA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.638 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.679 ' HE1' ' HG3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.501 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.032 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.966 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 1.032 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.658 ' CA ' HG23 ' A' ' 43' ' ' ILE . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 44.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.352 0.596 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.955 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.734 ' C ' HG23 ' A' ' 91' ' ' VAL . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' C ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.635 ' HD1' HG21 ' A' ' 118' ' ' THR . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.842 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 97' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.515 ' O ' HG21 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 127' ' ' VAL . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.798 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.798 ' H ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.803 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.803 ' N ' HG13 ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 110' ' ' VAL . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.697 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HG3' ' HE1' ' A' ' 55' ' ' MET . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 125' ' ' ILE . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.635 HG21 ' HD1' ' A' ' 94' ' ' PHE . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 116' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.009 HG22 HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.674 ' HG2' HG12 ' A' ' 38' ' ' VAL . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 1.036 ' O ' HG22 ' A' ' 86' ' ' THR . 14.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.545 0.688 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.987 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.581 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' ILE . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 48' ' ' HIS . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.876 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.576 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.608 ' HD2' ' HE2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.608 ' HE2' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 67' ' ' VAL . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.828 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 68' ' ' ALA . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 71' ' ' TYR . 1.7 mm-40 -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 75' ' ' LYS . 2.8 tmtm? . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 t0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.496 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 1.036 HG22 ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HB2' ' A' ' 94' ' ' PHE . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.859 ' HB2' HG12 ' A' ' 91' ' ' VAL . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.636 HD22 HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.544 ' CA ' ' HG2' ' A' ' 109' ' ' PRO . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.595 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' HD2' ' A' ' 102' ' ' PRO . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.685 ' H ' HG22 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.48 HG21 HD13 ' A' ' 101' ' ' LEU . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.06 ' HB3' HG23 ' A' ' 124' ' ' ILE . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG21 HD11 ' A' ' 125' ' ' ILE . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.566 HG23 ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.803 ' NE2' HG23 ' A' ' 116' ' ' VAL . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 98' ' ' ALA . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.987 HG23 ' HB ' ' A' ' 38' ' ' VAL . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.756 ' HA ' HG13 ' A' ' 103' ' ' VAL . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.632 ' H ' ' HA ' ' A' ' 38' ' ' VAL . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.209 0.528 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.057 ' CG2' HG23 ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.701 ' CD2' HD11 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.042 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 43' ' ' ILE . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.822 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.59 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.842 HD23 ' CE2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' HD3' ' A' ' 108' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.592 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.842 ' CE2' HD23 ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.69 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.603 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 1.1 mp0 -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.572 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 39.0 t0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.011 0.434 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD11 ' CD2' ' A' ' 42' ' ' HIS . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 91' ' ' VAL . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.857 ' HB3' HG12 ' A' ' 91' ' ' VAL . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' HD23 ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.899 HG12 HG11 ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.75 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.6 HG21 HD13 ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.451 ' N ' HG23 ' A' ' 112' ' ' THR . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.662 ' O ' HG13 ' A' ' 116' ' ' VAL . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.648 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 119' ' ' LYS . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' H ' HG23 ' A' ' 118' ' ' THR . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.671 ' HA ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.52 HG23 ' CB ' ' A' ' 114' ' ' PRO . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 1.057 HG23 ' CG2' ' A' ' 40' ' ' VAL . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.899 HG11 HG12 ' A' ' 103' ' ' VAL . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.972 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.628 0.728 . . . . 0.0 109.806 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.827 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 127' ' ' VAL . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 127' ' ' VAL . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.898 ' CD2' HD13 ' A' ' 82' ' ' LEU . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.02 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HA ' ' HB ' ' A' ' 51' ' ' ILE . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.689 ' HB3' ' HE3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.643 HD23 ' HG3' ' A' ' 106' ' ' MET . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.681 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.477 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 68' ' ' ALA . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.743 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.537 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 8.5 tptt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 5.4 t0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.898 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.972 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.547 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.611 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.045 HD12 HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.563 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.643 ' HG3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB2' ' CE ' ' A' ' 106' ' ' MET . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.045 HG21 HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.831 ' N ' HG13 ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.863 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' HE1' HD11 ' A' ' 125' ' ' ILE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.863 HG23 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.685 ' H ' HG11 ' A' ' 103' ' ' VAL . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 86' ' ' THR . 40.0 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.128 0.489 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.82 HG23 HG13 ' A' ' 40' ' ' VAL . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.625 HD21 ' ND1' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 48' ' ' HIS . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.806 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.603 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.806 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.621 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 42.0 t30 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 68' ' ' ALA . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.717 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.8 mm-40 -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.753 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 120.729 0.299 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.554 ' HE1' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 91' ' ' VAL . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.812 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.875 ' HG ' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.63 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.875 HG13 ' HG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 112' ' ' THR . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.043 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.98 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.495 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.56 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.59 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.812 HD11 ' CD1' ' A' ' 94' ' ' PHE . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' HD21 ' A' ' 58' ' ' LEU . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.74 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.296 0.569 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.788 ' CG2' HG13 ' A' ' 127' ' ' VAL . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.859 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.859 ' HG3' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.672 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.561 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 67' ' ' VAL . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.561 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.594 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.864 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.027 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.862 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.516 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.4 mm100 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 1.027 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 42' ' ' HIS . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.43 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.613 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.079 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 112' ' ' THR . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.996 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.599 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.584 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.585 HG21 HD13 ' A' ' 101' ' ' LEU . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.06 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.544 ' H ' ' HE2' ' A' ' 123' ' ' HIS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' HE2' ' H ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.776 HD12 HG21 ' A' ' 116' ' ' VAL . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.645 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.079 HG21 ' HB1' ' A' ' 98' ' ' ALA . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.734 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.952 ' O ' HG22 ' A' ' 86' ' ' THR . 91.0 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.353 0.597 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 125' ' ' ILE . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.595 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.4 p80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' ND1' ' A' ' 123' ' ' HIS . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.439 ' H ' ' HG3' ' A' ' 47' ' ' LYS . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.708 HD13 ' CE1' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.86 ' HE3' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.556 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.572 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.848 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.165 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.637 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.2 mm-40 -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 1.165 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 37.3 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.095 0.474 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD11 ' CD2' ' A' ' 42' ' ' HIS . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG23 ' HD2' ' A' ' 93' ' ' PRO . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HD2' HG23 ' A' ' 91' ' ' VAL . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG21 ' A' ' 40' ' ' VAL . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD22 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 128' ' ' GLU . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.59 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 111' ' ' PHE . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.687 ' H ' HG22 ' A' ' 110' ' ' VAL . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.563 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 112' ' ' THR . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 1.0 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.632 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.99 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.649 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.776 ' ND1' HD22 ' A' ' 44' ' ' LEU . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.0 HG23 ' CB ' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.658 HG23 HG23 ' A' ' 40' ' ' VAL . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.59 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.904 ' HA ' HG23 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.988 ' O ' HG22 ' A' ' 86' ' ' THR . 20.7 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.347 0.594 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.009 ' CG2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.009 HG13 ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' HD3' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.748 HD12 ' OE1' ' A' ' 73' ' ' GLU . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' LYS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.55 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.945 HD12 ' CE ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.958 ' HE2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.087 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 1.087 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.919 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.748 ' OE1' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 13.3 tptt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' GLY . 27.9 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.035 0.445 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.988 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.597 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.74 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 110' ' ' VAL . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.932 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.576 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.566 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' H ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.711 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.932 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' H ' HG22 ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 93' ' ' PRO . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.503 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.858 ' O ' HG22 ' A' ' 116' ' ' VAL . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 HG21 ' A' ' 43' ' ' ILE . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 98' ' ' ALA . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.742 0.782 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.798 ' HB3' ' HG3' ' A' ' 131' ' ' LYS . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.936 ' HB ' HG13 ' A' ' 127' ' ' VAL . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 HG23 ' A' ' 38' ' ' VAL . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.634 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.708 ' NE2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 HD11 ' A' ' 58' ' ' LEU . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.159 HD22 ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.999 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.855 HD11 HD12 ' A' ' 43' ' ' ILE . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.68 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.546 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.653 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.613 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.226 0.536 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.588 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' A' ' 94' ' ' PHE . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.811 ' N ' HG13 ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.845 ' HB3' HG12 ' A' ' 91' ' ' VAL . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.747 HD22 ' HD2' ' A' ' 111' ' ' PHE . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 127' ' ' VAL . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.747 ' HD2' HD22 ' A' ' 101' ' ' LEU . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.861 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 1.159 ' CE1' HD22 ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.724 HG23 ' CB ' ' A' ' 114' ' ' PRO . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.634 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.936 HG13 ' HB ' ' A' ' 38' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.798 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.28 0.562 . . . . 2.4900000000000002 110.605 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 0.72999999999999998 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 0.88 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 1.71 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 82' ' ' LEU . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 1.4399999999999999 113.074 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' CD ' ' HG2' ' A' ' 126' ' ' MET . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 1.8899999999999999 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.664 ' ND1' HD12 ' A' ' 82' ' ' LEU . 11.3 p-80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 3.2000000000000002 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.67 HD13 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 0.84999999999999998 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.078 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 1.77 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 1.078 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 1.6699999999999999 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6000000000000001 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.04 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.6399999999999999 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 1.71 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 0.83999999999999997 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.578 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.1499999999999999 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 0.55000000000000004 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.584 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 0.97999999999999998 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.9299999999999999 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.21 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.96999999999999997 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.1299999999999999 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.0 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 0.89000000000000001 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.546 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.2799999999999998 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 1.8899999999999999 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.0699999999999998 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 1.8799999999999999 110.56 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.3900000000000001 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 63' ' ' ARG . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 0.64000000000000001 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 0.56000000000000005 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.8 mm-40 -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.2799999999999998 113.556 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.1000000000000001 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.5900000000000001 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.9399999999999999 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.5299999999999998 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.04 111.016 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 83' ' ' GLY . 18.4 t0 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.631 -0.137 . . . . 2.1099999999999999 110.631 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.664 HD12 ' ND1' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 1.5600000000000001 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 0.77000000000000002 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 0.95999999999999996 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 1.6599999999999999 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.27 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 2.75 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.24 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.6399999999999999 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.8600000000000001 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 1.8 109.632 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.82999999999999996 109.697 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 0.89000000000000001 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 1.5800000000000001 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.1499999999999999 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.6099999999999999 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 0.81000000000000005 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 0.82999999999999996 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 36' ' ' ASN . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 1.8100000000000001 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.29 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 1.77 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.1399999999999999 110.872 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 127' ' ' VAL . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 1.48 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.4399999999999999 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.05 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.496 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 1.6399999999999999 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.8900000000000001 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.2699999999999996 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 2.6000000000000001 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.3300000000000001 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.72 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 1.9399999999999999 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 0.96999999999999997 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.3100000000000001 109.589 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.995 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 0.67000000000000004 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 0.62 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 0.59999999999999998 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.0800000000000001 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.49 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.0899999999999999 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 2.8599999999999999 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 0.83999999999999997 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 1.6699999999999999 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.7599999999999998 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.995 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 0.45000000000000001 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.521 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 0.78000000000000003 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.501 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.1899999999999999 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 103' ' ' VAL . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.03 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.2999999999999998 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.1599999999999999 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.2400000000000002 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 3.75 110.221 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 p -128.02 66.54 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 152.59 28.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.73 90.37 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.69 1.363 . . . . 0.0 110.643 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -133.54 107.72 8.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.24 35.44 0.83 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.06 -70.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 68.1 76.65 0.41 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.986 ' O ' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -125.55 -5.76 7.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -1.174 . . . . 0.0 110.319 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 131' ' ' LYS . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.896 ' HB ' HG13 ' A' ' 127' ' ' VAL . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' CB ' ' HG3' ' A' ' 77' ' ' ARG . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.705 ' NE2' HD22 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.841 HD12 ' CB ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.033 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 115' ' ' PRO . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.56 ' CE ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.538 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.715 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.684 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.532 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.9 tptp -57.09 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' ' HA3' ' A' ' 80' ' ' GLY . . . 167.64 152.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.178 -0.951 . . . . 0.0 110.518 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 1.121 ' NH2' HG22 ' A' ' 124' ' ' ILE . 5.4 ttt-85 -94.04 -65.76 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.636 ' NE2' ' HB2' ' A' ' 68' ' ' ALA . 2.2 mp0 -60.18 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.744 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.13 -27.32 45.6 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.842 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . -84.4 -1.95 89.2 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 58.0 t0 -41.22 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 110.177 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.705 HD22 ' NE2' ' A' ' 42' ' ' HIS . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.59 ' C ' HG12 ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.807 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.615 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 110' ' ' VAL . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 1.018 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 104' ' ' SER . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 110' ' ' VAL . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.528 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' H ' ' HE3' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.018 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.665 ' H ' HG22 ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 110' ' ' VAL . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.935 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.617 HG22 ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.586 ' N ' HG23 ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.121 HG22 ' NH2' ' A' ' 77' ' ' ARG . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.878 HG21 ' HB2' ' A' ' 98' ' ' ALA . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.738 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' SER . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -43.71 118.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.145 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.64 177.55 16.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.56 96.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.828 1.436 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 78.21 1.3 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.27 -139.01 20.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -124.27 -117.92 2.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' HA2' ' OXT' ' A' ' 131' ' ' LYS . . . -144.56 96.79 0.19 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.991 ' O ' HG22 ' A' ' 86' ' ' THR . 1.8 t-20 -116.06 -20.81 9.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -1.101 . . . . 0.0 110.256 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 40' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG13 HG23 ' A' ' 38' ' ' VAL . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CD2' HD13 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.835 HD12 ' HD2' ' A' ' 77' ' ' ARG . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.816 ' N ' HD12 ' A' ' 44' ' ' LEU . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 71' ' ' TYR . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.5 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.533 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.81 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.795 HG23 ' H ' ' A' ' 68' ' ' ALA . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.795 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 72' ' ' SER . 2.2 mm-40 -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' CB ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 4.0 ttpt -130.38 1.84 4.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 68.14 148.48 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 111.311 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.835 ' HD2' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -100.67 -61.45 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.858 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.82 -17.98 44.72 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -94.71 -3.06 62.72 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.6 t70 -38.35 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.957 . . . . 0.0 110.309 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 42' ' ' HIS . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.991 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.892 HD13 ' CG2' ' A' ' 110' ' ' VAL . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.904 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.647 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.609 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.642 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.647 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.892 ' CG2' HD13 ' A' ' 101' ' ' LEU . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.63 ' H ' HG22 ' A' ' 110' ' ' VAL . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.758 ' HB ' HD11 ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.051 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.051 HG23 ' CB ' ' A' ' 114' ' ' PRO . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.904 ' C ' HG22 ' A' ' 103' ' ' VAL . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 t -173.25 145.7 1.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.83 -170.75 22.97 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 100.74 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.827 1.435 . . . . 0.0 110.512 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.91 157.57 18.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.222 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.78 138.07 3.46 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -129.23 49.73 0.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 36' ' ' ASN . . . 47.03 -117.43 3.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.967 ' O ' HG22 ' A' ' 86' ' ' THR . 6.3 t-20 63.38 15.23 8.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -1.147 . . . . 0.0 110.217 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 127' ' ' VAL . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.74 HG13 HD23 ' A' ' 82' ' ' LEU . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.877 ' HB3' HD21 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.993 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.993 ' N ' HD12 ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' HIS . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.606 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.622 ' HD2' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 54' ' ' ALA . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.686 HG23 ' N ' ' A' ' 68' ' ' ALA . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -68.31 -5.85 20.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 73.47 149.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 111.379 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.632 ' NH1' ' HE2' ' A' ' 126' ' ' MET . 2.0 ptp180 -108.63 -168.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.259 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.462 ' OE1' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 45.14 -91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.223 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -57.51 -25.05 54.46 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -91.85 -53.29 2.11 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 31.76 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.02 -0.694 . . . . 0.0 111.083 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.877 HD21 ' HB3' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.967 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 85' ' ' MET . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.555 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.534 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.736 ' HD2' HD23 ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.486 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.586 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.802 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.802 ' N ' HG13 ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.101 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.725 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.101 HG23 ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.632 ' HE2' ' NH1' ' A' ' 77' ' ' ARG . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.712 HG13 ' HB ' ' A' ' 38' ' ' VAL . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 m 48.83 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.252 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.86 151.87 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.65 -60.13 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.764 1.402 . . . . 0.0 110.588 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.74 19.65 7.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 161.42 32.77 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.97 -136.45 13.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.17 -161.43 32.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.81 -71.59 0.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -1.184 . . . . 0.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' ND1' HD23 ' A' ' 82' ' ' LEU . 7.3 m80 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' LYS . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.724 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.724 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.595 ' HE2' ' HG3' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.626 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' ' HE1' ' A' ' 126' ' ' MET . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.68 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 68' ' ' ALA . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 72' ' ' SER . 0.2 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.82 ' HB3' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -56.54 122.05 11.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -96.18 -92.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.001 -1.062 . . . . 0.0 111.325 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 49.44 90.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.951 -1.093 . . . . 0.0 108.841 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 64' ' ' PHE . 1.7 tm0? 60.02 -75.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 109.469 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -166.0 47.97 0.27 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.667 ' O ' HD22 ' A' ' 82' ' ' LEU . . . 80.07 41.91 11.56 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -75.06 78.35 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -1.132 . . . . 0.0 110.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD22 ' O ' ' A' ' 80' ' ' GLY . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.431 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.935 HG12 ' HD2' ' A' ' 93' ' ' PRO . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.935 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.539 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.699 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 97' ' ' ALA . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.71 HG22 HG12 ' A' ' 127' ' ' VAL . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.752 ' HE1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.752 ' N ' ' HE1' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.912 HG22 ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' THR . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.014 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.658 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.602 HG22 ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.014 HG23 ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.637 ' HE1' ' CE1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.71 HG12 HG22 ' A' ' 103' ' ' VAL . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -83.75 92.67 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 173.44 53.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.22 -31.19 92.72 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.689 1.363 . . . . 0.0 110.506 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -138.82 142.16 38.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.128 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.98 64.01 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.94 -134.38 5.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . 87.45 -135.09 12.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 60.34 13.13 3.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG2' HG23 ' A' ' 125' ' ' ILE . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.088 ' CD2' HD13 ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.548 HD11 ' CD ' ' A' ' 78' ' ' GLN . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.036 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.036 ' N ' HD12 ' A' ' 44' ' ' LEU . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.645 HD13 ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.58 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.614 HD21 ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.611 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.906 HG23 ' H ' ' A' ' 68' ' ' ALA . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 77' ' ' ARG . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.603 ' HA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.844 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.763 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 56.2 mmtt -53.57 -18.84 3.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 78.44 -153.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.102 0.953 . . . . 0.0 112.34 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.908 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 36.8 ptt180 -55.96 154.48 7.38 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.902 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.653 ' CB ' ' CE1' ' A' ' 64' ' ' PHE . 2.2 mm100 -52.89 -23.37 6.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -44.6 -30.26 2.13 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 106.269 -2.733 . . . . 0.0 106.269 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -56.75 -50.01 66.45 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' GLN . 14.1 t70 26.29 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.319 -0.518 . . . . 0.0 111.709 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.088 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.658 ' HE3' ' HB1' ' A' ' 37' ' ' ALA . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.55 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' C ' ' A' ' 90' ' ' MET . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.828 ' CE1' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.541 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' CG ' ' A' ' 59' ' ' LYS . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 111' ' ' PHE . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.723 ' H ' HG22 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.446 HG21 HD13 ' A' ' 101' ' ' LEU . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.991 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' PHE . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.507 ' ND1' HD13 ' A' ' 44' ' ' LEU . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.828 HD11 ' CE1' ' A' ' 94' ' ' PHE . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 58' ' ' LEU . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 103' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -105.81 117.33 33.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -1.09 . . . . 0.0 110.17 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.21 -85.58 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.22 147.67 94.98 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.666 1.35 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -177.14 161.94 1.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.053 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.39 143.37 17.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.75 -151.02 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . -132.16 -43.38 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 55.2 17.61 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 110.191 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' CG ' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.609 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HD2' HD23 ' A' ' 82' ' ' LEU . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.694 HD12 ' CB ' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' HE2' HE22 ' A' ' 70' ' ' GLN . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.601 ' HE2' ' H ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.822 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.701 HD23 ' HE1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.598 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.701 ' HE1' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 57' ' ' LYS . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.909 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.554 HE22 ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.604 ' CE2' HG12 ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.694 ' CB ' HD12 ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm -54.92 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.885 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . . . -171.0 -135.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.766 -1.209 . . . . 0.0 110.925 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 68.46 105.64 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 -179.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 1.3 tm0? 64.7 -34.57 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.629 -0.669 . . . . 0.0 111.959 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.909 ' HA2' ' HB2' ' A' ' 68' ' ' ALA . . . 159.2 -51.31 0.39 Allowed Glycine 0 N--CA 1.481 1.676 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . -167.23 20.58 0.1 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' OD1' ' HB3' ' A' ' 77' ' ' ARG . 13.1 p30 -60.16 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.957 -1.319 . . . . 0.0 109.728 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 108' ' ' LYS . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.717 ' N ' HG13 ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.463 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.092 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.855 HG23 ' NE2' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.596 ' C ' HG22 ' A' ' 118' ' ' THR . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.855 ' NE2' HG23 ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.781 HD11 ' HE1' ' A' ' 123' ' ' HIS . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.504 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -90.96 -7.12 52.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.167 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -163.25 21.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.14 -154.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.616 1.324 . . . . 0.0 110.422 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 tttm 49.75 178.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.46 84.67 0.27 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.53 -140.45 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 131' ' ' LYS . . . 97.4 -160.32 21.25 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER 52.89 25.33 3.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -1.205 . . . . 0.0 110.304 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CG ' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 51' ' ' ILE . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 48' ' ' HIS . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 67' ' ' VAL . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' SD ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.537 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.706 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG23 ' H ' ' A' ' 68' ' ' ALA . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.9 mm-40 -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD2' HD12 ' A' ' 44' ' ' LEU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 3.2 mptt -45.66 -93.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.016 ' HB3' ' HA3' ' A' ' 80' ' ' GLY . . . 168.24 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' NH1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER 143.6 -80.47 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.712 ' OE1' ' HE1' ' A' ' 126' ' ' MET . 3.8 mp0 -61.81 -91.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.544 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.22 -19.09 30.71 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 1.016 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . -93.06 3.4 73.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 80' ' ' GLY . 31.0 t0 -29.21 112.65 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.025 -0.691 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.59 ' CZ3' ' HD2' ' A' ' 131' ' ' LYS . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.03 HG23 ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 87' ' ' ARG . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.43 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.963 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.687 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.653 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.963 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.67 HG12 ' CG1' ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.748 ' H ' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 112' ' ' THR . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.989 ' HB2' HG23 ' A' ' 124' ' ' ILE . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 114' ' ' PRO . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' C ' ' A' ' 117' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.989 HG23 ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.712 ' HE1' ' OE1' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.67 ' CG1' HG12 ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.59 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.81 74.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -1.155 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.31 153.87 16.99 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.52 -157.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.702 1.37 . . . . 0.0 110.562 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.81 130.95 25.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.25 59.6 10.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.07 42.85 1.18 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' OXT' ' A' ' 131' ' ' LYS . . . 78.7 -163.39 49.76 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER 63.04 17.42 10.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.143 -1.21 . . . . 0.0 110.031 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.89 ' CD2' HD22 ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.047 HD12 ' HD3' ' A' ' 77' ' ' ARG . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.161 HD12 ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.161 ' N ' HD12 ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 54' ' ' ALA . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.561 ' HG2' ' HE3' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.543 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.953 HG12 ' CE2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.8 mm-40 -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.953 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.611 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER 68.58 76.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . -44.15 176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.681 0.753 . . . . 0.0 112.33 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 1.047 ' HD3' HD12 ' A' ' 43' ' ' ILE . 13.8 ttp180 -87.4 -75.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.761 -0.587 . . . . 0.0 110.295 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.512 ' HG3' ' HB3' ' A' ' 64' ' ' PHE . 22.5 mm-40 -81.73 -49.78 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.11 57.79 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -121.22 -10.19 6.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 43.4 p-10 -40.68 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -1.113 . . . . 0.0 110.625 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.472 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.666 ' O ' HG13 ' A' ' 91' ' ' VAL . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.737 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 97' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.571 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.561 ' HE3' ' HG2' ' A' ' 59' ' ' LYS . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.787 ' CB ' HG23 ' A' ' 124' ' ' ILE . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.612 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.706 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 98' ' ' ALA . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.616 ' HE1' ' CZ ' ' A' ' 77' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 p -83.72 -48.99 9.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.149 . . . . 0.0 110.227 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.16 -76.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.45 92.25 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.728 1.383 . . . . 0.0 110.638 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -118.17 -13.88 9.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.8 -86.33 0.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.14 -24.3 0.46 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.03 65.19 0.1 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.816 ' O ' HG22 ' A' ' 86' ' ' THR . 16.8 t-20 -82.22 -72.99 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.919 ' HB ' HG13 ' A' ' 127' ' ' VAL . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.7 HG13 HG23 ' A' ' 38' ' ' VAL . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 1.121 ' CE1' HD13 ' A' ' 82' ' ' LEU . 1.8 m80 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.045 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.531 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 54' ' ' ALA . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.562 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.794 ' N ' HG22 ' A' ' 67' ' ' VAL . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -69.75 -16.22 63.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 75.8 -154.55 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.96 0.886 . . . . 0.0 111.92 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -44.14 157.35 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.846 -0.534 . . . . 0.0 109.889 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' N ' ' CB ' ' A' ' 68' ' ' ALA . 36.5 mm-40 -52.46 -23.99 7.11 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -49.54 -27.06 8.05 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -65.05 -11.44 51.45 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' C ' ' O ' ' A' ' 80' ' ' GLY . 26.8 t0 -32.56 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.839 -0.801 . . . . 0.0 111.025 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.121 HD13 ' CE1' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 92' ' ' GLY . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.759 ' CZ ' ' CD2' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.738 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.961 HD22 HG21 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 128' ' ' GLU . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.845 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.845 ' N ' ' HE2' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 112' ' ' THR . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' N ' HG22 ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.017 ' HB2' HG23 ' A' ' 124' ' ' ILE . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.936 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.836 HG21 ' HB2' ' A' ' 98' ' ' ALA . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.62 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.921 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.89 -162.02 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.165 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.57 -168.64 12.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.21 98.27 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.737 1.388 . . . . 0.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 1.2 tttt -102.73 -5.73 23.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.322 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.68 -44.7 0.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.8 -80.32 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.73 -144.51 16.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.32 -48.57 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 130' ' ' ARG . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.081 ' CG2' HG23 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD22 ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.861 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.861 HG21 ' CD2' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.542 ' CE ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.597 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.651 HG23 ' N ' ' A' ' 68' ' ' ALA . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' NE2' ' A' ' 70' ' ' GLN . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.606 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.727 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 43' ' ' ILE . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.587 ' N ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -56.32 151.02 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . . . -144.23 -109.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER 66.97 3.98 3.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.923 -1.111 . . . . 0.0 111.689 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.601 ' N ' ' CB ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 169.8 -40.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.021 -1.05 . . . . 0.0 109.673 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.848 ' HA2' ' HB2' ' A' ' 68' ' ' ALA . . . 166.54 38.01 0.02 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 91.1 19.59 42.12 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 -55.89 81.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -1.101 . . . . 0.0 110.666 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 110' ' ' VAL . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.73 HG22 ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.481 ' CA ' ' HG2' ' A' ' 126' ' ' MET . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' PRO . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.545 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.464 HG22 HD22 ' A' ' 101' ' ' LEU . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 113' ' ' ASP . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.973 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.601 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 93' ' ' PRO . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.729 ' HE1' HD11 ' A' ' 125' ' ' ILE . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.973 HG23 ' CB ' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.081 HG23 ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 ' HB ' ' A' ' 38' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.512 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -119.13 41.96 2.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -1.127 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.75 -77.68 1.38 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.28 -29.43 86.21 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.65 1.342 . . . . 0.0 110.607 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER 65.4 164.92 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.075 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.32 40.41 0.23 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.83 125.05 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.53 -178.45 32.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 54.39 95.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.366 -1.079 . . . . 0.0 110.135 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.779 ' HB ' HG23 ' A' ' 127' ' ' VAL . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.955 ' NE2' HD12 ' A' ' 82' ' ' LEU . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.658 HG23 ' CA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.109 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.109 ' N ' HD12 ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.579 ' HE3' ' CA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.638 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.679 ' HE1' ' HG3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.501 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.032 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.966 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.032 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.658 ' CA ' HG23 ' A' ' 43' ' ' ILE . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER 66.81 143.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -124.42 -106.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.018 . . . . 0.0 110.647 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 47.98 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.889 -1.132 . . . . 0.0 109.858 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' NE2' ' CA ' ' A' ' 79' ' ' GLY . 2.3 tm0? 60.84 -69.75 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.486 0.66 . . . . 0.0 109.419 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.729 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . -176.72 51.08 0.11 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 78.5 34.64 35.15 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 44.0 p-10 -58.73 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -1.081 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.955 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.734 ' C ' HG23 ' A' ' 91' ' ' VAL . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' C ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.635 ' HD1' HG21 ' A' ' 118' ' ' THR . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.842 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 97' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.515 ' O ' HG21 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 127' ' ' VAL . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.798 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.798 ' H ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.803 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.803 ' N ' HG13 ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 110' ' ' VAL . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.697 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HG3' ' HE1' ' A' ' 55' ' ' MET . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 125' ' ' ILE . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.635 HG21 ' HD1' ' A' ' 94' ' ' PHE . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 116' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.009 HG22 HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.674 ' HG2' HG12 ' A' ' 38' ' ' VAL . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -107.05 167.62 9.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -1.149 . . . . 0.0 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.58 -178.94 51.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.719 1.378 . . . . 0.0 110.496 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.79 82.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.6 89.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.38 -163.29 35.59 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.18 177.75 46.34 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 1.036 ' O ' HG22 ' A' ' 86' ' ' THR . 14.9 m-20 55.42 94.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.991 . . . . 0.0 110.372 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.987 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.581 ' O ' ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' ILE . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 48' ' ' HIS . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.876 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.576 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.608 ' HD2' ' HE2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.608 ' HE2' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 67' ' ' VAL . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.828 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 68' ' ' ALA . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 71' ' ' TYR . 1.7 mm-40 -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.8 tmtm? -112.72 20.12 16.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . 53.77 170.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.626 -1.296 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.866 ' NH2' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -123.53 -27.46 4.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.427 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.624 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mt-30 -92.89 -79.37 0.4 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.29 -19.2 45.71 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -90.02 -40.08 5.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 80' ' ' GLY . 4.8 t0 27.53 94.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.335 -0.509 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.496 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 1.036 HG22 ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HB2' ' A' ' 94' ' ' PHE . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.859 ' HB2' HG12 ' A' ' 91' ' ' VAL . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.636 HD22 HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.544 ' CA ' ' HG2' ' A' ' 109' ' ' PRO . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.595 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' HD2' ' A' ' 102' ' ' PRO . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.685 ' H ' HG22 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.48 HG21 HD13 ' A' ' 101' ' ' LEU . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.06 ' HB3' HG23 ' A' ' 124' ' ' ILE . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG21 HD11 ' A' ' 125' ' ' ILE . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.566 HG23 ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.803 ' NE2' HG23 ' A' ' 116' ' ' VAL . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 98' ' ' ALA . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.987 HG23 ' HB ' ' A' ' 38' ' ' VAL . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.756 ' HA ' HG13 ' A' ' 103' ' ' VAL . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.632 ' H ' ' HA ' ' A' ' 38' ' ' VAL . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 30' ' ' GLY . 1.1 p 51.28 -150.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.487 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -116.04 -79.99 0.81 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.2 Cg_exo -61.09 -150.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.76 1.4 . . . . 0.0 110.533 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 2.1 tptt 68.61 162.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 110.152 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.5 -89.98 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.67 -41.23 0.75 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 131' ' ' LYS . . . 75.24 161.63 9.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 -109.89 -43.9 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -1.193 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.057 ' CG2' HG23 ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.662 ' HE1' ' CB ' ' A' ' 75' ' ' LYS . 3.9 p-80 -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.042 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 43' ' ' ILE . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.822 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.59 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.842 HD23 ' CE2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' HD3' ' A' ' 108' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.592 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.842 ' CE2' HD23 ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.69 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.83 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.603 ' NE2' ' HB1' ' A' ' 69' ' ' ALA . 1.1 mp0 -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.662 ' CB ' ' HE1' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -42.61 118.0 1.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.83 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -105.4 -13.8 15.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.081 -1.012 . . . . 0.0 110.387 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' GLY . 2.5 ttp180 -40.92 105.57 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 109.833 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.59 -60.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.45 0.643 . . . . 0.0 109.748 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . -171.94 33.71 0.14 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.878 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 82.67 33.91 23.56 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 39.0 t0 -52.55 81.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.934 . . . . 0.0 111.416 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 80' ' ' GLY . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 91' ' ' VAL . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.857 ' HB3' HG12 ' A' ' 91' ' ' VAL . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' HD23 ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.899 HG12 HG11 ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.75 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.6 HG21 HD13 ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.451 ' N ' HG23 ' A' ' 112' ' ' THR . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.662 ' O ' HG13 ' A' ' 116' ' ' VAL . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.648 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 119' ' ' LYS . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' H ' HG23 ' A' ' 118' ' ' THR . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.671 ' HA ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.52 HG23 ' CB ' ' A' ' 114' ' ' PRO . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 1.057 HG23 ' CG2' ' A' ' 40' ' ' VAL . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.899 HG11 HG12 ' A' ' 103' ' ' VAL . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -54.02 141.34 28.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.279 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.54 -158.97 24.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.17 -172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.706 1.371 . . . . 0.0 110.617 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -71.59 117.42 13.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.203 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.64 -50.1 2.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.86 -40.93 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' CA ' ' HE3' ' A' ' 131' ' ' LYS . . . -103.4 174.23 22.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.972 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER 61.96 37.11 15.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.806 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.827 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 127' ' ' VAL . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 127' ' ' VAL . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.898 ' CD2' HD13 ' A' ' 82' ' ' LEU . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.02 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HA ' ' HB ' ' A' ' 51' ' ' ILE . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.689 ' HB3' ' HE3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.869 HD21 ' NH2' ' A' ' 77' ' ' ARG . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.681 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' CG ' ' NE2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 79' ' ' GLY . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 68' ' ' ALA . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.743 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.765 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 8.5 tptt 55.79 -101.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 75' ' ' LYS . . . 166.21 149.97 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.115 -0.991 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.869 ' NH2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -81.97 -66.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.689 179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.625 ' NE2' ' CG ' ' A' ' 64' ' ' PHE . 1.4 mt-30 -71.14 -67.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.83 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 65' ' ' ASN . . . -61.43 -29.65 72.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 76' ' ' ALA . . . -97.45 5.38 62.57 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.4 t0 -39.59 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -1.049 . . . . 0.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.898 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.972 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.547 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.611 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.045 HD12 HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.563 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.643 ' HG3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB2' ' CE ' ' A' ' 106' ' ' MET . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.045 HG21 HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.831 ' N ' HG13 ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.863 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' HE1' HD11 ' A' ' 125' ' ' ILE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.863 HG23 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.685 ' H ' HG11 ' A' ' 103' ' ' VAL . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -119.92 138.96 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -1.164 . . . . 0.0 110.096 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.73 -173.0 23.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.37 139.03 80.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.809 1.426 . . . . 0.0 110.673 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.43 -8.25 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.7 45.44 1.65 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 50.22 -169.74 0.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 131' ' ' LYS . . . 107.98 -111.62 3.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 86' ' ' THR . 40.0 m-20 60.46 12.95 3.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 110.517 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.82 HG23 HG13 ' A' ' 40' ' ' VAL . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.625 HD21 ' ND1' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 48' ' ' HIS . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.806 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.603 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.806 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.621 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 42.0 t30 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 68' ' ' ALA . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.717 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.8 mm-40 -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.753 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -40.88 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.681 ' HB1' ' HB1' ' A' ' 68' ' ' ALA . . . -52.65 175.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 111.369 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.69 ' HD2' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -95.7 -59.37 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.69 ' NE2' ' HD2' ' A' ' 77' ' ' ARG . 20.5 mm-40 -58.47 -92.03 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.765 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.59 -13.75 59.19 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.556 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -88.54 -30.58 15.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' ARG . 8.9 t0 22.32 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.42 -0.459 . . . . 0.0 111.524 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.554 ' HE1' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 91' ' ' VAL . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.812 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.875 ' HG ' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.63 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.875 HG13 ' HG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 112' ' ' THR . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.043 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.98 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.495 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.56 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.59 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.812 HD11 ' CD1' ' A' ' 94' ' ' PHE . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.664 ' HE1' HD21 ' A' ' 58' ' ' LEU . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.74 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.493 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -174.9 5.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.78 166.69 22.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.75 131.06 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.679 1.357 . . . . 0.0 110.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -74.08 -176.63 2.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 110.177 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.88 -170.45 14.4 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.58 11.17 71.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.63 96.55 2.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 -113.92 -25.19 8.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -1.151 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.788 ' CG2' HG13 ' A' ' 127' ' ' VAL . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 79' ' ' GLY . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.859 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.859 ' HG3' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.672 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.561 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 67' ' ' VAL . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.561 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.594 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.864 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.027 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.862 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.516 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.4 mm100 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.027 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -61.38 156.82 18.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 69' ' ' ALA . . . -152.36 -113.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.999 -1.063 . . . . 0.0 110.602 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' GLY . 6.5 tpp180 52.39 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.801 -1.187 . . . . 0.0 108.909 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.22 -70.14 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.674 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . -172.91 61.63 0.14 Allowed Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 58.91 41.9 96.47 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 -60.66 72.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -1.083 . . . . 0.0 110.977 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 80' ' ' GLY . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.43 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.613 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.079 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 112' ' ' THR . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.996 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.599 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.584 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.585 HG21 HD13 ' A' ' 101' ' ' LEU . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.06 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.544 ' H ' ' HE2' ' A' ' 123' ' ' HIS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' HE2' ' H ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.776 HD12 HG21 ' A' ' 116' ' ' VAL . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.645 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.079 HG21 ' HB1' ' A' ' 98' ' ' ALA . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.734 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 t -122.23 -30.36 4.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 0.0 110.308 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.07 70.38 0.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -42.44 30.12 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.681 1.358 . . . . 0.0 110.37 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.31 82.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.48 34.93 3.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.72 93.84 0.36 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 179.45 53.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.952 ' O ' HG22 ' A' ' 86' ' ' THR . 91.0 m-20 -140.08 -47.5 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -1.154 . . . . 0.0 110.028 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 125' ' ' ILE . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.621 ' HD2' HD21 ' A' ' 44' ' ' LEU . 5.0 p-80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' ND1' ' A' ' 123' ' ' HIS . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' H ' ' HG3' ' A' ' 47' ' ' LYS . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.708 HD13 ' CE1' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.86 ' HE3' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.556 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.572 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.848 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.165 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.637 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 1.2 mm-40 -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.165 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 37.3 tptt -55.04 157.1 3.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -161.29 -119.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.8 . . . . 0.0 109.796 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 1.7 ttt180 70.27 3.35 4.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.902 -1.124 . . . . 0.0 110.879 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.551 ' NE2' ' HD2' ' A' ' 41' ' ' ARG . 2.6 tm0? 159.59 -53.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 174.96 35.32 0.04 OUTLIER Glycine 0 C--N 1.298 -1.549 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.821 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 76.17 40.72 28.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 8.9 t0 -60.11 76.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -1.115 . . . . 0.0 110.577 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 80' ' ' GLY . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG23 ' HD2' ' A' ' 93' ' ' PRO . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HD2' HG23 ' A' ' 91' ' ' VAL . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG21 ' A' ' 40' ' ' VAL . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD22 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 128' ' ' GLU . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.59 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 111' ' ' PHE . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.687 ' H ' HG22 ' A' ' 110' ' ' VAL . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.563 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 112' ' ' THR . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 1.0 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.632 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.99 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.649 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.776 ' ND1' HD22 ' A' ' 44' ' ' LEU . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.0 HG23 ' CB ' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.658 HG23 HG23 ' A' ' 40' ' ' VAL . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.59 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.904 ' HA ' HG23 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -75.3 -71.45 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -1.172 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.98 75.24 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -63.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.74 1.389 . . . . 0.0 110.427 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 44.5 -150.28 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.324 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.07 -171.02 5.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.34 -2.85 29.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . -108.78 166.71 12.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.988 ' O ' HG22 ' A' ' 86' ' ' THR . 20.7 t30 178.51 -45.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -1.123 . . . . 0.0 110.008 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.009 ' CG2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.009 HG13 ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' NE ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.748 HD12 ' OE1' ' A' ' 73' ' ' GLU . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' LYS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.55 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.945 HD12 ' CE ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.958 ' HE2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.543 ' CD1' ' HG3' ' A' ' 78' ' ' GLN . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.087 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 1.087 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.919 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.748 ' OE1' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 13.3 tptt -130.54 -98.33 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' ' N ' ' A' ' 80' ' ' GLY . . . 177.11 127.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.07 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.974 ' NE ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.86 -33.01 65.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.373 -1.455 . . . . 0.0 109.51 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' HG3' ' CD1' ' A' ' 64' ' ' PHE . 14.5 mm100 -100.84 -54.57 2.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.901 -1.124 . . . . 0.0 108.77 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.99 -24.02 75.91 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.783 ' N ' ' HB3' ' A' ' 76' ' ' ALA . . . -103.64 5.66 47.97 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' GLY . 27.9 t0 -37.99 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.682 -0.893 . . . . 0.0 110.024 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.988 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.597 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.74 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 110' ' ' VAL . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.932 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.576 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.566 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' H ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.932 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' H ' HG22 ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 93' ' ' PRO . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.503 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.858 ' O ' HG22 ' A' ' 116' ' ' VAL . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 HG21 ' A' ' 43' ' ' ILE . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 98' ' ' ALA . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 m 47.95 74.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -1.153 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 76.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 2.9 Cg_endo -62.14 -163.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.634 1.334 . . . . 0.0 110.543 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 63.97 117.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.27 -125.41 1.49 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 27.14 8.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.35 32.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 55.32 95.86 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.798 ' HB3' ' HG3' ' A' ' 131' ' ' LYS . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.936 ' HB ' HG13 ' A' ' 127' ' ' VAL . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 HG23 ' A' ' 38' ' ' VAL . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 77' ' ' ARG . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.708 ' NE2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 HD11 ' A' ' 58' ' ' LEU . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.159 HD22 ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.999 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.855 HD11 HD12 ' A' ' 43' ' ' ILE . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.68 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.546 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.653 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.613 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt -126.51 -132.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB3' ' N ' ' A' ' 80' ' ' GLY . . . -167.13 140.15 3.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.981 -1.074 . . . . 0.0 110.296 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.778 HH11 HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -65.63 -31.26 72.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.25 -0.906 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 77' ' ' ARG . 4.7 mp0 -117.1 -64.99 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 108.749 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.45 -16.85 37.69 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.905 ' N ' ' HB3' ' A' ' 76' ' ' ALA . . . -121.01 2.4 11.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 -41.2 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.588 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' A' ' 94' ' ' PHE . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.811 ' N ' HG13 ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.845 ' HB3' HG12 ' A' ' 91' ' ' VAL . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.747 HD22 ' HD2' ' A' ' 111' ' ' PHE . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 127' ' ' VAL . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.747 ' HD2' HD22 ' A' ' 101' ' ' LEU . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.861 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 1.159 ' CE1' HD22 ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.724 HG23 ' CB ' ' A' ' 114' ' ' PRO . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.936 HG13 ' HB ' ' A' ' 38' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.798 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.467 -1.453 . . . . 15.25 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.522 ' N ' ' HD3' ' A' ' 32' ' ' LYS . 84.8 p -74.29 66.0 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -1.128 . . . . 14.16 110.163 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 79.57 -157.34 42.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.384 -1.486 . . . . 12.77 109.384 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.25 112.95 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.707 1.372 . . . . 12.08 110.227 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -170.67 -43.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.219 -0.926 . . . . 12.15 110.375 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' N ' ' HE3' ' A' ' 32' ' ' LYS . . . 72.36 95.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.901 -1.279 . . . . 8.0299999999999994 109.901 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' NZ ' ' A' ' 32' ' ' LYS . . . 58.25 152.84 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.874 -1.291 . . . . 6.2699999999999996 109.874 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 36' ' ' ASN . . . -53.05 137.61 36.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.46 -1.456 . . . . 4.1900000000000004 109.46 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 -143.71 -41.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 2.4900000000000002 110.605 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 0.72999999999999998 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 0.88 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 1.71 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 82' ' ' LEU . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 1.4399999999999999 113.074 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.697 ' HG2' HE22 ' A' ' 78' ' ' GLN . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 1.8899999999999999 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.664 ' ND1' HD12 ' A' ' 82' ' ' LEU . 11.3 p-80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 3.2000000000000002 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.761 ' HB ' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 0.84999999999999998 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.078 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 1.77 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 1.078 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 1.6699999999999999 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6000000000000001 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.04 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.6399999999999999 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 1.71 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 0.83999999999999997 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.578 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.1499999999999999 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 0.55000000000000004 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.584 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 0.97999999999999998 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.9299999999999999 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.21 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.96999999999999997 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.1299999999999999 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.0 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 0.89000000000000001 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.546 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.2799999999999998 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 1.8899999999999999 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.0699999999999998 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 1.8799999999999999 110.56 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.3900000000000001 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 63' ' ' ARG . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 0.57999999999999996 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 77' ' ' ARG . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 0.64000000000000001 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 0.56000000000000005 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.8 mm-40 -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.2799999999999998 113.556 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.1000000000000001 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.5900000000000001 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.9399999999999999 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.5299999999999998 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt 39.48 36.22 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.04 111.016 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' ALA . . . 40.73 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 2.0699999999999998 110.244 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.23 -94.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.821 -1.175 . . . . 8.1300000000000008 111.742 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.711 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -51.98 -55.39 20.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.837 -1.789 . . . . 2.8300000000000001 108.606 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.35 -24.5 16.64 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 106.68 -2.568 . . . . 3.6899999999999999 106.68 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -86.53 -49.35 4.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.043 -1.223 . . . . 1.8400000000000001 110.043 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 77' ' ' ARG . 18.4 t0 33.84 82.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.829 -0.806 . . . . 2.1099999999999999 110.631 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.664 HD12 ' ND1' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 1.5600000000000001 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 0.77000000000000002 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 0.95999999999999996 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 1.6599999999999999 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.27 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 2.75 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.24 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.6399999999999999 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.8600000000000001 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 1.8 109.632 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.82999999999999996 109.697 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 0.89000000000000001 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 1.5800000000000001 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.1499999999999999 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.6099999999999999 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 0.81000000000000005 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 0.82999999999999996 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 36' ' ' ASN . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 1.8100000000000001 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.29 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 1.77 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.1399999999999999 110.872 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 127' ' ' VAL . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 1.48 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.4399999999999999 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.05 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.496 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 1.6399999999999999 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.8900000000000001 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.2699999999999996 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 2.6000000000000001 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.3300000000000001 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.72 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 1.9399999999999999 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 0.96999999999999997 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.3100000000000001 109.589 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.995 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 0.67000000000000004 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 0.62 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 0.59999999999999998 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.0800000000000001 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.49 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.0899999999999999 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 2.8599999999999999 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 0.83999999999999997 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 1.6699999999999999 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.7599999999999998 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.995 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 0.45000000000000001 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.521 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 0.78000000000000003 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.501 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.1899999999999999 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 103' ' ' VAL . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.03 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.2999999999999998 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.1599999999999999 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.2400000000000002 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 3.75 110.221 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.986 ' O ' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 131' ' ' LYS . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.896 ' HB ' HG13 ' A' ' 127' ' ' VAL . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.705 ' NE2' HD22 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.693 HG21 HD12 ' A' ' 124' ' ' ILE . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.033 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 115' ' ' PRO . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.56 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.538 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.715 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.684 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.532 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 6.9 tptp . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 58.0 t0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.165 0.507 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.705 HD22 ' NE2' ' A' ' 42' ' ' HIS . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.59 ' C ' HG12 ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.807 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.615 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 110' ' ' VAL . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 1.018 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 104' ' ' SER . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 110' ' ' VAL . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.528 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' H ' ' HE3' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.018 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.665 ' H ' HG22 ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 110' ' ' VAL . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.935 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.617 HG22 ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.586 ' N ' HG23 ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.935 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.878 HG21 ' HB2' ' A' ' 98' ' ' ALA . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.738 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.991 ' O ' HG22 ' A' ' 86' ' ' THR . 1.8 t-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.146 0.498 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 40' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG13 HG23 ' A' ' 38' ' ' VAL . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CD2' HD13 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.755 HG21 HD12 ' A' ' 124' ' ' ILE . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.816 ' N ' HD12 ' A' ' 44' ' ' LEU . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 71' ' ' TYR . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.5 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.533 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.81 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.795 HG23 ' H ' ' A' ' 68' ' ' ALA . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.795 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' CB ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 4.0 ttpt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 82' ' ' LEU . 5.6 t70 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.28 0.562 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 42' ' ' HIS . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.991 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.892 HD13 ' CG2' ' A' ' 110' ' ' VAL . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.904 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.647 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.609 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.642 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.647 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.892 ' CG2' HD13 ' A' ' 101' ' ' LEU . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.63 ' H ' HG22 ' A' ' 110' ' ' VAL . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.758 ' HB ' HD11 ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.051 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.051 HG23 ' CB ' ' A' ' 114' ' ' PRO . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.904 ' C ' HG22 ' A' ' 103' ' ' VAL . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.967 ' O ' HG22 ' A' ' 86' ' ' THR . 6.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.152 0.501 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 127' ' ' VAL . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.74 HG13 HD23 ' A' ' 82' ' ' LEU . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.877 ' HB3' HD21 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.993 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.993 ' N ' HD12 ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.53 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' HIS . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.606 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.622 ' HD2' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 54' ' ' ALA . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.686 HG23 ' N ' ' A' ' 68' ' ' ALA . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.548 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.556 ' OG ' ' CG1' ' A' ' 43' ' ' ILE . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.993 0.425 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.877 HD21 ' HB3' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.967 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 85' ' ' MET . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.917 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.555 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.534 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.736 ' HD2' HD23 ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.486 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.586 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.802 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.802 ' N ' HG13 ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.101 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.725 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.101 HG23 ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.712 HG13 ' HB ' ' A' ' 38' ' ' VAL . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.455 0.645 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.745 ' CD2' HD23 ' A' ' 82' ' ' LEU . 14.3 m-70 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' LYS . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.724 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.724 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.595 ' HE2' ' HG3' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.626 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.68 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 68' ' ' ALA . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.491 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.82 ' HB3' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.039 0.447 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 42' ' ' HIS . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.431 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.935 HG12 ' HD2' ' A' ' 93' ' ' PRO . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.935 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.539 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.699 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 97' ' ' ALA . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.71 HG22 HG12 ' A' ' 127' ' ' VAL . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.752 ' HE1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.752 ' N ' ' HE1' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.912 HG22 ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' THR . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.014 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.658 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.602 HG22 ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.014 HG23 ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.589 ' HA ' ' CA ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.71 HG12 HG22 ' A' ' 103' ' ' VAL . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.304 0.573 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG2' HG23 ' A' ' 125' ' ' ILE . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 1.088 ' CD2' HD13 ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 124' ' ' ILE . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.036 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.036 ' N ' HD12 ' A' ' 44' ' ' LEU . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.645 HD13 ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.58 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.614 HD21 ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.611 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' OD1' ' OE1' ' A' ' 66' ' ' GLU . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.906 HG23 ' H ' ' A' ' 68' ' ' ALA . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.906 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.844 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 82' ' ' LEU . 56.2 mmtt . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 82' ' ' LEU . 14.1 t70 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.983 0.421 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.088 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.658 ' HE3' ' HB1' ' A' ' 37' ' ' ALA . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.55 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' C ' ' A' ' 90' ' ' MET . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.828 ' CE1' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.541 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' CG ' ' A' ' 59' ' ' LYS . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 111' ' ' PHE . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.723 ' H ' HG22 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.446 HG21 HD13 ' A' ' 101' ' ' LEU . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.991 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' PHE . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.507 ' ND1' HD13 ' A' ' 44' ' ' LEU . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.828 HD11 ' CE1' ' A' ' 94' ' ' PHE . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 58' ' ' LEU . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 103' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.509 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.307 0.575 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' CG ' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HD2' ' CG ' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HD2' HD23 ' A' ' 82' ' ' LEU . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.694 HD12 ' CB ' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.601 ' H ' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.556 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.822 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.701 HD23 ' HE1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.598 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.701 ' HE1' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 57' ' ' LYS . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.604 ' CE2' HG12 ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.694 ' CB ' HD12 ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.235 0.54 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.54 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 108' ' ' LYS . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.56 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.717 ' N ' HG13 ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.463 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.092 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.855 HG23 ' NE2' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.596 ' C ' HG22 ' A' ' 118' ' ' THR . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.855 ' NE2' HG23 ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.781 HD11 ' HE1' ' A' ' 123' ' ' HIS . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.574 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.504 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.304 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG2' ' CG ' ' A' ' 81' ' ' ASP . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CG ' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 51' ' ' ILE . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 48' ' ' HIS . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 67' ' ' VAL . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' SD ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.537 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.706 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG23 ' H ' ' A' ' 68' ' ' ALA . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.544 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD2' HD12 ' A' ' 44' ' ' LEU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.649 ' HG2' ' CE1' ' A' ' 42' ' ' HIS . 3.2 mptt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' HG2' ' A' ' 41' ' ' ARG . 31.0 t0 . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.163 0.506 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.59 ' CZ3' ' HD2' ' A' ' 131' ' ' LYS . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 1.03 HG23 ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 87' ' ' ARG . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.43 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.963 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.687 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.653 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.963 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.67 HG12 ' CG1' ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.748 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.748 ' H ' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 112' ' ' THR . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.989 ' HB2' HG23 ' A' ' 124' ' ' ILE . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 114' ' ' PRO . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' C ' ' A' ' 117' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.989 HG23 ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.67 ' CG1' HG12 ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.59 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.413 0.625 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.89 ' CD2' HD22 ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 124' ' ' ILE . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.161 HD12 ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.161 ' N ' HD12 ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.776 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 54' ' ' ALA . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.561 ' HG2' ' HE3' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.543 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.953 HG12 ' CE2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.639 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.953 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.611 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 43.4 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.014 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.472 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.666 ' O ' HG13 ' A' ' 91' ' ' VAL . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.737 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 97' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.571 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.561 ' HE3' ' HG2' ' A' ' 59' ' ' LYS . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.787 ' CB ' HG23 ' A' ' 124' ' ' ILE . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.612 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.706 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 98' ' ' ALA . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.576 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.816 ' O ' HG22 ' A' ' 86' ' ' THR . 16.8 t-20 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.37 0.605 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.919 ' HB ' HG13 ' A' ' 127' ' ' VAL . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.7 HG13 HG23 ' A' ' 38' ' ' VAL . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.939 ' CD2' HD13 ' A' ' 82' ' ' LEU . 4.4 m-70 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.045 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.531 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 54' ' ' ALA . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.562 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.794 ' N ' HG22 ' A' ' 67' ' ' VAL . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 42' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.8 t0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.153 0.502 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 92' ' ' GLY . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.738 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.961 HD22 HG21 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 128' ' ' GLU . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.845 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.845 ' N ' ' HE2' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 112' ' ' THR . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.569 ' N ' HG22 ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.017 ' HB2' HG23 ' A' ' 124' ' ' ILE . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.936 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.836 HG21 ' HB2' ' A' ' 98' ' ' ALA . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.62 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.921 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.373 0.606 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 130' ' ' ARG . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.081 ' CG2' HG23 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD22 ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.861 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.861 HG21 ' CD2' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.542 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.534 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.597 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.651 HG23 ' N ' ' A' ' 68' ' ' ALA . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.583 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.727 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 43' ' ' ILE . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.587 ' N ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.074 0.464 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 110' ' ' VAL . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.73 HG22 ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.481 ' CA ' ' HG2' ' A' ' 126' ' ' MET . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' PRO . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.545 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.464 HG22 HD22 ' A' ' 101' ' ' LEU . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.973 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.601 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 93' ' ' PRO . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.729 ' HE1' HD11 ' A' ' 125' ' ' ILE . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.973 HG23 ' CB ' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.081 HG23 ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 ' HB ' ' A' ' 38' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.512 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.715 0.769 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.779 ' HB ' HG23 ' A' ' 127' ' ' VAL . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.955 ' NE2' HD12 ' A' ' 82' ' ' LEU . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.658 HG23 ' CA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.109 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.109 ' N ' HD12 ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.579 ' HE3' ' CA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.638 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.679 ' HE1' ' HG3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.501 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.032 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.966 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.698 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 1.032 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.658 ' CA ' HG23 ' A' ' 43' ' ' ILE . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 44.0 p-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.352 0.596 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.955 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.734 ' C ' HG23 ' A' ' 91' ' ' VAL . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' C ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.635 ' HD1' HG21 ' A' ' 118' ' ' THR . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.842 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 97' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.515 ' O ' HG21 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 127' ' ' VAL . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.798 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.798 ' H ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.803 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.803 ' N ' HG13 ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 110' ' ' VAL . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.697 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HG3' ' HE1' ' A' ' 55' ' ' MET . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 125' ' ' ILE . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.635 HG21 ' HD1' ' A' ' 94' ' ' PHE . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 116' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.009 HG22 HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.674 ' HG2' HG12 ' A' ' 38' ' ' VAL . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 1.036 ' O ' HG22 ' A' ' 86' ' ' THR . 4.0 m120 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.545 0.688 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.987 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' ILE . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 48' ' ' HIS . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.876 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.576 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.608 ' HD2' ' HE2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.608 ' HE2' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 67' ' ' VAL . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.828 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 68' ' ' ALA . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.637 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 2.8 tmtm? . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 t0 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.001 0.429 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.496 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 1.036 HG22 ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HB2' ' A' ' 94' ' ' PHE . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.859 ' HB2' HG12 ' A' ' 91' ' ' VAL . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.636 HD22 HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.544 ' CA ' ' HG2' ' A' ' 109' ' ' PRO . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.595 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' HD2' ' A' ' 102' ' ' PRO . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.685 ' H ' HG22 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.48 HG21 HD13 ' A' ' 101' ' ' LEU . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.06 ' HB3' HG23 ' A' ' 124' ' ' ILE . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG21 HD11 ' A' ' 125' ' ' ILE . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.566 HG23 ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.803 ' NE2' HG23 ' A' ' 116' ' ' VAL . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 98' ' ' ALA . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.987 HG23 ' HB ' ' A' ' 38' ' ' VAL . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.756 ' HA ' HG13 ' A' ' 103' ' ' VAL . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.632 ' H ' ' HA ' ' A' ' 38' ' ' VAL . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.209 0.528 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.057 ' CG2' HG23 ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.701 ' CD2' HD11 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.042 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 43' ' ' ILE . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.822 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.59 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.842 HD23 ' CE2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' HD3' ' A' ' 108' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.592 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.842 ' CE2' HD23 ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.69 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.592 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.572 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 74' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 39.0 t0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.011 0.434 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.701 HD11 ' CD2' ' A' ' 42' ' ' HIS . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 91' ' ' VAL . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.857 ' HB3' HG12 ' A' ' 91' ' ' VAL . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' HD23 ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.899 HG12 HG11 ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.75 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.6 HG21 HD13 ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.451 ' N ' HG23 ' A' ' 112' ' ' THR . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.662 ' O ' HG13 ' A' ' 116' ' ' VAL . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.648 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 119' ' ' LYS . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' H ' HG23 ' A' ' 118' ' ' THR . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.671 ' HA ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.52 HG23 ' CB ' ' A' ' 114' ' ' PRO . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 1.057 HG23 ' CG2' ' A' ' 40' ' ' VAL . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.899 HG11 HG12 ' A' ' 103' ' ' VAL . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.972 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.628 0.728 . . . . 0.0 109.806 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.827 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 127' ' ' VAL . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 127' ' ' VAL . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.898 ' CD2' HD13 ' A' ' 82' ' ' LEU . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.02 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.02 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HA ' ' HB ' ' A' ' 51' ' ' ILE . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.689 ' HB3' ' HE3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.643 HD23 ' HG3' ' A' ' 106' ' ' MET . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.681 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.477 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 68' ' ' ALA . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.743 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.537 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 74' ' ' ASP . 8.5 tptt . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ARG . 5.4 t0 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.898 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.972 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.547 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.611 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.045 HD12 HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.563 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.643 ' HG3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB2' ' CE ' ' A' ' 106' ' ' MET . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.045 HG21 HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.831 ' N ' HG13 ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.863 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' HE1' HD11 ' A' ' 125' ' ' ILE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.863 HG23 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.685 ' H ' HG11 ' A' ' 103' ' ' VAL . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 86' ' ' THR . 40.0 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.128 0.489 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.82 HG23 HG13 ' A' ' 40' ' ' VAL . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.625 HD21 ' ND1' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 48' ' ' HIS . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.806 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.603 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.806 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.621 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.3 t-20 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 68' ' ' ALA . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.717 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.666 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.753 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 120.729 0.299 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.554 ' HE1' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 91' ' ' VAL . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.812 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.875 ' HG ' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.63 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.875 HG13 ' HG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 112' ' ' THR . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.043 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.98 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.495 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.56 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.59 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.812 HD11 ' CD1' ' A' ' 94' ' ' PHE . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.555 ' HE1' HD21 ' A' ' 58' ' ' LEU . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.74 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.296 0.569 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.788 ' CG2' HG13 ' A' ' 127' ' ' VAL . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.859 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.859 ' HG3' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.672 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.561 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 67' ' ' VAL . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.561 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.594 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.864 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.027 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.862 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.656 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 1.1 mm-40 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 1.027 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 42' ' ' HIS . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.43 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.613 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.079 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 112' ' ' THR . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.996 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.599 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.584 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.585 HG21 HD13 ' A' ' 101' ' ' LEU . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.06 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.606 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.544 ' H ' ' HE2' ' A' ' 123' ' ' HIS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' HE2' ' H ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.776 HD12 HG21 ' A' ' 116' ' ' VAL . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.645 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.079 HG21 ' HB1' ' A' ' 98' ' ' ALA . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.734 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.952 ' O ' HG22 ' A' ' 86' ' ' THR . 91.0 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.353 0.597 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 125' ' ' ILE . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.595 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.4 p80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' ND1' ' A' ' 123' ' ' HIS . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.439 ' H ' ' HG3' ' A' ' 47' ' ' LYS . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.708 HD13 ' CE1' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.86 ' HE3' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.556 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.572 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.848 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.165 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.78 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 1.165 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.419 ' N ' ' CG ' ' A' ' 74' ' ' ASP . 37.3 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.457 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.095 0.474 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD11 ' CD2' ' A' ' 42' ' ' HIS . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.496 HG23 ' HD2' ' A' ' 93' ' ' PRO . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HD2' HG23 ' A' ' 91' ' ' VAL . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG21 ' A' ' 40' ' ' VAL . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD22 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 128' ' ' GLU . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.59 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 111' ' ' PHE . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.687 ' H ' HG22 ' A' ' 110' ' ' VAL . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.563 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 112' ' ' THR . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 1.0 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.632 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.99 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.649 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.776 ' ND1' HD22 ' A' ' 44' ' ' LEU . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.0 HG23 ' CB ' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.658 HG23 HG23 ' A' ' 40' ' ' VAL . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.59 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.904 ' HA ' HG23 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.988 ' O ' HG22 ' A' ' 86' ' ' THR . 20.7 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.347 0.594 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.009 ' CG2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.009 HG13 ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' HD3' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.919 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.748 HD12 ' OE1' ' A' ' 73' ' ' GLU . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' LYS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.55 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.945 HD12 ' CE ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.958 ' HE2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.087 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 70' ' ' GLN . 7.5 tp60 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 1.087 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.919 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.748 ' OE1' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 13.3 tptt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' GLY . 27.9 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.035 0.445 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.988 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.597 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.74 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 110' ' ' VAL . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.932 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.576 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.566 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' H ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.711 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.932 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' H ' HG22 ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 93' ' ' PRO . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.503 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.858 ' O ' HG22 ' A' ' 116' ' ' VAL . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 HG21 ' A' ' 43' ' ' ILE . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 98' ' ' ALA . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.742 0.782 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.798 ' HB3' ' HG3' ' A' ' 131' ' ' LYS . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.936 ' HB ' HG13 ' A' ' 127' ' ' VAL . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 HG23 ' A' ' 38' ' ' VAL . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.634 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.708 ' NE2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 HD11 ' A' ' 58' ' ' LEU . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.159 HD22 ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.999 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.855 HD11 HD12 ' A' ' 43' ' ' ILE . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.68 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.546 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.653 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.604 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.613 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.226 0.536 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.588 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' A' ' 94' ' ' PHE . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.811 ' N ' HG13 ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.845 ' HB3' HG12 ' A' ' 91' ' ' VAL . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.747 HD22 ' HD2' ' A' ' 111' ' ' PHE . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 127' ' ' VAL . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.747 ' HD2' HD22 ' A' ' 101' ' ' LEU . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.861 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 1.159 ' CE1' HD22 ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.724 HG23 ' CB ' ' A' ' 114' ' ' PRO . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.634 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.936 HG13 ' HB ' ' A' ' 38' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.798 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.28 0.562 . . . . 2.49 110.605 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 0.73 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 0.88 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 1.71 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 82' ' ' LEU . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 1.44 113.074 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' CD ' ' HG2' ' A' ' 126' ' ' MET . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 1.89 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.859 ' CD2' HD12 ' A' ' 82' ' ' LEU . 2.3 p80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 3.2 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.67 HD13 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 0.85 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.078 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 1.77 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 1.078 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 1.67 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.04 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.64 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 1.71 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 0.84 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.578 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.15 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 0.55 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.584 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 0.98 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.93 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.21 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.97 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.13 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.0 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 0.89 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.546 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.28 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 1.89 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.07 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 1.88 110.56 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.39 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 63' ' ' ARG . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 0.58 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.709 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 0.64 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 0.56 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.625 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.28 113.556 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.1 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.59 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.94 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.53 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt . . . . . 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.04 111.016 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 83' ' ' GLY . 18.4 t0 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 110.631 -0.137 . . . . 2.11 110.631 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.859 HD12 ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 1.56 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 0.77 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 0.96 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 1.66 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.27 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 2.75 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.24 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.64 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.86 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 1.8 109.632 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.83 109.697 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 0.89 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 1.58 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.15 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.61 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 0.81 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 0.83 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 36' ' ' ASN . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 1.81 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.29 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 1.77 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.14 110.872 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 127' ' ' VAL . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 1.48 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.44 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.05 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.496 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 1.64 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.89 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.27 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 2.6 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.33 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.72 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 1.94 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 0.97 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.31 109.589 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.995 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 0.67 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 0.62 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 0.6 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.08 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.49 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.09 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 2.86 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 0.84 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 1.67 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.76 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.995 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 0.45 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.521 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 0.78 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.501 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.19 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 103' ' ' VAL . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.03 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.3 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.16 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.24 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 3.75 110.221 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 p -128.02 66.54 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -1.169 . . . . 0.0 110.189 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.31 152.59 28.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.73 90.37 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.69 1.363 . . . . 0.0 110.643 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -133.54 107.72 8.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -0.879 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.24 35.44 0.83 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.06 -70.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 68.1 76.65 0.41 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.986 ' O ' HG22 ' A' ' 86' ' ' THR . 0.1 OUTLIER -125.55 -5.76 7.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -1.174 . . . . 0.0 110.319 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 131' ' ' LYS . . . -139.97 150.09 44.06 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.896 ' HB ' HG13 ' A' ' 127' ' ' VAL . 15.8 m -147.15 151.39 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.665 -0.647 . . . . 0.0 109.502 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.24 101.11 13.52 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 117.181 -1.807 . . . . 0.0 109.109 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 31.3 m -101.85 149.84 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.997 0.903 . . . . 0.0 112.328 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' CB ' ' HG3' ' A' ' 77' ' ' ARG . 57.8 mtt180 -136.92 149.99 47.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.705 ' NE2' HD22 ' A' ' 82' ' ' LEU . 1.9 m-70 -135.46 149.0 49.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.222 -1.549 . . . . 0.0 113.188 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.841 HD12 ' CB ' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -147.27 124.66 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -121.92 150.2 42.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.684 -1.26 . . . . 0.0 109.743 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.033 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.7 m -131.31 90.02 2.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.058 -1.026 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.67 -31.02 2.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 16.3 mttt -82.37 -14.73 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.909 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.687 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.6 m80 56.66 16.02 2.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.36 -0.837 . . . . 0.0 110.084 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.4 -37.32 3.32 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.94 -11.68 46.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.352 -1.087 . . . . 0.0 109.998 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 115' ' ' PRO . 3.4 tp -49.89 -38.27 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.834 -1.166 . . . . 0.0 108.149 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.56 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -79.76 -46.86 16.22 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.1 tt0 -51.9 -29.65 20.84 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.684 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.71 -30.39 29.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.538 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 2.4 ttm -77.52 -33.06 54.38 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.593 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 2.2 tt0 -76.39 -56.94 4.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.373 -0.83 . . . . 0.0 110.025 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -45.23 -63.06 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 108.953 179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.9 mp -48.71 -33.77 10.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 110.567 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.75 -30.1 29.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.167 -0.958 . . . . 0.0 110.469 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -87.3 -11.44 49.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 0.0 109.701 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.57 25.35 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.545 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 3.1 tpp -82.42 -141.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.314 -1.109 . . . . 0.0 109.651 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.552 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -68.25 120.59 14.65 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 111.02 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.568 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 4.5 m-85 -90.4 -29.9 17.73 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' ALA . 2.4 t30 -90.47 -41.35 11.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.619 -0.676 . . . . 0.0 111.462 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.627 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -64.37 -55.15 23.03 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.034 -1.066 . . . . 0.0 108.159 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.715 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.3 m -52.97 -49.02 50.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 118.725 -1.19 . . . . 0.0 107.928 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.715 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -62.27 -29.92 70.75 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 120.655 -1.278 . . . . 0.0 108.358 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.257 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.569 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -91.26 -50.21 5.95 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 118.539 -1.264 . . . . 0.0 113.944 -178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.684 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 6.2 m-30 -44.2 -29.39 0.63 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.618 -1.301 . . . . 0.0 109.013 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.532 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 60.1 p -72.02 -0.88 12.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.489 -0.757 . . . . 0.0 110.506 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' GLN . 4.4 tm-20 29.42 42.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.995 0.903 . . . . 0.0 110.564 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 72' ' ' SER . 27.2 p-10 179.53 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.9 tptp -57.09 -90.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.975 -1.078 . . . . 0.0 109.521 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' HB3' ' HA3' ' A' ' 80' ' ' GLY . . . 167.64 152.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.178 -0.951 . . . . 0.0 110.518 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 1.121 ' NH2' HG22 ' A' ' 124' ' ' ILE . 5.4 ttt-85 -94.04 -65.76 0.97 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.157 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.568 ' HB2' ' O ' ' A' ' 64' ' ' PHE . 2.7 mp0 -60.18 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.744 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.13 -27.32 45.6 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.842 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . -84.4 -1.95 89.2 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 58.0 t0 -41.22 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -1.11 . . . . 0.0 110.177 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.705 HD22 ' NE2' ' A' ' 42' ' ' HIS . 10.3 mp -40.4 -76.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 110.331 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 144.84 -155.84 26.62 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.642 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 27.4 m95 -55.53 129.86 40.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -1.104 . . . . 0.0 110.134 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 3.3 mmt -137.96 127.51 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.178 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.986 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.3 p -109.62 150.1 28.72 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.93 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.496 ' HG2' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -62.08 153.95 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.375 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.44 -30.32 8.93 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.7 m -116.55 18.4 15.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -1.15 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.59 ' C ' HG12 ' A' ' 91' ' ' VAL . 1.9 ttm -107.35 -66.66 1.01 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.164 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.807 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER 174.43 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.807 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -170.62 -83.2 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.615 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.1 Cg_exo -60.49 -55.73 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.703 1.37 . . . . 0.0 110.32 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.591 ' CZ ' HG12 ' A' ' 125' ' ' ILE . 5.3 t80 -47.92 -38.41 16.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 110.155 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' NE2' ' HG2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -88.67 -31.04 18.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.7 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.1 mt-10 -58.27 -31.54 67.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -86.18 -81.19 0.22 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.301 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.878 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -39.97 -71.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.571 -0.705 . . . . 0.0 110.59 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -42.12 -62.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.345 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -58.35 -16.81 16.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.76 HD22 HG11 ' A' ' 110' ' ' VAL . 29.5 mt -103.72 149.26 36.93 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.299 -0.876 . . . . 0.0 110.261 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 1.018 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -62.98 164.86 18.0 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.677 1.356 . . . . 0.0 110.891 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 104' ' ' SER . 8.8 t -41.39 159.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.387 -0.82 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 110' ' ' VAL . 5.0 p -179.45 -143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 0.0 110.943 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 111.64 166.92 18.22 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.528 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.2 ttp 65.86 -169.27 0.2 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.461 -1.023 . . . . 0.0 110.672 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' H ' ' HE3' ' A' ' 106' ' ' MET . 26.4 t0 -79.01 14.87 1.25 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.023 -1.048 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -141.53 52.21 2.65 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 120.992 -1.067 . . . . 0.0 109.357 178.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.1 Cg_exo -65.96 -151.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.604 1.318 . . . . 0.0 110.76 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.018 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -78.9 -160.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.441 -0.787 . . . . 0.0 110.752 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.665 ' H ' HG22 ' A' ' 110' ' ' VAL . 92.6 m-85 -52.18 -44.14 64.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.81 . . . . 0.0 110.467 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.942 HG22 HG12 ' A' ' 110' ' ' VAL . 6.5 t -62.02 -161.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.379 -0.826 . . . . 0.0 110.716 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.2 m-20 -122.03 153.3 60.89 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 0.0 109.574 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.935 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -60.21 -55.37 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.581 1.306 . . . . 0.0 111.787 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.644 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.23 77.01 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.003 1.135 . . . . 0.0 110.446 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.4 m -89.98 150.06 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.905 -1.122 . . . . 0.0 110.352 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 29.4 tttt -102.45 150.09 23.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 110.322 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.617 HG22 ' NE2' ' A' ' 123' ' ' HIS . 8.3 t -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.586 ' N ' HG23 ' A' ' 118' ' ' THR . 0.2 OUTLIER -175.34 27.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.143 -0.973 . . . . 0.0 110.474 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.09 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 98.24 -155.57 20.29 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.687 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 12.0 m-30 -100.43 124.45 45.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -1.105 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.655 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 3.8 p80 -120.9 146.78 46.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.096 -1.002 . . . . 0.0 109.729 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.121 HG22 ' NH2' ' A' ' 77' ' ' ARG . 8.5 mt -89.79 110.21 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.862 . . . . 0.0 110.145 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.878 HG21 ' HB2' ' A' ' 98' ' ' ALA . 22.9 mt -96.14 131.94 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.339 -0.851 . . . . 0.0 109.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -123.53 99.77 6.48 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.16 -0.963 . . . . 0.0 110.162 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 8.5 t -89.59 128.76 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.634 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -150.48 94.39 2.1 Favored 'General case' 0 C--O 1.197 -1.708 0 O-C-N 120.94 -1.1 . . . . 0.0 110.835 -178.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.642 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 119.75 71.57 0.34 Allowed Glycine 0 C--N 1.276 -2.804 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.738 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -70.44 -174.94 0.92 Allowed 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.974 -1.09 . . . . 0.0 109.483 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.105 . . . . 0.0 110.296 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' SER . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -43.71 118.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -1.154 . . . . 0.0 110.145 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.64 177.55 16.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.56 96.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.828 1.436 . . . . 0.0 110.541 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.85 78.21 1.3 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.27 -139.01 20.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -124.27 -117.92 2.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' HA2' ' OXT' ' A' ' 131' ' ' LYS . . . -144.56 96.79 0.19 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.991 ' O ' HG22 ' A' ' 86' ' ' THR . 1.8 t-20 -116.06 -20.81 9.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -1.101 . . . . 0.0 110.256 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -136.93 150.21 48.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.258 -0.901 . . . . 0.0 109.135 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 40' ' ' VAL . 3.3 m -150.66 151.07 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.8 tptm -88.53 107.96 19.16 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 119.641 -1.912 . . . . 0.0 109.223 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG13 HG23 ' A' ' 38' ' ' VAL . 8.3 m -107.47 130.9 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.69 0.757 . . . . 0.0 112.161 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HB3' ' HG2' ' A' ' 77' ' ' ARG . 14.9 mtt180 -118.29 142.16 47.78 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CD2' HD13 ' A' ' 82' ' ' LEU . 2.1 m-70 -122.56 146.39 47.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.6 -1.312 . . . . 0.0 111.117 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.835 HD12 ' HD2' ' A' ' 77' ' ' ARG . 1.7 tt -144.67 115.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -115.47 150.27 36.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.944 -1.098 . . . . 0.0 110.197 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.816 ' N ' HD12 ' A' ' 44' ' ' LEU . 58.8 m -123.15 83.13 2.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.856 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -27.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 42.0 mmtt -85.8 -15.51 41.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.529 ' NE2' ' CD2' ' A' ' 122' ' ' TYR . 0.6 OUTLIER 56.97 15.63 2.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.697 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -103.88 -2.24 45.86 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -128.98 -21.72 3.29 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.27 -1.135 . . . . 0.0 110.656 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' CA ' ' SG ' ' A' ' 45' ' ' CYS . 11.2 tp -48.59 -26.98 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.781 -1.2 . . . . 0.0 109.085 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.697 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.18 -29.7 18.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -71.17 -29.51 65.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 71' ' ' TYR . . . -67.04 -33.69 76.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.5 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtt -68.61 -44.07 75.08 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . 12.5 mt-10 -76.36 -58.26 3.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.843 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.616 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 3.6 mttm -47.16 -69.7 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.034 -1.041 . . . . 0.0 109.152 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 76.5 mt -42.23 -34.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.523 -0.736 . . . . 0.0 109.855 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 60' ' ' SER . 1.6 mtmt -73.67 -76.85 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 0.0 109.845 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.533 ' HB2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -35.08 -63.66 0.31 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.2 0.524 . . . . 0.0 110.614 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.65 44.84 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.314 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -86.3 -147.07 0.12 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.0 -1.294 . . . . 0.0 109.589 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.773 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -74.02 135.14 43.08 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.649 -0.657 . . . . 0.0 110.148 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -90.26 -29.8 17.94 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 118.929 -1.108 . . . . 0.0 108.159 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.57 -34.78 15.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 111.297 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.81 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -62.38 -61.18 2.62 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.64 -1.287 . . . . 0.0 107.742 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.795 HG23 ' H ' ' A' ' 68' ' ' ALA . 3.5 m -49.21 -57.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.795 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.18 -46.44 4.39 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -40.93 -68.66 0.17 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.113 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.548 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.3 -52.49 4.78 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.707 178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.4 m-30 -41.15 -29.68 0.13 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 5.4 t -88.02 -179.28 6.17 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.68 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' CB ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -74.85 53.25 0.57 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 57.5 t0 58.2 15.49 3.35 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 109.47 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 4.0 ttpt -130.38 1.84 4.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.532 -0.73 . . . . 0.0 109.585 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 68.14 148.48 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -0.771 . . . . 0.0 111.311 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.835 ' HD2' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -100.67 -61.45 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.76 -68.74 0.33 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.858 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.82 -17.98 44.72 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -94.71 -3.06 62.72 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.6 t70 -38.35 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.573 -0.957 . . . . 0.0 110.309 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 42' ' ' HIS . 10.4 mp -40.68 -38.47 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 110.454 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.94 -168.37 12.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.62 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 26.4 m95 -47.48 144.45 3.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -1.089 . . . . 0.0 110.461 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 2.7 mmt -148.54 135.53 20.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.11 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.991 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.4 p -111.78 150.1 30.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.208 -0.933 . . . . 0.0 110.31 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -63.86 89.76 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.0 110.31 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.87 -33.89 0.08 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.7 -16.58 14.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -1.169 . . . . 0.0 110.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.535 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 2.6 tpp -67.05 -140.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.334 -0.854 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.7 t -124.61 -153.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -91.79 -77.97 1.37 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.15 -40.97 46.51 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.732 1.385 . . . . 0.0 110.419 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.613 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 1.2 t80 -46.23 -41.6 13.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 110.001 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' PHE . 27.8 mt-30 -74.84 -54.65 6.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 110.425 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.7 mm-40 -41.73 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.209 -0.932 . . . . 0.0 110.633 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -40.94 -34.24 0.39 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.365 -0.834 . . . . 0.0 111.04 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.665 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -95.83 -77.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 0.0 110.935 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 95' ' ' GLN . 3.1 m-85 -44.52 -29.04 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.112 -0.992 . . . . 0.0 110.722 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.795 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -88.74 0.01 56.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.127 -0.983 . . . . 0.0 110.448 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.892 HD13 ' CG2' ' A' ' 110' ' ' VAL . 16.3 mt -124.73 167.24 16.47 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 110.583 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -59.16 178.64 0.27 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.693 1.365 . . . . 0.0 110.485 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.904 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -109.22 126.69 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.34 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.647 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 168.31 -34.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.132 -0.98 . . . . 0.0 111.365 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . 45.62 -167.95 0.04 OUTLIER Glycine 0 N--CA 1.495 2.608 0 O-C-N 120.804 -1.185 . . . . 0.0 111.128 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER 80.1 31.88 0.21 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 111.598 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.609 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 4.7 p-10 35.79 78.38 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.69 . . . . 0.0 112.618 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.642 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 175.05 -52.77 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.141 -0.975 . . . . 0.0 110.766 178.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.647 ' CG ' ' HB3' ' A' ' 104' ' ' SER . 2.3 Cg_endo -69.91 -73.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.296 1.156 . . . . 0.0 110.098 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.892 ' CG2' HD13 ' A' ' 101' ' ' LEU . 7.7 p -47.88 179.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.618 -0.676 . . . . 0.0 110.351 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.63 ' H ' HG22 ' A' ' 110' ' ' VAL . 64.1 m-85 -109.4 -45.1 3.77 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.855 -1.153 . . . . 0.0 111.908 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.758 ' HB ' HD11 ' A' ' 101' ' ' LEU . 7.8 t -52.16 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 0.0 110.992 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.09 134.32 21.47 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.051 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.72 -55.23 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.352 1.185 . . . . 0.0 111.5 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -65.82 75.9 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.972 1.115 . . . . 0.0 110.497 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 4.9 m -89.91 150.17 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.101 -1.0 . . . . 0.0 109.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -103.81 141.64 35.75 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 110.803 -179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.46 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 1.5 t 177.55 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.438 -0.789 . . . . 0.0 109.965 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.33 -74.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 110.592 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 16.25 1.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.962 . . . . 0.0 110.825 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 162.13 -146.01 11.48 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CE1' ' HG3' ' A' ' 117' ' ' LYS . 24.1 m-85 -114.8 140.63 48.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.264 -1.139 . . . . 0.0 110.12 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 31.3 p80 -140.18 150.26 43.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.075 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.051 HG23 ' CB ' ' A' ' 114' ' ' PRO . 17.1 mt -89.41 117.43 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.665 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.5 mt -90.99 142.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.521 -0.737 . . . . 0.0 109.256 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -138.0 102.43 4.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.904 ' C ' HG22 ' A' ' 103' ' ' VAL . 4.2 t -89.44 128.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.645 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.4 tp10 -150.63 97.4 2.5 Favored 'General case' 0 C--O 1.194 -1.842 0 O-C-N 120.351 -1.468 . . . . 0.0 111.324 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.62 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 111.42 91.99 2.08 Favored Glycine 0 C--N 1.272 -2.987 0 O-C-N 120.511 -1.368 . . . . 0.0 109.773 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 28.2 mtm180 -110.69 160.39 16.75 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.167 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.217 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 t -173.25 145.7 1.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.83 -170.75 22.97 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.18 100.74 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.827 1.435 . . . . 0.0 110.512 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.91 157.57 18.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 0.0 110.222 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.78 138.07 3.46 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -129.23 49.73 0.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 36' ' ' ASN . . . 47.03 -117.43 3.1 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.967 ' O ' HG22 ' A' ' 86' ' ' THR . 6.3 t-20 63.38 15.23 8.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -1.147 . . . . 0.0 110.217 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -149.91 150.24 31.61 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 127' ' ' VAL . 3.4 m -150.37 150.88 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.349 -0.844 . . . . 0.0 110.914 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.5 tptp -88.42 94.94 10.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 117.705 -1.598 . . . . 0.0 109.05 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.74 HG13 HD23 ' A' ' 82' ' ' LEU . 6.8 p -98.01 146.52 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.999 0.904 . . . . 0.0 112.279 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 23.2 mtt180 -123.12 150.32 43.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.877 ' HB3' HD21 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -134.21 129.92 36.43 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 117.192 -1.803 . . . . 0.0 113.68 -177.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -121.34 112.95 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.993 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -112.63 150.6 31.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.72 -1.237 . . . . 0.0 108.527 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.993 ' N ' HD12 ' A' ' 44' ' ' LEU . 59.3 m -123.99 -31.79 3.34 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.255 -0.903 . . . . 0.0 110.895 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 20.5 tt0 70.95 -54.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.106 -0.997 . . . . 0.0 109.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 14.7 mttt -86.98 -17.01 34.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.381 -0.824 . . . . 0.0 109.2 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.5 m-70 63.99 10.16 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.651 -0.655 . . . . 0.0 110.358 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.85 -25.6 73.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.77 -11.16 11.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -1.102 . . . . 0.0 109.949 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' HIS . 11.2 tp -47.51 -31.48 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.414 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.606 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -87.75 -34.49 18.32 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 52' ' ' MET . 1.9 tt0 -64.56 -29.33 70.35 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -70.47 -31.09 68.09 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 2.4 mtt -73.14 -46.17 52.54 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 21.7 mm-40 -71.35 -58.99 3.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.613 -0.679 . . . . 0.0 110.018 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.622 ' HD2' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -42.24 -72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.495 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 54' ' ' ALA . 5.6 mp -43.96 -31.5 0.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 110.125 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -80.87 -75.03 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.263 -0.898 . . . . 0.0 110.551 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -38.89 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.441 -0.787 . . . . 0.0 110.344 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 107.26 28.2 5.01 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -70.93 -144.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -1.19 . . . . 0.0 109.729 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -79.9 129.54 34.57 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.657 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -90.22 -30.54 17.49 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.22 -0.925 . . . . 0.0 108.508 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -90.54 -34.57 15.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.58 -0.7 . . . . 0.0 110.957 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.3 mm-40 -68.63 -51.54 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.043 -1.036 . . . . 0.0 108.425 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.686 HG23 ' N ' ' A' ' 68' ' ' ALA . 30.6 m -60.31 -48.95 86.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -53.88 -29.81 43.2 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -66.68 -71.0 0.21 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.328 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.548 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.04 -46.83 7.91 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.7 m-30 -47.02 -29.31 2.04 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.616 -1.303 . . . . 0.0 108.488 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.595 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 39.3 m -77.8 -5.48 50.92 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.569 -0.707 . . . . 0.0 110.478 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 3.4 tm-20 28.1 50.96 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.789 -0.569 . . . . 0.0 111.092 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.588 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 42.7 p-10 -178.35 -137.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.811 -0.755 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.74 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -68.31 -5.85 20.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.107 -0.996 . . . . 0.0 110.392 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 73.47 149.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 111.379 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.632 ' NH1' ' HE2' ' A' ' 126' ' ' MET . 2.0 ptp180 -108.63 -168.56 1.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.617 -0.677 . . . . 0.0 109.259 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.462 ' OE1' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 45.14 -91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -0.935 . . . . 0.0 109.223 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -57.51 -25.05 54.46 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -91.85 -53.29 2.11 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.493 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 23.9 t0 31.76 95.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 122.02 -0.694 . . . . 0.0 111.083 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.877 HD21 ' HB3' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -39.46 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 110.369 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 94.52 -176.36 35.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.595 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 45.3 m95 -52.89 137.83 31.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -1.087 . . . . 0.0 110.285 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.519 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -142.58 130.87 22.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.356 -0.84 . . . . 0.0 109.586 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.967 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.6 p -108.99 150.16 28.15 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.742 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HD3' ' CE1' ' A' ' 99' ' ' PHE . 3.2 ttp180 -49.56 173.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.484 -0.76 . . . . 0.0 110.044 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.45 -40.84 3.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 90' ' ' MET . 0.9 OUTLIER -100.27 -141.28 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.813 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 85' ' ' MET . 7.5 ttm 43.08 -144.93 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.253 -0.904 . . . . 0.0 110.018 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.917 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.3 t -124.56 149.27 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.197 -0.94 . . . . 0.0 109.943 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.555 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -48.63 -56.57 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.3 Cg_exo -60.73 -50.66 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.476 1.25 . . . . 0.0 111.361 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -43.11 -63.73 0.76 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.086 -1.009 . . . . 0.0 110.087 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 99' ' ' PHE . 24.8 mt-30 -62.19 -42.16 99.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.973 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.1 mt-10 -42.36 -35.79 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.411 -0.806 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -87.91 -81.38 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.317 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -50.33 -67.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.402 -0.811 . . . . 0.0 110.646 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.534 ' CE1' ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -40.53 -31.09 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.314 -0.866 . . . . 0.0 110.692 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -97.25 -23.89 15.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.245 -0.909 . . . . 0.0 110.092 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 102' ' ' PRO . 0.2 OUTLIER -92.84 170.81 8.29 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.736 ' HD2' HD23 ' A' ' 101' ' ' LEU . 3.2 Cg_exo -59.37 -159.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.7 1.368 . . . . 0.0 110.805 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' N ' ' A' ' 104' ' ' SER . 5.2 t -98.61 174.53 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.403 -0.811 . . . . 0.0 110.129 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.553 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.8 m 61.96 171.95 0.12 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.54 -0.725 . . . . 0.0 111.161 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -157.85 -107.86 0.25 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.486 ' HG2' ' OD2' ' A' ' 107' ' ' ASP . 35.2 ttp 59.61 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -1.084 . . . . 0.0 110.257 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' N ' ' O ' ' A' ' 105' ' ' GLY . 1.6 p30 -178.49 -35.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.896 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.586 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -79.8 -61.05 0.48 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.935 . . . . 0.0 110.343 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.9 Cg_endo -58.72 -150.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.05 1.026 . . . . 0.0 110.314 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.802 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.6 p 31.57 -146.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.917 -0.489 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.802 ' N ' HG13 ' A' ' 110' ' ' VAL . 9.9 m-85 -156.79 -59.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.692 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' PHE . 15.4 t -53.57 -168.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.281 -0.887 . . . . 0.0 110.457 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.43 134.72 32.14 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.101 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.6 Cg_exo -58.16 -54.41 3.16 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.347 1.183 . . . . 0.0 111.793 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.36 77.69 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.142 1.228 . . . . 0.0 110.837 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.7 m -95.99 150.11 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -91.06 147.41 23.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 110.325 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 2.2 t 177.61 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -111.43 -56.0 2.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 110.33 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -170.94 58.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . 126.9 -167.27 19.4 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 115' ' ' PRO . 19.2 m-30 -91.1 132.0 36.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -1.167 . . . . 0.0 110.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.725 ' CE1' HD22 ' A' ' 44' ' ' LEU . 2.3 m-70 -135.4 145.25 47.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.124 -0.985 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.101 HG23 ' CB ' ' A' ' 114' ' ' PRO . 16.5 mt -89.8 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.09 -1.006 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 mt -121.83 149.36 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.295 -0.878 . . . . 0.0 110.718 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.632 ' HE2' ' NH1' ' A' ' 77' ' ' ARG . 20.4 mtm -141.21 113.1 7.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.51 -0.744 . . . . 0.0 109.862 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.712 HG13 ' HB ' ' A' ' 38' ' ' VAL . 42.9 t -89.75 148.36 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.313 -0.867 . . . . 0.0 110.221 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.643 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -150.22 89.65 1.6 Allowed 'General case' 0 C--O 1.202 -1.412 0 CA-C-O 122.497 1.141 . . . . 0.0 111.646 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.595 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 97.94 96.9 1.99 Allowed Glycine 0 C--N 1.28 -2.567 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -88.29 6.97 34.5 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.538 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.136 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 m 48.83 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -1.143 . . . . 0.0 110.252 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.86 151.87 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.65 -60.13 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.764 1.402 . . . . 0.0 110.588 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.74 19.65 7.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.24 161.42 32.77 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.97 -136.45 13.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.17 -161.43 32.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.81 -71.59 0.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -1.184 . . . . 0.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -107.75 150.21 27.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.304 -0.873 . . . . 0.0 109.719 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.685 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -147.36 150.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 13.9 tptp -88.83 89.71 8.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 117.139 -1.824 . . . . 0.0 109.575 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 126' ' ' MET . 3.9 p -96.92 147.41 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.3 -0.875 . . . . 0.0 112.216 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' NH1' ' CG ' ' A' ' 126' ' ' MET . 0.1 OUTLIER -122.57 150.03 43.16 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.745 ' CD2' HD23 ' A' ' 82' ' ' LEU . 14.3 m-70 -120.1 118.92 31.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.697 -1.252 . . . . 0.0 112.143 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 7.0 mt -129.35 104.66 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.526 -0.734 . . . . 0.0 110.071 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD23 ' HB3' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -111.85 139.0 47.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 47' ' ' LYS . 75.6 m -102.12 -14.93 16.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.652 -1.28 . . . . 0.0 110.497 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER 69.08 -56.55 0.54 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.17 -0.956 . . . . 0.0 109.314 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mtmm -93.53 -15.79 25.12 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.4 m-70 64.45 9.1 4.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.594 -0.692 . . . . 0.0 110.55 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.724 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -73.76 -12.5 80.79 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -123.21 -11.97 7.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.465 -1.021 . . . . 0.0 109.934 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.4 tp -47.68 -29.13 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.674 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.724 ' HE1' ' O ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -90.14 -30.3 17.73 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.624 -0.83 . . . . 0.0 108.923 178.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.4 tt0 -69.49 -29.49 67.14 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' LEU . . . -72.15 -33.51 67.81 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.595 ' HE2' ' HG3' ' A' ' 115' ' ' PRO . 0.8 OUTLIER -72.04 -43.14 65.42 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 60' ' ' SER . 4.5 mm-40 -76.43 -60.29 2.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.582 -0.699 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 2.4 mmmt -42.77 -65.32 0.49 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.244 -0.91 . . . . 0.0 109.095 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 64' ' ' PHE . 67.2 mt -43.22 -39.7 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.489 -0.757 . . . . 0.0 109.323 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -75.75 -70.39 0.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.526 -0.734 . . . . 0.0 110.449 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -37.43 -29.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.77 -0.581 . . . . 0.0 110.247 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 106.62 36.51 2.6 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tpp -91.24 -144.27 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.07 -1.253 . . . . 0.0 109.489 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.626 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 4.0 mtt180 -81.82 136.77 35.37 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' ' HE1' ' A' ' 126' ' ' MET . 0.4 OUTLIER -90.27 -38.73 13.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.68 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 20.2 p30 -90.33 -36.77 14.47 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.656 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' HB2' ' CB ' ' A' ' 63' ' ' ARG . 55.5 mm-40 -55.73 -55.62 30.12 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 HG23 ' N ' ' A' ' 68' ' ' ALA . 15.8 m -51.13 -48.01 31.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 72' ' ' SER . . . -50.71 -44.44 58.13 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -40.61 -64.99 0.46 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.491 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.99 -63.29 1.29 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.61 178.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 5.1 m-30 -40.71 -29.85 0.11 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.794 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.721 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 1.1 p -89.42 -173.45 3.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.888 -1.133 . . . . 0.0 109.722 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.82 ' HB3' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -80.43 61.66 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 108.808 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 19.3 t70 70.79 -64.17 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.019 0.438 . . . . 0.0 109.926 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -56.54 122.05 11.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.081 . . . . 0.0 109.075 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -96.18 -92.61 0.21 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.001 -1.062 . . . . 0.0 111.325 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 49.44 90.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.951 -1.093 . . . . 0.0 108.841 -178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 64' ' ' PHE . 1.7 tm0? 60.02 -75.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 109.469 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -166.0 47.97 0.27 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.667 ' O ' HD22 ' A' ' 82' ' ' LEU . . . 80.07 41.91 11.56 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -75.06 78.35 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.275 -1.132 . . . . 0.0 110.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.745 HD23 ' CD2' ' A' ' 42' ' ' HIS . 3.3 mm? -57.15 -17.02 9.21 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 109.565 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 101.52 174.85 28.47 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 36.9 m95 -41.84 147.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -1.043 . . . . 0.0 109.71 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -142.54 134.85 27.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.884 -1.135 . . . . 0.0 111.021 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.15 149.49 41.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.937 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.584 ' HG3' ' CD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -57.97 156.59 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.276 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.57 -22.03 35.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 8.59 5.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.131 -1.217 . . . . 0.0 110.334 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.431 ' SD ' ' CD1' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -106.94 -147.71 0.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.935 HG12 ' HD2' ' A' ' 93' ' ' PRO . 4.5 t -115.51 160.03 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 0.0 110.206 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -67.05 -60.69 5.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.935 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -59.37 -53.5 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.718 1.378 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.687 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 6.6 t80 -51.8 -54.72 25.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.539 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 2.2 tm0? -62.6 -46.95 85.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -45.53 -32.49 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.511 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.699 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.13 -83.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.067 -1.021 . . . . 0.0 110.539 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -46.59 -69.48 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.446 -0.783 . . . . 0.0 110.783 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -41.9 -32.15 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -0.893 . . . . 0.0 110.816 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -103.4 6.5 37.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.634 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 97' ' ' ALA . 15.0 mt -117.22 166.54 12.82 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 110.883 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.3 Cg_endo -64.78 155.24 68.52 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.562 1.508 . . . . 0.0 111.579 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.71 HG22 HG12 ' A' ' 127' ' ' VAL . 2.2 t -75.84 155.66 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER 166.68 -73.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.903 -1.123 . . . . 0.0 111.645 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 57.53 160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.165 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.752 ' HE1' ' N ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER 77.46 -127.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.88 -0.776 . . . . 0.0 112.502 178.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.752 ' N ' ' HE1' ' A' ' 106' ' ' MET . 2.3 p30 -79.99 -25.88 40.13 Favored 'General case' 0 N--CA 1.511 2.617 0 O-C-N 120.65 -1.281 . . . . 0.0 112.177 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -119.12 49.13 1.14 Allowed Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 120.841 -1.162 . . . . 0.0 110.83 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 104' ' ' SER . 3.1 Cg_exo -56.03 -171.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.667 1.351 . . . . 0.0 111.5 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.912 ' CG2' HG22 ' A' ' 112' ' ' THR 0.253 15.8 m -45.08 -169.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.429 1.109 . . . . 0.0 112.078 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.73 -19.12 59.3 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.912 HG22 ' CG2' ' A' ' 110' ' ' VAL . 15.4 t -91.35 -149.62 0.23 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.13 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' THR . 9.9 m-20 -107.57 146.6 33.68 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.01 -1.056 . . . . 0.0 110.158 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.014 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.2 Cg_exo -60.47 -55.62 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.646 1.34 . . . . 0.0 111.634 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.658 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -67.95 84.24 0.43 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.196 1.264 . . . . 0.0 110.941 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 123' ' ' HIS . 3.6 m -100.32 150.09 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.901 -1.125 . . . . 0.0 110.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -97.82 142.25 29.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 110.371 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.602 HG22 ' NE2' ' A' ' 123' ' ' HIS . 5.0 t -174.09 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.183 -0.948 . . . . 0.0 110.517 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' PHE . 16.0 tptt -101.59 -32.57 10.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 110.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 20.4 t80 -177.72 -27.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.022 -1.049 . . . . 0.0 111.208 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -154.08 -164.61 12.93 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 31.4 m-85 -89.83 124.6 34.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -1.212 . . . . 0.0 109.911 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 20.9 p80 -125.2 150.22 47.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.132 -0.98 . . . . 0.0 109.302 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.014 HG23 ' CB ' ' A' ' 114' ' ' PRO . 5.1 mt -89.39 112.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.131 -0.981 . . . . 0.0 110.178 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 98' ' ' ALA . 4.0 mt -89.92 126.19 42.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.552 -0.718 . . . . 0.0 109.451 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.637 ' HE1' ' CE1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -123.4 103.24 8.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.381 -0.824 . . . . 0.0 109.398 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.71 HG12 HG22 ' A' ' 103' ' ' VAL . 23.7 t -89.54 148.23 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.618 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -150.12 89.93 1.63 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.777 1.275 . . . . 0.0 111.961 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 86.43 129.02 2.44 Favored Glycine 0 C--N 1.28 -2.535 0 O-C-N 120.95 -1.094 . . . . 0.0 111.194 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -143.38 -176.64 5.02 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.793 -0.828 . . . . 0.0 110.146 178.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.225 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -83.75 92.67 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.84 173.44 53.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.22 -31.19 92.72 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.689 1.363 . . . . 0.0 110.506 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -138.82 142.16 38.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.128 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.98 64.01 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.94 -134.38 5.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . 87.45 -135.09 12.91 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' THR . 9.0 m-20 60.34 13.13 3.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -1.148 . . . . 0.0 110.364 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -99.55 139.25 35.48 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.267 -0.896 . . . . 0.0 109.605 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.687 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.6 m -150.73 150.73 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.774 -0.579 . . . . 0.0 109.601 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 9.2 tptp -88.92 91.26 8.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 119.827 -1.795 . . . . 0.0 109.18 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' CG2' HG23 ' A' ' 125' ' ' ILE . 10.6 p -98.73 130.7 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.417 -0.802 . . . . 0.0 112.585 -177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB2' ' CG ' ' A' ' 126' ' ' MET . 1.4 mtt180 -100.41 150.05 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 1.088 ' CD2' HD13 ' A' ' 82' ' ' LEU . 6.9 m-70 -118.14 140.56 49.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.664 -1.272 . . . . 0.0 112.569 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.548 HD11 ' CD ' ' A' ' 78' ' ' GLN . 44.8 mt -149.74 114.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.036 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.0 137.68 51.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.751 -1.218 . . . . 0.0 110.325 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.036 ' N ' HD12 ' A' ' 44' ' ' LEU . 24.3 p -105.96 116.33 31.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.512 -0.742 . . . . 0.0 109.351 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -76.2 -31.95 58.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.085 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -101.64 -5.78 24.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 109.503 179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER 59.04 13.24 2.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.712 -0.618 . . . . 0.0 110.344 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.9 -41.96 6.16 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -84.82 -15.36 45.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.645 HD13 ' SG ' ' A' ' 45' ' ' CYS . 10.2 tp -47.08 -40.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.9 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.58 ' HE3' ' HB3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.12 -41.95 21.68 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.5 tt0 -56.43 -29.46 61.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -82.41 -29.86 30.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.58 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 13.4 ttm -74.57 -46.1 41.06 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.455 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -69.05 -57.05 5.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.851 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 67' ' ' VAL . 20.7 mttp -43.37 -70.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.538 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.614 HD21 ' HE1' ' A' ' 126' ' ' MET . 0.1 OUTLIER -40.82 -32.3 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.416 -0.803 . . . . 0.0 109.936 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' CG ' ' OD1' ' A' ' 107' ' ' ASP . 1.4 mmmt -83.09 -69.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.305 -0.872 . . . . 0.0 110.122 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -41.92 -39.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 110.015 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.93 30.6 1.21 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.532 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.8 mpp? -84.95 -167.69 1.92 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.072 -1.252 . . . . 0.0 109.733 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.611 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 6.9 mtt180 -56.55 130.04 43.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 110.277 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CE1' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -90.39 -35.45 15.17 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ARG . 4.4 p30 -90.21 -32.65 16.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 111.058 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 6.3 mm-40 -65.69 -44.79 85.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.451 -1.406 . . . . 0.0 108.354 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.906 HG23 ' H ' ' A' ' 68' ' ' ALA . 4.3 m -57.46 -62.65 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 118.396 -1.322 . . . . 0.0 107.449 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 77' ' ' ARG . . . -48.84 -33.7 11.06 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.38 -71.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.03 -44.28 9.41 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 118.183 -1.407 . . . . 0.0 111.335 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.844 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -49.09 -29.87 5.74 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.189 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 68' ' ' ALA . 34.0 t -74.07 -10.1 59.29 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.481 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 3.2 tm-20 32.91 44.73 0.05 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.445 0.641 . . . . 0.0 110.665 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 3.6 t0 165.36 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.173 0.511 . . . . 0.0 110.358 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.763 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 56.2 mmtt -53.57 -18.84 3.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.201 -0.937 . . . . 0.0 110.307 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 78.44 -153.57 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.102 0.953 . . . . 0.0 112.34 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.908 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 36.8 ptt180 -55.96 154.48 7.38 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.902 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.653 ' CB ' ' CE1' ' A' ' 64' ' ' PHE . 2.2 mm100 -52.89 -23.37 6.97 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -44.6 -30.26 2.13 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 106.269 -2.733 . . . . 0.0 106.269 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -56.75 -50.01 66.45 Favored Glycine 0 N--CA 1.48 1.593 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' GLN . 14.1 t70 26.29 88.13 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.319 -0.518 . . . . 0.0 111.709 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.088 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.6 mp -41.74 -27.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.67 174.8 39.95 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.658 ' HE3' ' HB1' ' A' ' 37' ' ' ALA . 54.4 m95 -40.5 133.61 1.9 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.557 -0.966 . . . . 0.0 109.979 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.59 133.57 32.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.14 -0.975 . . . . 0.0 110.458 -179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -98.55 145.94 26.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.454 -0.778 . . . . 0.0 110.23 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.578 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -50.53 -32.69 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -44.76 -39.0 5.9 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.4 t -128.75 85.46 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.198 -1.178 . . . . 0.0 110.187 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.55 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.26 39.3 0.21 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.204 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG23 ' C ' ' A' ' 90' ' ' MET . 2.0 t 59.66 -142.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -124.19 -76.98 0.32 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 2.9 Cg_endo -61.5 -36.9 74.56 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.744 1.392 . . . . 0.0 110.137 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.828 ' CE1' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -47.02 -42.05 17.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.339 -0.85 . . . . 0.0 109.874 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.564 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 tm0? -86.41 -48.68 8.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.076 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.5 mt-10 -38.78 -33.12 0.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.491 -0.755 . . . . 0.0 110.56 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -79.94 -74.0 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -45.54 -40.63 8.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 110.532 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 5.0 m-85 -71.05 -67.15 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.412 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -46.38 -39.83 11.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 110' ' ' VAL . 2.0 mt -93.85 164.01 22.09 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.429 -0.795 . . . . 0.0 110.143 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 2.9 Cg_endo -60.44 166.94 8.73 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.635 1.334 . . . . 0.0 110.473 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 127' ' ' VAL . 6.8 m -60.05 -161.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.096 -1.002 . . . . 0.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.546 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 37.5 m 55.86 169.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.526 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -148.18 -98.62 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.541 ' HG3' ' HD2' ' A' ' 109' ' ' PRO . 1.1 ptp 28.93 -135.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 122.193 -0.592 . . . . 0.0 111.201 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' OD1' ' CG ' ' A' ' 59' ' ' LYS . 28.1 p-10 -135.76 78.37 1.72 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.3 OUTLIER 174.1 -53.12 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.817 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -66.56 -75.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.238 1.125 . . . . 0.0 110.419 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 111' ' ' PHE . 2.2 p -57.96 -164.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.502 -0.749 . . . . 0.0 110.259 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.723 ' H ' HG22 ' A' ' 110' ' ' VAL . 27.0 m-85 -119.15 -32.38 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.532 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.446 HG21 HD13 ' A' ' 101' ' ' LEU . 4.2 t -75.39 -175.87 2.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.091 -1.005 . . . . 0.0 110.4 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.2 m-20 -91.97 143.17 27.29 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.584 -0.698 . . . . 0.0 109.175 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.991 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.5 Cg_endo -53.99 -59.25 0.98 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.424 1.223 . . . . 0.0 111.171 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -58.47 80.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.204 1.107 . . . . 0.0 110.415 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.77 149.88 3.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.924 -1.11 . . . . 0.0 109.532 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -104.15 137.13 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 110.82 -179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.502 HG21 ' CD1' ' A' ' 94' ' ' PHE . 68.7 p -123.31 -32.49 3.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.521 -0.737 . . . . 0.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 118' ' ' THR . 2.0 ttmt 175.02 -27.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.837 . . . . 0.0 110.475 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.33 -53.84 3.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.945 . . . . 0.0 110.708 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' C ' ' CE1' ' A' ' 123' ' ' HIS . . . -168.11 -144.73 4.28 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' A' ' 115' ' ' PRO . 4.7 m-85 -99.23 147.56 25.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.344 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.507 ' ND1' HD13 ' A' ' 44' ' ' LEU . 1.8 m-70 -149.7 140.15 22.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 114' ' ' PRO . 19.1 mt -89.66 125.39 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.014 -1.054 . . . . 0.0 109.852 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.828 HD11 ' CE1' ' A' ' 94' ' ' PHE . 44.9 mt -118.13 110.94 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.456 -0.778 . . . . 0.0 110.219 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.614 ' HE1' HD21 ' A' ' 58' ' ' LEU . 6.0 ptp -115.07 121.67 43.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.991 -1.068 . . . . 0.0 109.831 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 103' ' ' VAL . 16.5 t -89.72 150.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.713 -0.617 . . . . 0.0 110.185 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.64 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -145.37 89.57 1.95 Allowed 'General case' 0 C--O 1.203 -1.36 0 CA-C-O 122.88 1.324 . . . . 0.0 111.516 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.38 116.39 1.54 Allowed Glycine 0 C--N 1.278 -2.666 0 O-C-N 120.828 -1.17 . . . . 0.0 110.784 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptp180 -110.75 166.65 10.85 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.448 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.509 ' N ' ' HD3' ' A' ' 131' ' ' LYS . 3.0 mmtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.145 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -105.81 117.33 33.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -1.09 . . . . 0.0 110.17 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.21 -85.58 0.62 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.22 147.67 94.98 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.666 1.35 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -177.14 161.94 1.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.0 110.053 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.39 143.37 17.87 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.75 -151.02 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . -132.16 -43.38 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' N ' ' OXT' ' A' ' 131' ' ' LYS . 75.7 m-20 55.2 17.61 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 110.191 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -103.2 150.11 24.01 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG12 ' CG ' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -150.17 150.48 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 tptp -88.85 89.74 8.11 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.702 -1.999 . . . . 0.0 109.424 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 126' ' ' MET . 6.4 p -96.93 144.75 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 111.573 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.609 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 8.2 mtt180 -125.15 110.89 14.65 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' HD2' HD23 ' A' ' 82' ' ' LEU . 70.2 m-70 -90.04 126.2 35.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 111.628 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.647 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 9.0 mt -124.37 107.92 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.694 HD12 ' CB ' ' A' ' 73' ' ' GLU . 35.8 mt -89.48 117.36 28.34 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.295 -0.878 . . . . 0.0 111.155 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 8.0 p -49.33 -21.83 0.95 Allowed 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 118.767 -1.173 . . . . 0.0 108.235 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 8.6 tp10 68.26 -54.89 0.52 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.497 -0.752 . . . . 0.0 110.368 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 6.9 mttt -108.93 3.82 22.69 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.914 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.62 ' NE2' ' CD1' ' A' ' 122' ' ' TYR . 17.0 m80 56.7 15.93 2.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.314 -0.866 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -110.73 -6.78 26.4 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -123.14 -6.94 8.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.554 -0.968 . . . . 0.0 108.989 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 10.5 tp -45.57 -29.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.325 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.601 ' H ' ' HE2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.33 -29.88 17.81 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.645 -0.822 . . . . 0.0 108.956 178.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.2 tt0 -69.84 -29.74 67.07 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.556 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -73.62 -32.23 63.96 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -70.11 -44.32 69.24 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.366 0.603 . . . . 0.0 109.753 178.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' ' 57' ' ' LYS . 11.0 mt-10 -74.26 -65.33 0.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.483 -0.761 . . . . 0.0 110.889 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.822 ' HB3' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -37.95 -56.97 1.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.361 -0.837 . . . . 0.0 110.318 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.701 HD23 ' HE1' ' A' ' 64' ' ' PHE . 1.8 mp -59.56 -31.04 69.06 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 111.561 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.589 ' CG ' ' N ' ' A' ' 60' ' ' SER . 2.3 tttt -90.28 -70.96 0.64 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.661 -1.274 . . . . 0.0 110.473 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.589 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 1.3 m -34.5 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.325 0.583 . . . . 0.0 110.785 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 113.1 38.63 1.23 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.598 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 2.3 tpp -95.78 -141.56 0.26 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.106 -1.231 . . . . 0.0 109.317 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 8.1 mtt85 -78.31 126.55 30.95 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.722 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.701 ' HE1' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -87.19 -37.27 17.45 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.855 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 6.3 p30 -89.9 -36.75 14.86 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.54 -0.725 . . . . 0.0 112.298 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 31.7 mm-40 -58.97 -55.86 29.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.244 -1.535 . . . . 0.0 107.153 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 57' ' ' LYS . 16.5 m -49.93 -46.66 23.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.909 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . . . -47.56 -46.46 27.96 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.669 0.747 . . . . 0.0 109.011 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -44.01 -68.87 0.16 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -91.05 -65.04 1.05 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.036 -1.066 . . . . 0.0 112.206 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.604 ' CE2' HG12 ' A' ' 67' ' ' VAL . 5.6 m-30 -36.11 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -91.57 -177.25 4.75 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.029 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.694 ' CB ' HD12 ' A' ' 44' ' ' LEU . 3.5 pt-20 -70.98 60.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 51.8 t0 71.57 -48.35 0.67 Allowed 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.995 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.2 mmtm -54.92 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.972 -1.08 . . . . 0.0 109.469 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.885 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . . . -171.0 -135.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.766 -1.209 . . . . 0.0 110.925 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 68.46 105.64 0.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 -179.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 1.3 tm0? 64.7 -34.57 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.629 -0.669 . . . . 0.0 111.959 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.909 ' HA2' ' HB2' ' A' ' 68' ' ' ALA . . . 159.2 -51.31 0.39 Allowed Glycine 0 N--CA 1.481 1.676 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . -167.23 20.58 0.1 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' OD1' ' HB3' ' A' ' 77' ' ' ARG . 13.1 p30 -60.16 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.957 -1.319 . . . . 0.0 109.728 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -74.42 -1.53 21.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 84' ' ' TRP . . . 116.84 156.82 10.69 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.531 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 28.6 m95 -40.62 161.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -1.056 . . . . 0.0 109.693 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.0 mmt -148.49 133.71 18.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.868 -1.145 . . . . 0.0 111.098 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 3.0 t -147.32 151.15 36.11 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.451 1.119 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' CG ' ' OE1' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -42.55 159.44 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.216 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.43 -27.52 16.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 90' ' ' MET . 4.2 m -122.34 -37.26 2.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -1.167 . . . . 0.0 110.114 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 89' ' ' SER . 1.4 mtt -52.14 -174.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 92' ' ' GLY . 1.9 t -103.83 -143.53 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.311 -0.868 . . . . 0.0 109.789 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -86.96 -78.35 1.24 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -63.13 -34.04 70.63 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.768 1.404 . . . . 0.0 110.472 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.445 ' HB2' ' HB ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -42.55 -64.5 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 110.526 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' OE1' ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -67.6 -33.7 75.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.73 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.9 mt-10 -55.18 -35.25 64.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -0.965 . . . . 0.0 110.601 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -88.53 -82.9 0.23 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 110.245 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.8 -60.98 0.67 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.577 -0.702 . . . . 0.0 111.183 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -55.29 -57.5 11.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.199 -0.938 . . . . 0.0 110.832 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.53 -52.38 61.4 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 0.0 110.491 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 2.8 mm? -61.44 161.96 16.9 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.54 ' O ' HG23 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -60.87 167.33 8.87 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.901 1.474 . . . . 0.0 110.808 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 104' ' ' SER . 2.2 t -67.26 176.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 109.445 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 26.8 m 59.49 167.39 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.335 -0.853 . . . . 0.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 107' ' ' ASP . . . -163.09 -99.45 0.14 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 108' ' ' LYS . 31.6 ttp 54.38 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -1.139 . . . . 0.0 110.087 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 105' ' ' GLY . 61.1 t0 -178.14 60.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.118 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 176.37 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.287 -0.883 . . . . 0.0 110.905 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.3 Cg_exo -57.4 -79.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.204 0 O-C-N 123.25 1.132 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -53.17 -170.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.094 -1.004 . . . . 0.0 109.837 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.717 ' N ' HG13 ' A' ' 110' ' ' VAL . 23.4 m-85 -121.22 -44.19 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.932 -1.105 . . . . 0.0 111.351 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.463 ' HB ' HD11 ' A' ' 101' ' ' LEU . 10.2 t -53.93 -170.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 1.4 p30 -97.74 130.36 29.21 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.42 -0.8 . . . . 0.0 109.537 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.092 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -55.6 -57.28 1.66 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.453 1.238 . . . . 0.0 112.104 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.605 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -58.77 67.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.219 1.279 . . . . 0.0 111.519 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.855 HG23 ' NE2' ' A' ' 123' ' ' HIS . 14.5 m -90.13 150.41 3.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 120.992 -1.067 . . . . 0.0 109.618 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.596 ' C ' HG22 ' A' ' 118' ' ' THR . 31.6 tttm -113.17 146.84 38.57 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.27 -0.894 . . . . 0.0 110.819 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 117' ' ' LYS . 0.1 OUTLIER 170.28 -26.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.485 -0.759 . . . . 0.0 110.008 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -73.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.471 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -149.04 53.77 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 127.33 -154.56 19.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 7.6 m-85 -103.89 105.48 15.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -1.158 . . . . 0.0 109.605 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.855 ' NE2' HG23 ' A' ' 116' ' ' VAL . 10.4 p80 -101.31 141.74 33.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.954 -1.091 . . . . 0.0 110.979 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 114' ' ' PRO . 27.3 mt -89.5 115.2 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.781 HD11 ' HE1' ' A' ' 123' ' ' HIS . 34.1 mt -89.87 112.71 24.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.325 -0.859 . . . . 0.0 111.193 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.609 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -121.8 108.99 14.13 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 39' ' ' LYS . 97.4 t -89.5 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.8 OUTLIER -146.27 89.61 1.88 Allowed 'General case' 0 C--O 1.203 -1.369 0 CA-C-O 122.957 1.361 . . . . 0.0 111.121 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.531 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 88.29 115.52 1.26 Allowed Glycine 0 C--N 1.279 -2.599 0 O-C-N 120.84 -1.162 . . . . 0.0 111.25 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -138.46 162.76 33.66 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.582 -0.952 . . . . 0.0 109.735 178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.504 ' OXT' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.183 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -90.96 -7.12 52.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -1.167 . . . . 0.0 110.208 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -163.25 21.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.14 -154.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.616 1.324 . . . . 0.0 110.422 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 tttm 49.75 178.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.248 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.46 84.67 0.27 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.53 -140.45 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 131' ' ' LYS . . . 97.4 -160.32 21.25 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.453 ' O ' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER 52.89 25.33 3.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -1.205 . . . . 0.0 110.304 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.03 ' HB2' HG23 ' A' ' 86' ' ' THR . . . -142.2 127.2 18.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.245 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 130' ' ' ARG . 2.6 m -98.45 150.75 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.399 -0.813 . . . . 0.0 110.065 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.673 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 2.0 tmtp? -89.27 90.95 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.191 -1.568 . . . . 0.0 109.483 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.8 p -96.01 150.09 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 112.654 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' HD2' ' A' ' 77' ' ' ARG . 3.5 mtt180 -114.59 150.13 35.5 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' CG ' HD12 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -121.34 119.93 33.6 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -177.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -124.99 119.29 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 121.17 -0.956 . . . . 0.0 109.216 177.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.677 ' CD2' ' CB ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -104.31 150.81 24.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.301 -1.499 . . . . 0.0 110.988 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' HIS . 71.5 m -137.34 68.89 1.41 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -38.76 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.306 -0.871 . . . . 0.0 110.424 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' CYS . 12.8 mttt -97.29 -23.78 15.98 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.071 -1.018 . . . . 0.0 109.45 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.754 ' O ' HG22 ' A' ' 51' ' ' ILE . 48.4 m-70 62.77 9.8 3.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.768 -0.583 . . . . 0.0 110.807 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.99 -19.37 78.78 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.591 -2.203 . . . . 0.0 107.591 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -116.22 -15.67 11.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.645 -0.914 . . . . 0.0 109.535 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 48' ' ' HIS . 8.9 tp -47.43 -30.94 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.771 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -87.46 -41.07 13.8 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.3 tt0 -57.35 -29.7 64.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -67.58 -29.84 69.3 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 7.3 mtt -70.75 -48.24 55.47 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.956 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 60' ' ' SER . 1.3 mt-10 -70.28 -60.21 2.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.537 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.8 mttt -41.91 -72.0 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.812 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 67' ' ' VAL . 10.8 mp -44.47 -32.66 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.514 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' HG2' ' SD ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -81.34 -71.34 0.48 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.095 -1.003 . . . . 0.0 110.473 -179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -40.21 -36.66 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.517 -0.74 . . . . 0.0 110.146 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.81 33.76 1.5 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.537 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.8 tpp -78.63 -150.75 0.05 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.178 -1.189 . . . . 0.0 109.024 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.706 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.8 mtt180 -71.48 125.55 27.33 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.923 -1.111 . . . . 0.0 110.376 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 2.1 m-85 -88.71 -32.7 17.83 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.478 178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.48 -31.97 16.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.876 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.917 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.6 mm-40 -68.4 -51.93 38.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 108.123 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG23 ' H ' ' A' ' 68' ' ' ALA . 21.8 m -55.86 -54.8 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.56 -1.256 . . . . 0.0 108.011 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.732 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -48.14 -35.75 12.13 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.917 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -54.31 -76.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.19 -1.004 . . . . 0.0 108.791 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.646 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.02 -39.52 11.6 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 117.82 -1.552 . . . . 0.0 114.374 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.632 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -42.26 -29.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 76' ' ' ALA . 22.1 t -96.62 103.36 15.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 1.3 mp0 -67.69 55.36 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.982 -1.074 . . . . 0.0 110.632 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD2' HD12 ' A' ' 44' ' ' LEU . 3.1 p30 159.87 -110.03 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 122.112 -0.368 . . . . 0.0 110.469 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 3.2 mptt -45.66 -93.77 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.786 -1.196 . . . . 0.0 110.21 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.016 ' HB3' ' HA3' ' A' ' 80' ' ' GLY . . . 168.24 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' NH1' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER 143.6 -80.47 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.712 ' OE1' ' HE1' ' A' ' 126' ' ' MET . 3.8 mp0 -61.81 -91.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.544 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.22 -19.09 30.71 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 1.016 ' HA3' ' HB3' ' A' ' 76' ' ' ALA . . . -93.06 3.4 73.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 80' ' ' GLY . 31.0 t0 -29.21 112.65 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.025 -0.691 . . . . 0.0 110.94 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD12 ' CG ' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -39.4 -48.13 1.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.517 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 117.29 152.91 9.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.59 ' CZ3' ' HD2' ' A' ' 131' ' ' LYS . 45.3 m95 -41.69 118.11 1.04 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.379 -1.071 . . . . 0.0 110.023 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -127.43 136.43 51.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.56 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.03 HG23 ' HB2' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -96.4 150.03 21.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.595 -0.691 . . . . 0.0 110.166 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 ttp85 -48.74 163.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.151 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 87' ' ' ARG . . . 84.86 -52.51 4.71 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.5 t -95.04 46.89 1.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.122 . . . . 0.0 110.162 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.43 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -154.56 64.59 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.1 t 54.9 -139.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.876 . . . . 0.0 109.939 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.35 -87.04 0.68 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.36 -30.28 87.16 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.688 1.362 . . . . 0.0 110.56 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.597 ' CE2' ' CE1' ' A' ' 123' ' ' HIS . 8.7 t80 -54.96 -33.71 62.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 110.208 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' NE2' ' CG ' ' A' ' 87' ' ' ARG . 5.0 pt20 -89.0 -34.33 16.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 110.691 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.963 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -73.63 -30.0 62.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.059 -1.026 . . . . 0.0 110.608 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.687 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -89.5 -29.82 18.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.217 -0.927 . . . . 0.0 111.166 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 127' ' ' VAL . . . -105.55 -47.12 4.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.219 -0.925 . . . . 0.0 111.76 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.653 ' CD2' HG13 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -80.76 -20.02 43.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.057 -1.027 . . . . 0.0 110.479 -178.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.963 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -89.61 -42.94 11.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.943 -1.098 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 97' ' ' ALA . 16.3 mt -72.72 170.2 14.26 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.603 -0.686 . . . . 0.0 109.544 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 3.4 Cg_exo -51.46 143.84 34.01 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.42 1.221 . . . . 0.0 110.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.67 HG12 ' CG1' ' A' ' 127' ' ' VAL . 14.7 m -56.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 110.645 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.587 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 40.8 m 57.5 163.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.395 -0.816 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 125' ' ' ILE . . . -169.81 -107.96 0.2 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 28.1 ttp 60.31 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -1.175 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 55' ' ' MET . 14.3 p-10 -175.18 52.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.864 -1.148 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.592 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -177.48 -59.9 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.069 -1.019 . . . . 0.0 110.54 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -57.52 -150.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.239 1.126 . . . . 0.0 110.414 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.748 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.8 p 38.45 -157.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.549 -0.72 . . . . 0.0 110.084 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.748 ' H ' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -132.58 -29.1 1.57 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.633 -1.292 . . . . 0.0 111.091 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 112' ' ' THR . 2.1 t -96.92 177.06 5.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.036 -1.04 . . . . 0.0 111.042 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.533 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 8.4 p-10 -78.37 138.27 59.67 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.989 ' HB2' HG23 ' A' ' 124' ' ' ILE . 2.7 Cg_endo -60.36 -59.1 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.347 1.183 . . . . 0.0 112.631 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -60.73 71.72 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.409 1.406 . . . . 0.0 111.251 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 114' ' ' PRO . 6.0 m -97.36 150.52 4.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.087 -1.008 . . . . 0.0 110.355 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -89.67 138.85 31.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 111.488 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.528 HG23 ' C ' ' A' ' 117' ' ' LYS . 33.4 p -152.04 71.94 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.725 -0.61 . . . . 0.0 109.577 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.4 OUTLIER 62.91 32.12 15.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.581 -0.699 . . . . 0.0 110.737 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.18 -81.0 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -164.41 -161.71 14.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.601 ' CD2' ' NE2' ' A' ' 48' ' ' HIS . 15.0 m-85 -89.21 110.66 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.684 -1.48 . . . . 0.0 108.793 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CB ' ' CD2' ' A' ' 44' ' ' LEU . 31.7 p80 -107.85 146.06 32.82 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.222 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.989 HG23 ' HB2' ' A' ' 114' ' ' PRO . 27.4 mt -89.26 124.1 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -101.42 124.24 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.583 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.712 ' HE1' ' OE1' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -126.95 108.51 11.03 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.67 ' CG1' HG12 ' A' ' 103' ' ' VAL . 35.8 t -89.37 147.1 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -0.823 . . . . 0.0 110.666 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 5.4 tt0 -150.28 89.74 1.6 Allowed 'General case' 0 C--O 1.197 -1.675 0 O-C-N 121.271 -0.893 . . . . 0.0 111.968 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 99.79 110.05 3.11 Favored Glycine 0 C--N 1.282 -2.443 0 O-C-N 120.601 -1.312 . . . . 0.0 111.61 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -136.37 -175.47 4.01 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.64 -0.918 . . . . 0.0 110.381 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.59 ' HD2' ' CZ3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.199 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.81 74.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -1.155 . . . . 0.0 110.25 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.31 153.87 16.99 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.52 -157.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.702 1.37 . . . . 0.0 110.562 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.81 130.95 25.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.25 59.6 10.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.07 42.85 1.18 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' OXT' ' A' ' 131' ' ' LYS . . . 78.7 -163.39 49.76 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER 63.04 17.42 10.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.143 -1.21 . . . . 0.0 110.031 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.72 150.24 33.6 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.415 -0.803 . . . . 0.0 109.708 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 130' ' ' ARG . 1.7 m -149.36 151.07 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 7.1 tptm -88.28 97.98 11.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.747 -1.846 . . . . 0.0 110.184 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.0 t -93.3 150.11 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.431 1.11 . . . . 0.0 112.987 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.576 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -139.57 150.22 44.78 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.89 ' CD2' HD22 ' A' ' 82' ' ' LEU . 8.1 p80 -143.66 137.87 28.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 119.937 -1.727 . . . . 0.0 114.299 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.047 HD12 ' HD3' ' A' ' 77' ' ' ARG . 1.1 tt -129.19 113.93 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.161 HD12 ' N ' ' A' ' 45' ' ' CYS 0.272 0.1 OUTLIER -105.63 150.14 25.69 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 120.58 -1.325 . . . . 0.0 108.949 -178.23 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.161 ' N ' HD12 ' A' ' 44' ' ' LEU . 23.2 m -128.7 110.63 12.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.76 -0.587 . . . . 0.0 109.891 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -63.51 -33.24 75.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 110.151 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 47.3 mttt -100.81 1.37 40.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.321 -0.862 . . . . 0.0 109.771 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.576 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 1.1 m80 57.54 15.03 2.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.96 -35.16 5.66 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -76.35 -18.48 58.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.987 . . . . 0.0 109.447 179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' N ' ' A' ' 52' ' ' MET . 8.4 tp -53.48 -45.63 58.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.555 ' CE ' ' HB2' ' A' ' 56' ' ' GLU . 1.7 tmm? -72.49 -45.51 59.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.455 -0.778 . . . . 0.0 109.118 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 1.3 tt0 -55.11 -29.64 58.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.776 ' O ' HD22 ' A' ' 58' ' ' LEU . . . -78.51 -33.13 48.28 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.508 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 1.4 mmt -73.15 -53.06 11.95 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.843 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.555 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 1.9 tt0 -68.56 -66.57 0.56 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 111.053 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' CB ' ' HG3' ' A' ' 62' ' ' MET . 0.3 OUTLIER -40.81 -60.69 1.11 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.312 -0.868 . . . . 0.0 110.513 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.776 HD22 ' O ' ' A' ' 54' ' ' ALA . 8.2 mp -45.79 -35.0 4.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.948 -1.095 . . . . 0.0 109.278 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.561 ' HG2' ' HE3' ' A' ' 106' ' ' MET . 0.4 OUTLIER -84.73 -63.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -35.78 -46.49 0.45 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.751 -0.593 . . . . 0.0 110.832 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 136.37 9.71 1.36 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.865 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.543 ' HG3' ' CB ' ' A' ' 57' ' ' LYS . 7.0 mmt -60.87 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.661 -1.493 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.644 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -106.45 156.18 18.81 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.267 -0.895 . . . . 0.0 110.523 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.733 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 18.1 m-85 -90.41 -29.09 18.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -89.89 -36.73 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.543 -0.723 . . . . 0.0 111.55 -178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.844 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 5.5 mm-40 -61.98 -61.61 2.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.678 -1.264 . . . . 0.0 107.783 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.953 HG12 ' CE2' ' A' ' 71' ' ' TYR . 22.4 m -54.73 -51.87 47.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.353 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 64' ' ' PHE . . . -48.93 -29.9 5.3 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -60.07 -73.89 0.08 Allowed 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.93 179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.639 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.74 -43.28 9.65 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.107 -1.437 . . . . 0.0 112.785 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.953 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.7 m-30 -46.46 -29.31 1.68 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.989 -1.069 . . . . 0.0 108.64 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.611 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 35.8 t -84.58 -12.27 54.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.678 -0.638 . . . . 0.0 110.634 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.745 ' OE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER 27.16 83.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.713 1.244 . . . . 0.0 111.028 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 7.7 t0 90.46 113.46 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.93 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 0.8 OUTLIER 68.58 76.65 0.24 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 109.599 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . -44.15 176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.681 0.753 . . . . 0.0 112.33 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 1.047 ' HD3' HD12 ' A' ' 43' ' ' ILE . 13.8 ttp180 -87.4 -75.15 0.42 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.761 -0.587 . . . . 0.0 110.295 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.512 ' HG3' ' HB3' ' A' ' 64' ' ' PHE . 22.5 mm-40 -81.73 -49.78 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 108.957 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.11 57.79 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -121.22 -10.19 6.86 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 77' ' ' ARG . 43.4 p-10 -40.68 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.307 -1.113 . . . . 0.0 110.625 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -43.86 -27.0 0.3 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.062 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 92.16 -163.38 27.81 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.535 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 20.4 m95 -43.68 140.07 1.98 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.6 mmm -146.31 139.75 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.161 -0.962 . . . . 0.0 110.358 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -125.58 149.95 47.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -0.921 . . . . 0.0 110.233 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.455 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -41.98 -28.23 0.16 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.803 . . . . 0.0 110.394 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -59.91 -17.59 43.96 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.472 ' HB3' ' SD ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -112.34 -66.76 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -1.157 . . . . 0.0 110.244 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.666 ' O ' HG13 ' A' ' 91' ' ' VAL . 5.9 ptp -51.01 164.88 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 90' ' ' MET . 12.4 m -158.89 -176.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.858 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 91' ' ' VAL . . . 42.69 -144.97 1.02 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.32 -29.94 91.54 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.58 1.305 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -41.92 -45.73 3.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 110.543 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -89.99 -38.95 13.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.189 -0.945 . . . . 0.0 110.709 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 5.4 mt-10 -52.96 -40.26 63.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.764 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.737 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -90.07 -83.95 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.125 -0.984 . . . . 0.0 110.469 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' N ' HD12 ' A' ' 101' ' ' LEU . . . -38.14 -68.45 0.15 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.687 -0.633 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.565 ' CD1' ' SD ' ' A' ' 90' ' ' MET . 1.5 t80 -41.05 -53.81 2.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 110.674 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -87.22 17.77 4.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.409 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.737 HD12 ' C ' ' A' ' 97' ' ' ALA . 13.2 mt -110.6 149.55 40.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.613 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 101' ' ' LEU . 2.7 Cg_endo -64.54 147.75 90.37 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.765 1.402 . . . . 0.0 110.751 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 6.2 m -57.99 177.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.258 -0.901 . . . . 0.0 110.432 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.571 ' HB3' ' CB ' ' A' ' 109' ' ' PRO . 2.3 m 58.55 128.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.57 -0.706 . . . . 0.0 110.731 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -143.56 -108.02 0.62 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.561 ' HE3' ' HG2' ' A' ' 59' ' ' LYS . 45.5 ttp 68.6 -73.97 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.626 -0.926 . . . . 0.0 111.113 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 3.7 p30 -171.57 39.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.682 -1.262 . . . . 0.0 111.273 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 9.2 tppt? -169.1 -63.45 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 110.854 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -56.85 -150.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.033 1.017 . . . . 0.0 110.757 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' N ' ' A' ' 111' ' ' PHE . 0.8 OUTLIER 52.72 -176.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 110.066 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 110' ' ' VAL . 0.2 OUTLIER -113.58 -33.32 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.2 t -99.47 -165.37 1.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.91 . . . . 0.0 110.277 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.13 139.23 34.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.001 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.787 ' CB ' HG23 ' A' ' 124' ' ' ILE . 4.2 Cg_exo -56.86 -53.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.362 1.19 . . . . 0.0 111.388 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.612 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -64.16 79.13 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.532 1.28 . . . . 0.0 110.485 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.0 m -89.9 150.09 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.144 -0.972 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -112.45 126.23 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 21.9 p -111.93 -43.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER -177.02 39.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.15 -48.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . -177.61 -156.83 17.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 9.2 m-30 -94.94 137.9 33.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.375 -1.073 . . . . 0.0 110.046 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.706 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.5 m-70 -140.01 140.15 36.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.133 -0.979 . . . . 0.0 109.746 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.816 HD12 HG21 ' A' ' 43' ' ' ILE . 46.7 mt -89.6 104.48 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.679 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 98' ' ' ALA . 19.7 mt -89.72 120.16 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.317 -0.864 . . . . 0.0 110.478 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.616 ' HE1' ' CZ ' ' A' ' 77' ' ' ARG . 7.7 mtm -112.36 108.41 17.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.183 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -89.64 145.04 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.621 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -148.2 89.9 1.77 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.935 1.35 . . . . 0.0 112.123 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.535 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 89.98 115.96 1.66 Allowed Glycine 0 C--N 1.277 -2.697 0 O-C-N 121.041 -1.037 . . . . 0.0 110.782 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -125.63 172.37 9.81 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.042 179.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 11.6 mtpt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.281 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 p -83.72 -48.99 9.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -1.149 . . . . 0.0 110.227 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.16 -76.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.45 92.25 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.728 1.383 . . . . 0.0 110.638 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -118.17 -13.88 9.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.216 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.8 -86.33 0.86 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.14 -24.3 0.46 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.03 65.19 0.1 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.816 ' O ' HG22 ' A' ' 86' ' ' THR . 16.8 t-20 -82.22 -72.99 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.22 -1.165 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -113.83 150.14 33.99 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 110.15 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.919 ' HB ' HG13 ' A' ' 127' ' ' VAL . 10.8 m -150.43 150.27 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tmtp? -89.47 93.58 9.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 117.306 -1.757 . . . . 0.0 107.689 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.7 HG13 HG23 ' A' ' 38' ' ' VAL . 33.4 m -89.88 144.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.03 0.919 . . . . 0.0 113.241 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' CB ' ' SD ' ' A' ' 126' ' ' MET . 19.2 mtt180 -126.76 150.23 49.22 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.939 ' CD2' HD13 ' A' ' 82' ' ' LEU . 4.4 m-70 -125.3 126.44 45.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.609 -1.307 . . . . 0.0 112.471 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.726 ' CD1' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -134.71 114.43 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -127.77 147.95 50.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.875 -1.141 . . . . 0.0 110.531 -178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.045 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.8 m -125.28 98.23 5.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -0.903 . . . . 0.0 109.953 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -50.54 -37.94 42.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.659 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 10.3 mttt -72.77 -12.47 61.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.117 -0.989 . . . . 0.0 110.282 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 2.7 m80 58.44 12.36 2.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.459 -0.775 . . . . 0.0 110.425 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.83 -27.8 6.9 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.321 -1.912 . . . . 0.0 108.321 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.622 ' HB3' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -97.16 -24.68 15.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.657 -0.908 . . . . 0.0 109.321 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -41.5 -32.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.736 -0.786 . . . . 0.0 109.666 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.548 ' CE ' ' CG ' ' A' ' 56' ' ' GLU . 2.1 tpt -86.86 -45.13 11.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -57.6 -29.7 64.72 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.85 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -64.99 -29.84 70.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.531 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 6.2 ttm -86.08 -49.18 7.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' CG ' ' CE ' ' A' ' 52' ' ' MET . 0.1 OUTLIER -60.46 -55.62 31.28 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.366 -0.834 . . . . 0.0 108.957 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 1.8 mmmm -48.43 -68.39 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.896 . . . . 0.0 109.335 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 54' ' ' ALA . 79.4 mt -48.59 -32.96 8.92 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.251 -0.905 . . . . 0.0 109.888 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' CD ' ' CG ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -75.06 -64.46 1.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 p -39.84 -63.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.58 -0.7 . . . . 0.0 110.335 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 62' ' ' MET . . . 159.81 -18.11 0.23 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.397 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.562 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.13 147.06 1.14 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.793 -1.416 . . . . 0.0 109.526 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.598 ' O ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -36.65 154.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.812 -0.555 . . . . 0.0 109.844 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' HD23 ' A' ' 58' ' ' LEU . 9.2 m-30 -90.77 -29.24 17.74 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.603 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 69' ' ' ALA . 8.0 p30 -84.84 -29.71 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.354 -0.841 . . . . 0.0 113.014 -177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 41.3 mm-40 -67.36 -53.91 25.24 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -56.77 -68.87 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 176.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.794 ' N ' HG22 ' A' ' 67' ' ' VAL . . . -44.05 -33.05 1.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.118 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -41.21 -72.29 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.535 -1.284 . . . . 0.0 107.535 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.28 -53.95 4.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.669 -1.213 . . . . 0.0 111.072 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 50' ' ' LYS . 59.1 m-85 -36.2 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.592 ' O ' ' N ' ' A' ' 74' ' ' ASP . 6.4 t -89.13 77.99 7.46 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 0.9 OUTLIER -63.71 62.36 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.356 1.074 . . . . 0.0 109.75 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 72' ' ' SER . 3.8 t70 168.73 -82.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.545 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.769 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -69.75 -16.22 63.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.105 -0.997 . . . . 0.0 110.892 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 75' ' ' LYS . . . 75.8 -154.55 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.96 0.886 . . . . 0.0 111.92 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -44.14 157.35 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.846 -0.534 . . . . 0.0 109.889 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' N ' ' CB ' ' A' ' 68' ' ' ALA . 36.5 mm-40 -52.46 -23.99 7.11 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 77' ' ' ARG . . . -49.54 -27.06 8.05 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 106.822 -2.511 . . . . 0.0 106.822 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -65.05 -11.44 51.45 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' C ' ' O ' ' A' ' 80' ' ' GLY . 26.8 t0 -32.56 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.839 -0.801 . . . . 0.0 111.025 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.939 HD13 ' CD2' ' A' ' 42' ' ' HIS . 1.4 mp -40.98 -37.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.426 -0.796 . . . . 0.0 110.246 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 39' ' ' LYS . . . 105.56 -173.81 20.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.639 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 74.1 m95 -52.43 134.71 34.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.534 -0.98 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 21.3 mmt -150.15 150.12 31.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 0.0 110.563 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.3 OUTLIER -126.38 147.63 49.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.101 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.543 ' N ' ' CZ ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -42.55 127.45 3.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 110.27 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.38 -14.56 2.74 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.93 59.96 0.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.264 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB3' ' CG ' ' A' ' 95' ' ' GLN . 1.5 ttp -155.79 54.48 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.303 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 92' ' ' GLY . 19.0 t 58.98 176.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.262 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -92.49 -72.6 1.21 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.2 Cg_exo -59.52 -39.06 78.86 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.593 1.312 . . . . 0.0 110.98 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.64 ' CZ ' ' CE1' ' A' ' 42' ' ' HIS . 19.0 t80 -46.9 -37.51 9.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 110.218 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.524 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 22.9 mt-30 -84.1 -41.85 16.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.738 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.6 mm-40 -41.88 -34.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 101' ' ' LEU . . . -90.16 -83.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -39.31 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.525 -0.734 . . . . 0.0 110.931 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CZ ' ' N ' ' A' ' 87' ' ' ARG . 2.4 m-85 -40.69 -61.05 1.01 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.324 -0.86 . . . . 0.0 110.595 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -62.91 -12.33 24.48 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.438 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.961 HD22 HG21 ' A' ' 110' ' ' VAL . 40.3 mt -110.01 150.68 41.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 0.0 110.471 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.8 Cg_endo -61.9 178.15 0.84 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.679 1.357 . . . . 0.0 110.678 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 128' ' ' GLU . 3.1 t -59.47 154.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 0.0 109.713 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.57 ' HB2' ' HA ' ' A' ' 109' ' ' PRO . 27.6 p -175.58 -129.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.845 -1.159 . . . . 0.0 111.712 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 77.0 160.14 10.83 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.845 ' HE2' ' N ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER 61.41 -159.97 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -1.107 . . . . 0.0 110.401 178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.845 ' N ' ' HE2' ' A' ' 106' ' ' MET . 13.5 t0 -68.24 10.63 0.22 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.803 -1.186 . . . . 0.0 112.718 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.727 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -131.24 51.61 7.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.601 -1.312 . . . . 0.0 109.61 178.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -65.59 -177.78 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.521 1.274 . . . . 0.0 111.411 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 112' ' ' THR . 2.7 p -99.88 173.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.382 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' N ' HG22 ' A' ' 110' ' ' VAL . 72.6 m-85 -27.22 -46.17 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.315 0.579 . . . . 0.0 111.299 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 110' ' ' VAL . 10.8 t -74.86 -157.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.419 -0.801 . . . . 0.0 110.251 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -122.25 152.77 61.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.017 ' HB2' HG23 ' A' ' 124' ' ' ILE . 3.7 Cg_exo -58.91 -53.44 3.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.302 . . . . 0.0 111.838 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD3' ' CG ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.06 74.26 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.046 1.164 . . . . 0.0 110.594 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.96 150.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.155 -0.965 . . . . 0.0 110.294 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 31.0 ttpt -95.91 148.69 22.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.21 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.1 p -136.15 -44.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.46 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.337 -0.852 . . . . 0.0 110.0 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -93.41 -41.09 10.01 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 0.0 110.139 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . 177.27 -151.56 11.15 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CE1' ' HB2' ' A' ' 117' ' ' LYS . 24.4 m-85 -96.04 129.36 43.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -1.114 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.936 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.3 m-70 -124.84 146.47 49.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.156 -0.965 . . . . 0.0 109.769 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.017 HG23 ' HB2' ' A' ' 114' ' ' PRO . 23.7 mt -89.78 108.88 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.884 -1.135 . . . . 0.0 108.899 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.836 HG21 ' HB2' ' A' ' 98' ' ' ALA . 10.6 mt -89.78 135.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.358 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.62 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -127.51 97.4 4.86 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.56 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.921 ' CG2' ' HB1' ' A' ' 98' ' ' ALA . 92.7 t -89.58 109.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.625 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.0 tt0 -150.43 99.04 2.73 Favored 'General case' 0 C--O 1.196 -1.728 0 O-C-N 121.29 -0.881 . . . . 0.0 109.471 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.639 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 130.47 82.02 0.26 Allowed Glycine 0 C--N 1.277 -2.746 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ptm180 -123.22 -159.77 0.86 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.385 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 130' ' ' ARG . 12.6 mtpp . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.89 -162.02 1.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -1.165 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.57 -168.64 12.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.21 98.27 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.737 1.388 . . . . 0.0 110.48 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 1.2 tttt -102.73 -5.73 23.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.322 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.68 -44.7 0.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.8 -80.32 0.29 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -95.73 -144.51 16.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.32 -48.57 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 110.253 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -150.11 119.41 6.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.804 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG12 ' HG2' ' A' ' 130' ' ' ARG . 2.8 m -100.11 150.3 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.313 -0.867 . . . . 0.0 110.152 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 8.2 tptp -88.47 94.26 9.81 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 117.913 -1.515 . . . . 0.0 108.657 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.081 ' CG2' HG23 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -96.77 127.09 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.517 0.675 . . . . 0.0 111.927 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NH1' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -105.91 133.81 50.03 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 75' ' ' LYS . 13.1 p80 -118.69 118.68 32.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.58 -1.325 . . . . 0.0 113.955 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.795 HG23 ' HB2' ' A' ' 72' ' ' SER . 2.9 mt -107.42 126.71 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD22 ' CB ' ' A' ' 123' ' ' HIS . 0.1 OUTLIER -110.05 150.88 27.91 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 119.97 -1.706 . . . . 0.0 113.583 -176.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' O ' ' N ' ' A' ' 48' ' ' HIS . 81.8 m -144.81 72.49 1.34 Allowed 'General case' 0 C--N 1.288 -2.077 0 O-C-N 121.389 -0.819 . . . . 0.0 109.037 177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' CYS . 4.9 mm-40 -36.07 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.784 -0.572 . . . . 0.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.9 ptpp? -109.25 -16.16 14.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.861 ' CD2' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER 68.57 15.52 9.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.534 0.683 . . . . 0.0 110.916 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.16 -18.92 79.45 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -115.66 -21.52 9.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.582 -0.952 . . . . 0.0 109.866 179.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.861 HG21 ' CD2' ' A' ' 48' ' ' HIS . 4.2 tp -44.79 -28.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.154 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.542 ' O ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -87.51 -46.86 9.21 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 2.4 tt0 -54.16 -29.3 45.02 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 71' ' ' TYR . . . -83.14 -30.54 27.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.534 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -76.78 -41.69 43.65 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.494 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -66.76 -60.56 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.893 . . . . 0.0 109.567 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 62' ' ' MET . 3.1 mptt -42.17 -67.58 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 109.382 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.6 OUTLIER -40.11 -33.22 0.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.822 179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.9 OUTLIER -84.92 -66.95 0.84 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.414 -0.804 . . . . 0.0 109.845 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.53 ' OG ' ' HA ' ' A' ' 57' ' ' LYS . 5.2 p -37.79 -42.07 0.56 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.598 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.25 15.75 6.43 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.597 ' HB3' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER -78.05 -141.06 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.182 -1.187 . . . . 0.0 109.69 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 26.5 mtt85 -75.07 128.42 35.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.405 -0.81 . . . . 0.0 110.561 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -90.06 -38.81 13.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 8.0 p-10 -91.26 -41.7 10.81 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.248 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 63' ' ' ARG . 8.4 mt-10 -52.73 -45.49 66.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.651 HG23 ' N ' ' A' ' 68' ' ' ALA . 12.2 m -64.01 -44.08 97.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . . . -55.15 -29.6 58.1 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.059 0.933 . . . . 0.0 109.093 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -64.73 -78.11 0.05 Allowed 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.739 -1.184 . . . . 0.0 108.736 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.583 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -92.37 -42.09 9.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.727 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.1 m-30 -47.13 -29.53 2.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB2' HG23 ' A' ' 43' ' ' ILE . 1.9 t -91.61 -120.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.587 ' N ' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER 173.31 35.56 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.545 -1.347 . . . . 0.0 110.263 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 5.3 t70 -176.87 -133.65 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.459 -0.776 . . . . 0.0 109.821 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -56.32 151.02 13.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.015 -1.053 . . . . 0.0 110.001 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . . . -144.23 -109.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER 66.97 3.98 3.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.923 -1.111 . . . . 0.0 111.689 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.601 ' N ' ' CB ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 169.8 -40.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.021 -1.05 . . . . 0.0 109.673 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.848 ' HA2' ' HB2' ' A' ' 68' ' ' ALA . . . 166.54 38.01 0.02 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 91.1 19.59 42.12 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 4.1 t0 -55.89 81.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.328 -1.101 . . . . 0.0 110.666 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -63.85 -32.97 74.67 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.035 -1.041 . . . . 0.0 109.338 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 126.84 154.63 8.63 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.602 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 13.5 m95 -43.53 144.82 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.634 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -150.02 150.06 31.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 110.85 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' ARG . 3.3 t -121.08 151.14 40.18 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.393 1.092 . . . . 0.0 110.857 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' HA ' ' HB2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -40.13 -29.61 0.08 Allowed 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.267 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -56.93 -33.23 63.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 m -111.34 20.78 16.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.089 -1.242 . . . . 0.0 110.517 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.489 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 1.4 ttt -105.63 172.49 6.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.061 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 94' ' ' PHE . 17.3 m -109.56 -120.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.399 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -109.53 -76.91 0.93 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.627 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.2 Cg_exo -57.98 -39.79 83.18 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.675 1.355 . . . . 0.0 110.96 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . 4.4 t80 -53.24 -46.61 69.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.069 -1.019 . . . . 0.0 110.377 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 2.0 tt0 -87.4 -42.44 12.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.254 -0.904 . . . . 0.0 110.172 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 20.3 mt-10 -44.45 -66.61 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.462 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -56.68 -60.84 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 110.404 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -44.88 -77.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.403 -0.811 . . . . 0.0 110.509 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 1.6 m-85 -42.75 -31.79 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.311 -0.868 . . . . 0.0 110.513 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.2 -42.73 25.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.0 110.3 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 110' ' ' VAL . 4.2 pp -88.18 163.71 36.0 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 110.428 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.3 Cg_endo -67.3 157.27 62.51 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.804 1.669 . . . . 0.0 112.318 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.73 HG22 ' CG1' ' A' ' 127' ' ' VAL . 2.1 t -49.34 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 109.092 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.68 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 26.5 m 69.65 -177.31 0.21 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 121.735 0.779 . . . . 0.0 111.882 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.481 ' CA ' ' HG2' ' A' ' 126' ' ' MET . . . -172.56 -120.55 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' PRO . 46.9 ttp 61.41 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.108 . . . . 0.0 110.241 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 106' ' ' MET . 1.7 p30 173.79 64.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.006 -1.059 . . . . 0.0 111.259 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER 174.02 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.828 -1.17 . . . . 0.0 111.425 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 3.0 Cg_endo -61.25 -63.25 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.237 1.125 . . . . 0.0 111.535 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -47.8 -169.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-O 122.555 1.169 . . . . 0.0 112.282 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.545 ' HB2' ' CD ' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -118.17 -16.84 9.7 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.64 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.464 HG22 HD22 ' A' ' 101' ' ' LEU . 12.8 t -113.84 -158.52 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.365 -0.834 . . . . 0.0 110.571 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 113' ' ' ASP . 2.3 p30 -104.19 129.62 24.82 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.973 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.1 Cg_exo -54.18 -59.86 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.25 1.132 . . . . 0.0 112.169 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.601 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 3.0 Cg_endo -55.31 77.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.479 1.252 . . . . 0.0 110.983 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.3 m -102.86 150.29 6.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.197 -0.939 . . . . 0.0 110.314 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -94.56 147.23 23.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 110.723 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.627 HG22 ' HB2' ' A' ' 93' ' ' PRO . 52.3 p -151.27 -83.4 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.252 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' N ' ' OG1' ' A' ' 118' ' ' THR . 24.0 mtmt -136.76 48.1 2.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 110.083 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.52 -33.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.928 . . . . 0.0 110.105 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 151.63 -157.28 27.14 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.702 ' CB ' ' CE1' ' A' ' 48' ' ' HIS . 21.6 m-85 -89.77 132.99 34.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -1.162 . . . . 0.0 110.227 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.729 ' HE1' HD11 ' A' ' 125' ' ' ILE . 16.2 p80 -137.37 147.78 45.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 110.527 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.973 HG23 ' CB ' ' A' ' 114' ' ' PRO . 14.3 mt -89.61 121.73 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.081 HG23 ' CG2' ' A' ' 40' ' ' VAL . 16.0 mt -101.46 119.08 49.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.048 -1.033 . . . . 0.0 111.506 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 19.9 mtm -115.37 112.1 21.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.747 HG13 ' HB ' ' A' ' 38' ' ' VAL . 14.9 t -89.33 142.94 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.087 -1.008 . . . . 0.0 110.546 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -150.06 89.88 1.63 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.357 1.075 . . . . 0.0 110.939 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 96.04 104.08 2.07 Favored Glycine 0 C--N 1.281 -2.498 0 O-C-N 120.368 -1.457 . . . . 0.0 110.115 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.806 ' HG2' HG12 ' A' ' 38' ' ' VAL . 28.6 mtm180 -95.4 9.11 41.13 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.797 -0.825 . . . . 0.0 110.595 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.512 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 1.1 mttt . . . . . 0 C--N 1.295 -1.784 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.059 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -119.13 41.96 2.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -1.127 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.75 -77.68 1.38 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.0 Cg_endo -61.28 -29.43 86.21 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.65 1.342 . . . . 0.0 110.607 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER 65.4 164.92 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 110.075 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.32 40.41 0.23 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.83 125.05 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.53 -178.45 32.53 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.489 ' CA ' ' O ' ' A' ' 131' ' ' LYS . 16.4 m-20 54.39 95.47 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.366 -1.079 . . . . 0.0 110.135 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.603 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . -149.03 113.82 5.38 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.824 -0.547 . . . . 0.0 109.756 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.779 ' HB ' HG23 ' A' ' 127' ' ' VAL . 3.2 m -90.18 150.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.376 -0.827 . . . . 0.0 110.233 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.53 92.18 9.0 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.236 -1.54 . . . . 0.0 107.527 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -108.44 150.06 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-O 122.237 1.018 . . . . 0.0 113.445 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -127.86 150.09 50.0 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.955 ' NE2' HD12 ' A' ' 82' ' ' LEU . 2.2 m-70 -132.8 150.1 52.2 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.221 -1.549 . . . . 0.0 113.047 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.658 HG23 ' CA ' ' A' ' 72' ' ' SER . 14.1 mt -141.18 119.22 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.109 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -116.71 144.89 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.754 -1.216 . . . . 0.0 110.849 -178.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.109 ' N ' HD12 ' A' ' 44' ' ' LEU . 77.7 m -118.89 118.1 30.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 109.85 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.37 -40.63 97.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.205 -0.934 . . . . 0.0 110.854 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -91.77 -0.53 57.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.074 -1.016 . . . . 0.0 110.191 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.6 m80 57.23 13.93 1.88 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 0.0 110.598 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.51 -66.77 1.24 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.49 -19.39 5.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.105 . . . . 0.0 109.752 179.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -46.09 -37.14 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.991 -1.068 . . . . 0.0 108.866 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.579 ' HE3' ' CA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -83.2 -42.56 17.13 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 tt0 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.638 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -76.73 -29.89 56.38 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.679 ' HE1' ' HG3' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -77.19 -48.94 16.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OG ' ' A' ' 60' ' ' SER . 2.8 mt-10 -65.16 -56.57 12.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.396 -0.815 . . . . 0.0 109.523 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.59 ' CD ' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -42.77 -69.79 0.13 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.18 -0.95 . . . . 0.0 109.523 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.8 mp -40.23 -29.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.539 -0.725 . . . . 0.0 109.969 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 60' ' ' SER . 1.0 OUTLIER -89.7 -70.67 0.65 Allowed 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.298 -0.876 . . . . 0.0 110.065 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.501 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -31.89 -65.76 0.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.837 -0.539 . . . . 0.0 111.15 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.14 34.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.402 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 57' ' ' LYS . 3.3 mmt -93.35 -148.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.775 -1.427 . . . . 0.0 108.864 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.536 ' HD3' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -96.97 156.11 16.49 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.326 -0.859 . . . . 0.0 109.253 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 24.7 m-85 -90.36 -31.3 16.94 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.989 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 69' ' ' ALA . 15.3 p30 -90.98 -34.71 15.05 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.448 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.2 mm-40 -58.0 -56.77 17.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.173 -1.579 . . . . 0.0 107.229 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.032 HG12 ' CE2' ' A' ' 71' ' ' TYR . 2.0 m -50.9 -65.98 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.966 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -42.46 -35.15 0.96 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -44.57 -70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.698 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.55 -40.33 11.41 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.529 177.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.032 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.6 m-30 -51.08 -31.48 19.07 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.658 ' CA ' HG23 ' A' ' 43' ' ' ILE . 17.6 m -77.35 -16.16 59.04 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.212 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 3.5 tm-20 39.25 42.49 0.78 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.0 0.905 . . . . 0.0 109.727 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER 162.06 99.33 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.284 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.7 OUTLIER 66.81 143.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 109.584 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -124.42 -106.57 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.018 . . . . 0.0 110.647 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER 47.98 96.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.889 -1.132 . . . . 0.0 109.858 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' NE2' ' CA ' ' A' ' 79' ' ' GLY . 2.3 tm0? 60.84 -69.75 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.486 0.66 . . . . 0.0 109.419 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.729 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . -176.72 51.08 0.11 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 82' ' ' LEU . . . 78.5 34.64 35.15 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 44.0 p-10 -58.73 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -1.081 . . . . 0.0 110.497 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.955 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.3 mt -58.26 -28.08 64.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.745 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 95.89 165.34 34.23 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.616 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 47.9 m95 -40.73 116.86 0.75 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.547 -0.973 . . . . 0.0 110.081 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -136.03 140.02 43.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.572 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.3 t -106.41 151.28 25.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.383 1.087 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.433 ' HD2' ' CD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -43.1 -28.53 0.29 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.186 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -43.89 -29.61 1.46 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.25 99.0 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -1.203 . . . . 0.0 110.328 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.734 ' C ' HG23 ' A' ' 91' ' ' VAL . 2.4 ttt -160.86 36.9 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.155 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG23 ' C ' ' A' ' 90' ' ' MET . 1.9 t 70.53 -144.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.795 . . . . 0.0 110.352 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -125.56 -75.55 0.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HB2' ' HA ' ' A' ' 118' ' ' THR . 3.3 Cg_exo -56.95 -38.88 94.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.466 1.245 . . . . 0.0 110.286 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.635 ' HD1' HG21 ' A' ' 118' ' ' THR . 0.2 OUTLIER -48.21 -42.11 29.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.548 ' CG ' ' HB3' ' A' ' 90' ' ' MET . 25.7 mt-30 -74.19 -50.14 20.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.377 -0.827 . . . . 0.0 110.264 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.602 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.0 mt-10 -49.02 -30.62 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.86 . . . . 0.0 110.68 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.842 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -90.19 -80.72 0.31 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.134 -0.979 . . . . 0.0 110.633 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -54.43 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.808 . . . . 0.0 110.867 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -35.26 -54.77 0.64 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.565 -0.709 . . . . 0.0 111.19 -179.258 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -56.37 -51.0 69.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 110.271 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.842 HD12 ' O ' ' A' ' 97' ' ' ALA . 2.9 mt -84.36 160.52 56.74 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.515 ' O ' HG21 ' A' ' 110' ' ' VAL . 2.6 Cg_endo -65.12 155.37 68.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.516 1.272 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 127' ' ' VAL . 2.9 m -49.17 -177.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.391 -0.818 . . . . 0.0 110.821 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 5.0 m 97.18 119.99 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.901 0.858 . . . . 0.0 112.172 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . -144.29 -136.61 3.09 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.798 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 3.1 ttp 63.7 -156.96 0.32 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.973 -1.31 . . . . 0.0 110.498 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.798 ' H ' ' HE3' ' A' ' 106' ' ' MET . 8.1 t70 -75.48 3.71 8.79 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.013 -1.055 . . . . 0.0 110.789 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 2.8 tttt -141.18 56.37 6.33 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.704 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.5 Cg_exo -64.02 169.38 10.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 124.101 1.579 . . . . 0.0 112.167 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.803 HG13 ' N ' ' A' ' 111' ' ' PHE . 1.9 p -57.13 -144.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.91 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.803 ' N ' HG13 ' A' ' 110' ' ' VAL . 49.5 m-85 -67.59 -35.13 78.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 111.137 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.676 HG22 ' CG1' ' A' ' 110' ' ' VAL . 2.5 t -79.93 178.9 7.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.052 -1.03 . . . . 0.0 111.046 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.33 159.86 38.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.513 -0.742 . . . . 0.0 109.084 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.697 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -62.71 -57.98 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.421 1.222 . . . . 0.0 111.844 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.679 ' HG3' ' HE1' ' A' ' 55' ' ' MET . 2.5 Cg_endo -67.37 85.47 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 120.834 1.023 . . . . 0.0 110.151 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.739 HG21 HD12 ' A' ' 125' ' ' ILE . 3.2 m -89.73 150.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 110.001 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.7 OUTLIER -95.23 120.84 36.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.635 HG21 ' HD1' ' A' ' 94' ' ' PHE . 59.4 p -128.72 59.18 1.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.383 -0.823 . . . . 0.0 110.039 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 118' ' ' THR . 3.0 tttt 64.8 31.18 11.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.158 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -149.15 -51.5 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 110.32 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 165.2 -115.08 0.62 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CD2' ' HB2' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -117.17 125.96 52.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.248 -1.148 . . . . 0.0 109.89 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 116' ' ' VAL . 1.7 m-70 -136.51 135.52 38.61 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.974 -1.079 . . . . 0.0 110.692 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' A' ' 114' ' ' PRO . 12.9 mt -89.72 102.45 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 109.575 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 116' ' ' VAL . 28.4 mt -98.85 130.01 48.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 111.011 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.6 mtm -118.14 96.02 5.15 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -0.797 . . . . 0.0 109.064 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.009 HG22 HG12 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -89.13 123.21 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.607 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.1 tt0 -151.09 95.81 2.23 Favored 'General case' 0 C--O 1.198 -1.651 0 O-C-N 121.408 -0.808 . . . . 0.0 111.089 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 131.39 77.39 0.15 Allowed Glycine 0 C--N 1.281 -2.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.277 177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.674 ' HG2' HG12 ' A' ' 38' ' ' VAL . 29.2 mtm180 -98.29 162.43 13.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.834 -0.803 . . . . 0.0 109.674 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.602 ' HD2' ' CE3' ' A' ' 84' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -107.05 167.62 9.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -1.149 . . . . 0.0 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.58 -178.94 51.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.719 1.378 . . . . 0.0 110.496 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.79 82.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.211 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.6 89.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.38 -163.29 35.59 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.18 177.75 46.34 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 1.036 ' O ' HG22 ' A' ' 86' ' ' THR . 4.0 m120 55.42 94.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.991 . . . . 0.0 110.372 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 86' ' ' THR . . . -146.24 110.48 5.04 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.766 -0.584 . . . . 0.0 109.442 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.987 ' HB ' HG23 ' A' ' 127' ' ' VAL . 29.3 m -89.94 149.32 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.303 -0.873 . . . . 0.0 111.182 -179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.7 91.79 8.8 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.376 -1.452 . . . . 0.0 107.425 178.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 126' ' ' MET . 4.6 p -96.67 150.02 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 27.0 mtt180 -129.35 149.99 50.9 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.92 129.15 35.92 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.218 -1.551 . . . . 0.0 113.37 -178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -119.26 112.28 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 121.706 -0.621 . . . . 0.0 109.737 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -92.41 150.47 20.79 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.765 -1.21 . . . . 0.0 112.02 -179.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 51' ' ' ILE . 71.7 m -141.46 71.98 1.37 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 45' ' ' CYS . 1.2 tp10 -38.58 -26.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.49 -0.756 . . . . 0.0 111.271 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -109.9 -2.93 16.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.934 -1.104 . . . . 0.0 110.33 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.707 ' O ' HG22 ' A' ' 51' ' ' ILE . 3.5 m-70 59.52 12.54 2.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.479 -0.763 . . . . 0.0 110.509 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.87 -34.0 19.74 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.8 OUTLIER -90.9 -25.31 19.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.992 . . . . 0.0 109.317 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 48' ' ' HIS . 6.3 tp -45.7 -33.37 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -82.65 -48.05 11.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -54.37 -29.41 48.4 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 177.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.876 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -79.23 -31.88 43.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.576 ' HB2' ' HA ' ' A' ' 52' ' ' MET . 5.2 mtt -78.08 -45.07 24.5 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.972 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 2.5 mt-10 -72.11 -62.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.608 ' HD2' ' HE2' ' A' ' 62' ' ' MET . 0.1 OUTLIER -43.53 -62.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.686 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.876 HD13 ' O ' ' A' ' 54' ' ' ALA . 2.6 mp -45.62 -38.7 6.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.918 -1.114 . . . . 0.0 109.249 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -76.56 -71.49 0.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 110.455 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.17 -29.18 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.484 -0.76 . . . . 0.0 110.336 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 103.35 34.4 3.92 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.608 ' HE2' ' HD2' ' A' ' 57' ' ' LYS . 2.9 tpp -84.56 -145.17 0.09 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.112 -1.228 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 67' ' ' VAL . 3.0 mtt180 -71.8 124.81 25.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.278 -0.888 . . . . 0.0 110.748 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 25.8 m-85 -89.88 -30.82 17.64 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -90.61 -35.51 14.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 111.247 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.828 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 4.4 mm-40 -66.56 -47.26 73.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.848 -1.158 . . . . 0.0 108.56 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 68' ' ' ALA . 27.2 m -62.9 -53.87 41.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.944 -1.103 . . . . 0.0 108.453 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.714 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -52.41 -35.84 52.84 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.97 -80.31 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.253 -0.979 . . . . 0.0 108.79 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.637 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -92.06 -42.38 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 117.953 -1.499 . . . . 0.0 114.649 -179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.661 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.9 m-30 -40.08 -29.93 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 43' ' ' ILE . 47.0 t -94.0 102.38 14.46 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' HG3' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -68.47 51.11 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.552 -1.342 . . . . 0.0 110.905 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 72' ' ' SER . 39.2 t0 -170.07 -98.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.649 -1.282 . . . . 0.0 112.265 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 80' ' ' GLY . 2.8 tmtm? -112.72 20.12 16.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.906 -1.121 . . . . 0.0 112.274 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 72' ' ' SER . . . 53.77 170.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.626 -1.296 . . . . 0.0 110.411 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.866 ' NH2' HG22 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -123.53 -27.46 4.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.427 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.624 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 5.0 mt-30 -92.89 -79.37 0.4 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.29 -19.2 45.71 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -90.02 -40.08 5.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' O ' ' A' ' 80' ' ' GLY . 4.8 t0 27.53 94.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 122.335 -0.509 . . . . 0.0 111.079 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 42' ' ' HIS . 4.2 mm? -42.19 -26.68 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 110.507 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 93.06 175.04 40.93 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.496 ' CE2' ' HG2' ' A' ' 39' ' ' LYS . 38.0 m95 -55.61 139.72 43.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -1.111 . . . . 0.0 110.385 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.426 ' SD ' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -143.97 128.8 18.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.391 -0.818 . . . . 0.0 109.948 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 1.036 HG22 ' O ' ' A' ' 36' ' ' ASN . 2.1 p -107.42 150.1 27.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 110.309 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 1.5 tmm_? -43.03 -27.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.556 -0.715 . . . . 0.0 110.099 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.08 -31.28 72.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 86' ' ' THR . 10.1 m -113.36 92.13 3.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -1.146 . . . . 0.0 110.051 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.26 -168.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 109.981 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG12 ' HB2' ' A' ' 94' ' ' PHE . 6.3 p -125.83 162.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 0.0 110.332 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' N ' ' HD2' ' A' ' 93' ' ' PRO . . . -38.0 -62.03 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HD2' HG22 ' A' ' 91' ' ' VAL . 3.5 Cg_exo -57.05 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.643 1.339 . . . . 0.0 111.643 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.859 ' HB2' HG12 ' A' ' 91' ' ' VAL . 1.7 m-85 -40.39 -39.1 0.92 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.038 -1.038 . . . . 0.0 110.869 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 99' ' ' PHE . 1.7 mt-30 -78.97 -40.65 31.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.106 -0.996 . . . . 0.0 110.985 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.814 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 1.4 pp20? -72.28 -31.75 66.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 111.043 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 96' ' ' GLU . . . -90.11 -83.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -47.18 -74.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.527 -0.733 . . . . 0.0 111.074 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -42.13 -55.91 3.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.861 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -63.48 -9.52 13.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.636 HD22 HG22 ' A' ' 110' ' ' VAL . 23.2 mt -103.83 150.03 37.77 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.887 . . . . 0.0 110.652 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.825 ' HD2' HG23 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -64.18 146.11 90.0 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.816 1.43 . . . . 0.0 111.268 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.886 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -44.18 147.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 108.761 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.544 ' CA ' ' HG2' ' A' ' 109' ' ' PRO . 44.1 p -179.37 -123.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.939 -1.101 . . . . 0.0 110.486 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.582 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 108.7 157.9 18.84 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.966 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.511 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 15.0 ttp 71.95 18.16 5.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.817 -0.813 . . . . 0.0 111.853 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.595 ' CB ' ' HG3' ' A' ' 114' ' ' PRO . 35.8 t70 57.88 66.48 1.11 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.957 . . . . 0.0 112.522 178.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 0.7 OUTLIER -157.2 -69.68 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.778 -1.201 . . . . 0.0 110.384 178.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.7 Cg_endo -61.71 -152.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.976 0 N-CA-C 110.055 -0.786 . . . . 0.0 110.055 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.825 HG23 ' HD2' ' A' ' 102' ' ' PRO . 1.5 p 38.31 -162.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.501 -0.749 . . . . 0.0 111.111 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.685 ' H ' HG22 ' A' ' 110' ' ' VAL . 67.8 m-85 -130.97 -43.85 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 111.413 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.48 HG21 HD13 ' A' ' 101' ' ' LEU . 9.2 t -52.4 -168.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.193 -0.942 . . . . 0.0 111.025 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.511 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 3.8 m-20 -111.02 144.71 30.94 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.666 -0.646 . . . . 0.0 109.354 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.06 ' HB3' HG23 ' A' ' 124' ' ' ILE . 3.3 Cg_exo -60.49 -54.98 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.537 1.283 . . . . 0.0 112.132 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.4 Cg_exo -63.51 69.32 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 120.962 1.108 . . . . 0.0 110.805 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG21 HD11 ' A' ' 125' ' ' ILE . 17.9 m -90.17 150.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.353 -0.842 . . . . 0.0 110.163 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 1.0 OUTLIER -112.91 111.42 22.17 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.291 -0.881 . . . . 0.0 110.914 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.566 HG23 ' NE2' ' A' ' 123' ' ' HIS . 37.7 p -110.14 56.05 0.63 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.488 -0.758 . . . . 0.0 109.866 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 118' ' ' THR . 0.0 OUTLIER 69.2 50.59 0.55 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.011 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.86 -70.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -163.38 -175.9 34.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' CG ' ' CE1' ' A' ' 48' ' ' HIS . 3.3 m-85 -89.83 92.78 9.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.162 -1.199 . . . . 0.0 110.129 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.803 ' NE2' HG23 ' A' ' 116' ' ' VAL . 17.6 p80 -93.81 139.58 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.011 -1.055 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' HB3' ' A' ' 114' ' ' PRO . 42.7 mt -88.73 115.42 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 98' ' ' ALA . 9.9 mt -89.84 138.57 19.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.828 0.823 . . . . 0.0 111.573 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -132.88 94.71 3.43 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.987 HG23 ' HB ' ' A' ' 38' ' ' VAL . 1.5 p -89.3 114.69 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.756 ' HA ' HG13 ' A' ' 103' ' ' VAL . 4.4 tp10 -150.65 106.09 3.37 Favored 'General case' 0 C--O 1.197 -1.698 0 O-C-N 121.152 -0.968 . . . . 0.0 110.049 -178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA3' ' CH2' ' A' ' 84' ' ' TRP . . . 145.21 -63.24 0.47 Allowed Glycine 0 C--N 1.274 -2.912 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.632 ' H ' ' HA ' ' A' ' 38' ' ' VAL . 2.8 ttt-85 56.29 13.02 1.12 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.965 -0.726 . . . . 0.0 111.379 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 1.7 tttt . . . . . 0 C--N 1.293 -1.874 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 30' ' ' GLY . 1.1 p 51.28 -150.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.487 ' N ' ' OG ' ' A' ' 29' ' ' SER . . . -116.04 -79.99 0.81 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 3.2 Cg_exo -61.09 -150.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.76 1.4 . . . . 0.0 110.533 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 2.1 tptt 68.61 162.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 110.152 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.5 -89.98 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.67 -41.23 0.75 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 131' ' ' LYS . . . 75.24 161.63 9.52 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' OD1' ' CE ' ' A' ' 131' ' ' LYS . 7.2 p-10 -109.89 -43.9 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -1.193 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -110.66 143.84 40.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.335 -0.853 . . . . 0.0 109.494 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.2 m -150.79 150.8 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 9.3 mmtt -88.44 89.95 8.2 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 116.96 -1.896 . . . . 0.0 109.187 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.057 ' CG2' HG23 ' A' ' 125' ' ' ILE . 3.3 p -99.53 142.5 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.736 0.779 . . . . 0.0 112.548 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -119.11 147.86 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.701 ' CD2' HD11 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -125.95 122.18 35.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.539 -1.35 . . . . 0.0 112.862 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.042 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.5 mt -119.52 145.42 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 43' ' ' ILE . 17.0 mt -135.77 150.15 49.38 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.178 -1.576 . . . . 0.0 111.948 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 47' ' ' LYS . 73.4 m -116.87 -14.87 10.69 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 120.834 -1.166 . . . . 0.0 110.511 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 0.4 OUTLIER 68.95 -58.49 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.098 -1.001 . . . . 0.0 108.516 -179.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' CYS . 9.7 mttm -89.71 -14.17 35.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.822 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.7 m-70 60.33 16.25 6.07 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.447 0.642 . . . . 0.0 110.839 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.47 -50.94 10.41 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -87.18 -5.92 58.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -1.073 . . . . 0.0 109.916 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.0 tp -48.51 -32.4 4.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.59 ' HA ' ' HG3' ' A' ' 55' ' ' MET . 0.0 OUTLIER -84.48 -34.28 23.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 52' ' ' MET . 0.8 OUTLIER -61.69 -29.93 70.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 176.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' LYS . . . -75.03 -35.4 61.94 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.59 ' HG3' ' HA ' ' A' ' 52' ' ' MET . 3.0 mtt -65.4 -60.09 3.33 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.653 0.739 . . . . 0.0 109.169 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.472 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 25.3 mt-10 -59.17 -55.0 40.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.531 -0.731 . . . . 0.0 110.34 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.592 ' HA ' ' CG ' ' A' ' 62' ' ' MET . 0.1 OUTLIER -41.68 -74.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.309 -0.869 . . . . 0.0 109.029 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.842 HD23 ' CE2' ' A' ' 64' ' ' PHE . 1.5 mp -33.78 -33.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.271 0.558 . . . . 0.0 110.544 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' CD ' ' HD3' ' A' ' 108' ' ' LYS . 17.8 mtmt -89.62 -59.94 2.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.964 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.6 OUTLIER -40.94 -31.59 0.18 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 0.0 110.618 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 62' ' ' MET . . . 122.62 4.18 8.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.592 ' CG ' ' HA ' ' A' ' 57' ' ' LYS . 9.5 mmt -59.97 -145.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -1.218 . . . . 0.0 109.806 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 1.5 mpt_? -100.32 144.4 29.38 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.63 -0.669 . . . . 0.0 109.769 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.842 ' CE2' HD23 ' A' ' 58' ' ' LEU . 4.6 m-85 -89.93 -37.66 14.23 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 13.5 p30 -90.76 -37.3 13.75 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.104 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 2.5 mt-10 -59.98 -49.33 78.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.204 -1.56 . . . . 0.0 107.212 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG23 ' N ' ' A' ' 68' ' ' ALA . 33.8 m -60.82 -46.3 96.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.69 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -48.67 -29.4 4.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.089 0.947 . . . . 0.0 108.779 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.83 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . . . -66.55 -75.36 0.09 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.644 -1.222 . . . . 0.0 108.89 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.592 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.92 -35.44 14.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.1 m-85 -54.75 -29.51 53.98 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -99.07 -160.22 0.79 Allowed 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 174.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.4 mt-10 -146.85 41.5 1.11 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 119.916 -1.74 . . . . 0.0 110.575 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.572 ' OD2' ' CE1' ' A' ' 42' ' ' HIS . 28.4 p30 176.18 -132.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.837 -0.539 . . . . 0.0 109.876 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CG ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -42.61 118.0 1.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.986 -1.071 . . . . 0.0 109.852 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.83 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . . . -105.4 -13.8 15.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.081 -1.012 . . . . 0.0 110.387 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' GLY . 2.5 ttp180 -40.92 105.57 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 0.0 109.833 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.59 -60.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.45 0.643 . . . . 0.0 109.748 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . -171.94 33.71 0.14 Allowed Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.878 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 82.67 33.91 23.56 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.457 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 39.0 t0 -52.55 81.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.612 -0.934 . . . . 0.0 111.416 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 80' ' ' GLY . 6.1 mp -50.1 -22.22 1.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 109.54 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 93.31 174.54 40.46 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.579 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 42.4 m95 -42.33 128.78 3.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -1.103 . . . . 0.0 109.322 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 4.7 mmt -143.39 145.46 32.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.93 -1.106 . . . . 0.0 111.056 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.7 OUTLIER -123.77 150.06 44.88 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' THR . 31.7 ttm180 -39.14 -42.27 0.92 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.533 -0.729 . . . . 0.0 110.544 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.07 -26.15 5.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -108.71 -38.79 5.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -1.116 . . . . 0.0 110.095 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -160.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 94' ' ' PHE . 3.9 p -128.39 -172.46 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.03 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.692 ' H ' HG22 ' A' ' 91' ' ' VAL . . . -71.61 -66.55 2.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 92' ' ' GLY . 3.2 Cg_exo -55.96 -67.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.629 1.331 . . . . 0.0 111.028 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.857 ' HB3' HG12 ' A' ' 91' ' ' VAL . 24.0 t80 -41.25 -38.49 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 110.86 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.577 ' HG2' ' CG ' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -88.42 -42.61 12.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' GLN . 10.8 mt-10 -40.9 -33.1 0.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.21 -0.931 . . . . 0.0 110.527 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -79.93 -74.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.957 . . . . 0.0 110.4 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -45.4 -65.12 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.833 . . . . 0.0 110.702 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CG ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 m-30 -43.56 -26.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.7 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -107.99 -2.49 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.037 -1.04 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.6 HD13 HG21 ' A' ' 112' ' ' THR . 1.3 mt -121.05 167.61 12.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.153 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HD2' HD23 ' A' ' 101' ' ' LEU . 2.5 Cg_endo -61.95 150.24 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.692 1.364 . . . . 0.0 110.333 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.899 HG12 HG11 ' A' ' 127' ' ' VAL . 5.0 m -59.57 -161.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.09 -1.006 . . . . 0.0 110.07 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.75 ' O ' HG13 ' A' ' 110' ' ' VAL . 40.4 m 56.99 165.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.129 -0.982 . . . . 0.0 110.896 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' HA ' ' A' ' 126' ' ' MET . . . -144.89 -117.05 1.1 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.516 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 2.3 ttm 60.55 -75.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -1.07 . . . . 0.0 110.207 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER 165.87 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.359 -0.838 . . . . 0.0 110.733 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -88.69 -48.39 0.43 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.12 -0.988 . . . . 0.0 112.328 -178.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 108' ' ' LYS . 3.4 Cg_exo -63.43 -68.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.219 1.115 . . . . 0.0 111.787 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -49.41 -172.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 122.34 1.067 . . . . 0.0 111.543 -179.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.25 -16.12 6.05 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.455 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.6 HG21 HD13 ' A' ' 101' ' ' LEU . 12.7 t -99.64 -156.14 0.54 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 110.132 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.451 ' N ' HG23 ' A' ' 112' ' ' THR . 13.0 p-10 -98.23 131.76 25.7 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.662 ' O ' HG13 ' A' ' 116' ' ' VAL . 3.4 Cg_exo -58.11 -55.66 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.201 1.106 . . . . 0.0 111.293 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.648 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.6 Cg_endo -66.25 78.22 0.32 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.23 1.286 . . . . 0.0 109.859 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 114' ' ' PRO . 4.1 m -89.8 150.02 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.877 -1.139 . . . . 0.0 110.451 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 1.4 tttt -95.79 147.51 23.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 119' ' ' LYS . 1.3 t -145.68 -49.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.439 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' H ' HG23 ' A' ' 118' ' ' THR . 0.6 OUTLIER -177.53 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.98 -38.35 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.803 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 168.63 -147.77 11.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.653 ' CD1' ' NE2' ' A' ' 48' ' ' HIS . 6.1 m-85 -99.78 123.05 43.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -1.139 . . . . 0.0 109.35 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.671 ' HA ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -116.14 135.67 53.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 110.953 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.52 HG23 ' CB ' ' A' ' 114' ' ' PRO . 26.0 mt -89.26 107.35 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 1.057 HG23 ' CG2' ' A' ' 40' ' ' VAL . 54.8 mt -100.3 120.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.608 0.718 . . . . 0.0 111.548 -177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.7 OUTLIER -121.16 115.23 22.67 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.899 HG11 HG12 ' A' ' 103' ' ' VAL . 5.6 t -89.3 150.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 110.424 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.75 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.44 89.16 2.4 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.966 1.365 . . . . 0.0 111.175 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.458 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 75.99 124.65 0.19 Allowed Glycine 0 C--N 1.275 -2.859 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.1 ptp180 -106.55 172.87 6.58 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.865 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.529 ' CE ' ' OD1' ' A' ' 36' ' ' ASN . 10.6 mmmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.121 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -54.02 141.34 28.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -1.143 . . . . 0.0 110.279 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.54 -158.97 24.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.17 -172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.706 1.371 . . . . 0.0 110.617 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -71.59 117.42 13.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.203 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.64 -50.1 2.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.86 -40.93 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' CA ' ' HE3' ' A' ' 131' ' ' LYS . . . -103.4 174.23 22.75 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.972 ' O ' HG22 ' A' ' 86' ' ' THR . 0.4 OUTLIER 61.96 37.11 15.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.806 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.827 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -138.76 150.59 46.28 Favored 'General case' 0 C--O 1.19 -2.046 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.636 ' HB ' HG13 ' A' ' 127' ' ' VAL . 5.0 m -148.67 150.56 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 120.966 -1.084 . . . . 0.0 110.67 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -89.11 89.74 8.09 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 117.35 -1.74 . . . . 0.0 107.684 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 127' ' ' VAL . 35.0 m -102.62 150.23 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.182 0.992 . . . . 0.0 113.432 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' HG3' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -130.92 148.64 52.7 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.898 ' CD2' HD13 ' A' ' 82' ' ' LEU . 17.5 m-70 -131.5 137.52 48.58 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.179 -1.576 . . . . 0.0 113.583 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 124' ' ' ILE . 0.2 OUTLIER -133.4 119.98 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.02 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -122.16 150.36 42.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.627 -1.295 . . . . 0.0 110.634 -178.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.02 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 t -122.69 104.83 9.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 110.195 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' N ' ' OE2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -51.08 -19.32 1.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 110.207 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' HG2' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -118.79 2.98 11.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' HA ' ' HB ' ' A' ' 51' ' ' ILE . 2.6 m-70 57.65 13.39 1.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.369 -0.832 . . . . 0.0 110.849 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.88 -65.23 2.0 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.516 ' HA ' ' CB ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.58 -18.53 60.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -1.123 . . . . 0.0 109.881 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HB ' ' CB ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -46.93 -33.86 2.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.536 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -88.94 -38.34 14.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 67.5 tt0 -56.33 -31.74 64.02 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -57.38 -29.84 64.38 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . 5.8 mtt -75.02 -58.55 3.21 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.542 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 19.9 mm-40 -63.38 -57.1 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.088 -1.007 . . . . 0.0 110.617 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.689 ' HB3' ' HE3' ' A' ' 62' ' ' MET . 0.1 OUTLIER -45.7 -71.1 0.08 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.029 -1.045 . . . . 0.0 109.29 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.869 HD21 ' NH2' ' A' ' 77' ' ' ARG . 3.1 mp -37.67 -33.19 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.01 -1.056 . . . . 0.0 111.758 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HG2' ' CE ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -80.21 -64.01 1.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.842 -1.161 . . . . 0.0 111.697 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -34.75 -67.27 0.15 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.723 . . . . 0.0 111.582 -179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 37.94 0.03 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.689 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -90.2 -161.47 0.79 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.759 -0.848 . . . . 0.0 111.375 -179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.681 ' O ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -72.85 138.64 46.43 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.411 0.624 . . . . 0.0 111.659 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' CG ' ' OE1' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -91.41 -35.02 14.62 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.543 -0.723 . . . . 0.0 109.558 177.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 79' ' ' GLY . 7.1 t-20 -90.31 -32.77 16.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 0.0 111.072 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.789 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 3.9 mp0 -67.48 -54.53 19.43 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.961 -1.096 . . . . 0.0 108.125 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 68' ' ' ALA . 8.3 m -53.32 -54.97 14.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.743 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -46.89 -38.22 10.1 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -56.27 -69.65 0.14 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.384 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.564 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -90.77 -46.63 8.11 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 120.901 -1.124 . . . . 0.0 113.616 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.6 m-30 -45.65 -29.46 1.24 Allowed 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.77 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.552 ' CB ' ' HA ' ' A' ' 76' ' ' ALA . 47.7 t -77.75 -0.11 25.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.664 -0.647 . . . . 0.0 110.718 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 1.3 tt0 23.99 45.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.7 0.762 . . . . 0.0 110.958 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 2.6 t0 161.12 112.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.765 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 8.5 tptt 55.79 -101.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.982 -1.074 . . . . 0.0 109.192 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 75' ' ' LYS . . . 166.21 149.97 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.115 -0.991 . . . . 0.0 110.53 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.869 ' NH2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -81.97 -66.45 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 109.689 179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' NE2' ' NH2' ' A' ' 77' ' ' ARG . 1.1 mt-30 -71.14 -67.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.83 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 65' ' ' ASN . . . -61.43 -29.65 72.18 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 76' ' ' ALA . . . -97.45 5.38 62.57 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 77' ' ' ARG . 5.4 t0 -39.59 100.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.416 -1.049 . . . . 0.0 110.485 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.898 HD13 ' CD2' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -43.92 -26.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 109.814 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 39' ' ' LYS . . . 79.79 -175.66 54.92 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.453 ' CZ3' ' O ' ' A' ' 131' ' ' LYS . 44.6 m95 -40.94 132.67 2.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -1.075 . . . . 0.0 110.358 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 137.32 19.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.271 -0.893 . . . . 0.0 109.988 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.972 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -107.28 150.13 27.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.204 -0.935 . . . . 0.0 110.5 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 40.8 ttt180 -42.68 -28.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.29 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 87' ' ' ARG . . . -44.59 -30.89 2.31 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -142.51 66.14 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -1.15 . . . . 0.0 110.157 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 3.2 ttm -133.49 29.88 3.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.708 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t 50.97 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 109.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -87.55 -68.96 1.3 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_exo -60.65 -51.69 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.584 1.307 . . . . 0.0 111.058 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.653 ' CE2' ' CE1' ' A' ' 42' ' ' HIS . 0.1 OUTLIER -41.29 -34.85 0.54 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 110.481 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.547 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 4.1 tt0 -90.04 -30.66 17.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 2.4 mt-10 -46.19 -49.83 16.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.552 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -87.47 -81.26 0.24 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.647 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.611 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -34.22 -47.19 0.28 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.789 -0.569 . . . . 0.0 111.182 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -83.9 45.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.075 -1.016 . . . . 0.0 110.293 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.51 -40.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.045 HD12 HG21 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -96.72 168.94 9.54 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.908 . . . . 0.0 110.435 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.563 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.4 Cg_endo -63.82 171.81 6.72 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.607 1.319 . . . . 0.0 110.785 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 127' ' ' VAL . 2.7 m -83.3 171.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 120.977 -1.077 . . . . 0.0 109.1 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER 164.66 -90.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 110.52 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 77.04 172.92 37.63 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.126 -1.035 . . . . 0.0 110.555 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.643 ' HG3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 68.68 -119.41 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.773 -0.84 . . . . 0.0 111.437 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HB2' ' CE ' ' A' ' 106' ' ' MET . 44.0 t0 -74.19 49.73 0.36 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 111.633 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 1.3 tttt 35.15 55.96 2.22 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 111.771 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.5 Cg_endo -65.59 -22.52 58.14 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.256 1.135 . . . . 0.0 110.776 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.045 HG21 HD12 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -85.42 -158.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.141 -0.974 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.831 ' N ' HG13 ' A' ' 110' ' ' VAL . 73.0 m-85 -87.06 -49.44 7.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 110' ' ' VAL . 6.2 t -68.46 -164.49 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.0 110.935 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.482 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 17.9 m-20 -116.33 143.73 31.68 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.691 -0.631 . . . . 0.0 109.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.863 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.5 Cg_exo -59.15 -54.92 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.421 1.222 . . . . 0.0 111.795 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.625 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 2.8 Cg_endo -64.15 78.19 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.184 1.097 . . . . 0.0 110.438 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.9 m -98.24 150.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -101.74 149.76 23.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 123' ' ' HIS . 64.3 p -144.51 -71.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.297 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' ' OG1' ' A' ' 118' ' ' THR . 1.0 OUTLIER -147.17 29.02 0.98 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 0.0 110.235 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.63 -42.94 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.489 ' C ' ' CD1' ' A' ' 122' ' ' TYR . . . 172.74 -104.69 0.2 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 121' ' ' GLY . 34.1 m-85 -143.23 124.9 14.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -1.092 . . . . 0.0 109.601 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' HE1' HD11 ' A' ' 125' ' ' ILE . 7.3 p80 -128.12 150.14 50.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.981 -1.074 . . . . 0.0 110.752 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.863 HG23 ' CB ' ' A' ' 114' ' ' PRO . 24.8 mt -89.64 107.67 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 109.539 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.9 mt -89.7 111.33 22.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.311 -0.868 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -105.62 95.45 5.82 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.985 HG12 HG12 ' A' ' 103' ' ' VAL . 20.3 t -89.27 137.07 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.659 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 25.1 tt0 -151.06 92.54 1.82 Allowed 'General case' 0 C--O 1.195 -1.801 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.266 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.685 ' H ' HG11 ' A' ' 103' ' ' VAL . . . 141.82 -61.74 0.53 Allowed Glycine 0 C--N 1.281 -2.501 0 O-C-N 120.092 -1.63 . . . . 0.0 112.458 177.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.827 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 57.05 148.13 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.891 -0.77 . . . . 0.0 109.69 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 37' ' ' ALA . 1.6 mmmt . . . . . 0 C--N 1.3 -1.584 0 O-C-N 120.758 -1.214 . . . . 0.0 110.109 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -119.92 138.96 53.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -1.164 . . . . 0.0 110.096 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.73 -173.0 23.37 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.37 139.03 80.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.809 1.426 . . . . 0.0 110.673 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.43 -8.25 27.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.235 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.7 45.44 1.65 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 50.22 -169.74 0.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' HA2' ' HG3' ' A' ' 131' ' ' LYS . . . 107.98 -111.62 3.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 86' ' ' THR . 40.0 m-20 60.46 12.95 3.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 110.517 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -112.72 150.0 32.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.82 HG23 HG13 ' A' ' 40' ' ' VAL . 2.0 m -147.84 150.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 2.6 tmtp? -88.68 89.86 8.17 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.728 -1.857 . . . . 0.0 109.193 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 127' ' ' VAL . 1.1 m -100.74 150.26 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 122.464 1.126 . . . . 0.0 112.269 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' CB ' ' HD3' ' A' ' 77' ' ' ARG . 0.9 OUTLIER -140.07 151.1 45.11 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 178.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.541 ' NE2' ' HB3' ' A' ' 75' ' ' LYS . 2.5 p80 -146.87 150.26 34.9 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 116.543 -2.063 . . . . 0.0 114.776 -176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.753 HG23 ' HB2' ' A' ' 72' ' ' SER . 11.8 mt -126.75 131.85 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.625 HD21 ' ND1' ' A' ' 123' ' ' HIS . 4.7 mt -113.71 150.64 33.02 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.433 -1.417 . . . . 0.0 111.399 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' O ' ' N ' ' A' ' 48' ' ' HIS . 6.1 m -130.73 70.35 1.46 Allowed 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.356 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' CG ' ' A' ' 73' ' ' GLU . 1.7 pt-20 -30.07 -37.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.469 -0.77 . . . . 0.0 111.946 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 19.5 mttm -91.47 -16.52 27.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.167 -0.958 . . . . 0.0 111.078 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.8 ' O ' HG22 ' A' ' 51' ' ' ILE . 4.3 m-70 63.16 10.26 4.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.586 -0.696 . . . . 0.0 110.109 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.84 -35.7 21.14 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -95.84 -17.94 20.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.575 -0.956 . . . . 0.0 109.106 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.8 HG22 ' O ' ' A' ' 48' ' ' HIS . 9.5 tp -44.86 -33.8 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.806 ' HE3' ' HB2' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -90.0 -35.7 15.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.2 tt0 -63.49 -29.29 70.58 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -83.64 -30.22 27.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.603 ' HE2' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -78.08 -40.1 39.49 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.209 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.806 ' HB2' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -72.07 -60.39 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.814 . . . . 0.0 109.783 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 12.1 mttp -42.42 -65.38 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 108.864 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.818 HD13 ' O ' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -36.97 -45.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.415 0.626 . . . . 0.0 110.326 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' C ' ' A' ' 60' ' ' SER . 3.2 mtmt -73.63 -73.54 0.21 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.343 -0.848 . . . . 0.0 110.501 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -37.44 -33.93 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.707 -0.621 . . . . 0.0 110.419 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 109.62 30.41 3.54 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.535 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 3.1 tpp -81.36 -145.46 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.161 -1.2 . . . . 0.0 109.415 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.621 ' CD ' ' HG2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -69.02 120.21 14.52 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.067 -1.021 . . . . 0.0 110.824 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 17.5 m-85 -90.41 -31.65 16.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.841 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 2.3 t-20 -91.16 -38.79 12.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.447 -0.783 . . . . 0.0 111.269 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -67.9 -43.29 79.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 108.69 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 68' ' ' ALA . 22.6 m -65.48 -51.55 62.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.717 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -56.85 -39.75 74.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -48.82 -78.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.995 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.666 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.78 -48.49 6.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.621 -1.632 . . . . 0.0 114.67 -179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.719 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 4.5 m-30 -38.07 -31.18 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.753 ' HB2' HG23 ' A' ' 43' ' ' ILE . 6.4 t -91.84 104.47 16.9 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -68.23 55.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.746 -1.221 . . . . 0.0 110.904 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER 159.55 -163.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 121.111 0.482 . . . . 0.0 109.747 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -40.88 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 109.953 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.681 ' HB1' ' HB1' ' A' ' 68' ' ' ALA . . . -52.65 175.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.582 -0.699 . . . . 0.0 111.369 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.69 ' HD2' ' NE2' ' A' ' 78' ' ' GLN . 0.1 OUTLIER -95.7 -59.37 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.69 ' NE2' ' HD2' ' A' ' 77' ' ' ARG . 20.5 mm-40 -58.47 -92.03 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.765 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.59 -13.75 59.19 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.556 ' O ' ' C ' ' A' ' 81' ' ' ASP . . . -88.54 -30.58 15.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 77' ' ' ARG . 8.9 t0 22.32 85.84 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.42 -0.459 . . . . 0.0 111.524 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD12 ' C ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -45.77 -46.39 15.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.703 -1.248 . . . . 0.0 110.108 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 82' ' ' LEU . . . 118.6 174.97 16.32 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.921 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.524 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 37.2 m95 -54.41 162.03 1.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.569 -0.959 . . . . 0.0 110.069 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -150.48 140.31 21.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.913 -1.117 . . . . 0.0 110.766 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -135.05 131.48 37.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.89 . . . . 0.0 109.969 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -41.43 159.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.409 -0.807 . . . . 0.0 110.137 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.76 -54.2 0.58 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.78 -19.5 15.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.142 . . . . 0.0 109.681 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.554 ' HE1' ' HB3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -63.2 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.515 -0.74 . . . . 0.0 109.94 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -123.55 -96.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 110.395 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 91' ' ' VAL . . . -149.5 -72.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 118' ' ' THR . 3.4 Cg_exo -58.63 -39.46 82.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.685 1.361 . . . . 0.0 110.436 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.812 ' CD1' HD11 ' A' ' 125' ' ' ILE . 1.6 t80 -60.09 -40.88 91.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.32 -0.862 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -87.76 -61.73 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.67 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 93' ' ' PRO . 1.0 OUTLIER -36.78 -30.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 0.0 111.035 -179.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -81.3 -79.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.184 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -41.0 -40.55 1.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.466 -0.772 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' GLN . 0.8 OUTLIER -69.71 -63.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 110.247 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -55.06 -35.05 64.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 110.105 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 4.6 mt -94.34 165.11 18.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 110.048 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 103' ' ' VAL . 2.6 Cg_endo -60.47 156.15 43.17 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.615 1.323 . . . . 0.0 110.011 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 110' ' ' VAL . 5.5 m -57.14 -160.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.943 -1.098 . . . . 0.0 109.533 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.875 ' HG ' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER 71.28 179.75 0.24 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.071 -1.018 . . . . 0.0 110.689 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.507 ' HA3' ' HG2' ' A' ' 126' ' ' MET . . . -151.78 -118.89 0.81 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.49 ' C ' ' O ' ' A' ' 105' ' ' GLY . 23.4 ttm 36.03 -136.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.488 -1.007 . . . . 0.0 110.453 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -144.11 58.9 1.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.157 . . . . 0.0 110.957 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.63 ' CB ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -151.89 -65.8 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.107 -0.995 . . . . 0.0 110.709 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.63 ' HD3' ' CB ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -61.46 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.956 0 O-C-N 122.751 0.869 . . . . 0.0 109.881 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.875 HG13 ' HG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -48.58 -169.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 122.569 1.176 . . . . 0.0 111.571 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -122.91 -16.37 7.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.548 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 112' ' ' THR . 8.0 t -100.46 -159.31 0.73 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.839 . . . . 0.0 110.683 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.35 147.78 36.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.043 ' HB3' HG23 ' A' ' 124' ' ' ILE . 2.0 Cg_endo -57.64 -62.33 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.453 1.238 . . . . 0.0 111.911 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.623 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.19 78.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 120.941 1.094 . . . . 0.0 110.483 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.98 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.66 148.08 4.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.793 -1.192 . . . . 0.0 109.705 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.0 OUTLIER -93.95 145.99 24.25 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.756 -179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.495 ' HA ' ' HG2' ' A' ' 93' ' ' PRO . 4.2 t -161.04 63.91 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.839 . . . . 0.0 110.514 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt 62.03 11.03 3.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.907 . . . . 0.0 110.543 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.56 ' HB3' ' CE1' ' A' ' 123' ' ' HIS . 5.1 m-85 -128.82 -79.67 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.237 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -162.21 -124.44 0.71 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.59 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 1.8 m-30 -116.59 104.83 11.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -1.108 . . . . 0.0 108.505 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 2.0 m-70 -105.99 130.01 54.0 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 114' ' ' PRO . 10.0 mt -89.53 101.2 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.812 HD11 ' CD1' ' A' ' 94' ' ' PHE . 17.3 mt -89.7 114.3 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.714 0.769 . . . . 0.0 111.105 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.664 ' HE1' HD21 ' A' ' 58' ' ' LEU . 13.0 mtm -111.18 103.87 12.33 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.091 HG22 HG12 ' A' ' 40' ' ' VAL . 21.5 t -89.6 150.14 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.231 -0.918 . . . . 0.0 110.032 -178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.654 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 1.9 tp10 -149.98 89.56 1.61 Allowed 'General case' 0 C--O 1.198 -1.627 0 CA-C-O 122.567 1.175 . . . . 0.0 112.104 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 92.45 112.39 1.99 Allowed Glycine 0 C--N 1.278 -2.673 0 O-C-N 120.659 -1.276 . . . . 0.0 111.477 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.74 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.1 -178.42 5.34 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.591 -0.946 . . . . 0.0 110.052 178.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.493 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.316 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -174.9 5.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -1.156 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.78 166.69 22.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.75 131.06 33.66 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.679 1.357 . . . . 0.0 110.474 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -74.08 -176.63 2.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 110.177 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.88 -170.45 14.4 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.58 11.17 71.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.63 96.55 2.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' O ' ' HB ' ' A' ' 86' ' ' THR . 17.3 p30 -113.92 -25.19 8.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -1.151 . . . . 0.0 110.154 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -148.01 144.24 27.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.788 ' CG2' HG13 ' A' ' 127' ' ' VAL . 1.4 m -150.12 150.14 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.7 OUTLIER -91.29 89.95 7.52 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.776 -1.828 . . . . 0.0 108.827 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 126' ' ' MET . 9.9 p -96.05 150.14 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 122.038 0.923 . . . . 0.0 112.353 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 126' ' ' MET . 0.0 OUTLIER -131.04 150.24 52.24 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 79' ' ' GLY . 1.1 p80 -132.98 128.72 37.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.288 -1.508 . . . . 0.0 113.938 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 68' ' ' ALA . 53.1 mt -122.78 129.95 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -128.94 115.66 18.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.034 -1.666 . . . . 0.0 111.227 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 27.2 m -84.95 124.76 32.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.803 -1.185 . . . . 0.0 109.842 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.1 -40.21 94.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 110.021 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 3.4 mtmt -106.33 -0.77 24.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.82 . . . . 0.0 110.253 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.744 ' O ' HG22 ' A' ' 51' ' ' ILE . 2.1 m-70 61.57 12.55 4.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HE1' ' A' ' 52' ' ' MET . . . -77.4 -11.17 85.75 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -125.27 -6.75 7.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -1.171 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.859 HG23 ' HG3' ' A' ' 52' ' ' MET . 3.0 tp -52.6 -31.89 16.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.482 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.859 ' HG3' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -87.75 -31.95 19.39 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 3.2 tt0 -65.74 -29.5 70.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.672 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -71.98 -36.74 69.89 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 59' ' ' LYS . 44.6 mt-10 -77.36 -68.1 0.65 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.511 -0.743 . . . . 0.0 109.869 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.561 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 4.1 mttp -40.94 -50.34 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.387 -0.821 . . . . 0.0 110.346 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 67' ' ' VAL . 96.7 mt -64.43 -41.65 96.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.559 -0.713 . . . . 0.0 111.787 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 56' ' ' GLU . 0.7 OUTLIER -85.17 -29.76 24.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.941 -1.099 . . . . 0.0 111.295 -178.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.5 m -73.0 -57.41 4.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 109.397 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.01 35.72 0.03 OUTLIER Glycine 0 N--CA 1.482 1.74 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.561 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 1.3 mpp? -103.14 173.36 6.34 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.077 -1.249 . . . . 0.0 109.574 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.594 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -41.55 145.95 0.26 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 110.543 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 67' ' ' VAL . 1.7 m-85 -91.15 -38.47 12.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' ALA . 17.2 p30 -90.53 -38.82 12.95 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.736 -0.603 . . . . 0.0 112.287 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.864 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 62.7 mm-40 -49.85 -54.59 18.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.027 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.66 -76.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 176.315 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.862 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -34.24 -37.76 0.06 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.462 0.649 . . . . 0.0 109.859 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.864 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.18 -76.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.656 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 1.1 mm-40 -91.96 -32.73 15.13 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 117.519 -1.673 . . . . 0.0 112.776 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.027 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.1 m-30 -47.3 -29.56 2.56 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 51.7 p -80.44 -144.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 6.7 tp10 -136.36 0.24 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.445 -1.409 . . . . 0.0 110.407 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 29.3 t70 178.5 -72.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.532 -0.73 . . . . 0.0 109.877 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HB3' ' NE2' ' A' ' 42' ' ' HIS . 0.4 OUTLIER -61.38 156.82 18.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.397 179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 69' ' ' ALA . . . -152.36 -113.35 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.999 -1.063 . . . . 0.0 110.602 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 79' ' ' GLY . 6.5 tpp180 52.39 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.801 -1.187 . . . . 0.0 108.909 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 77' ' ' ARG . 3.0 tm0? 62.22 -70.14 0.05 Allowed 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.79 0.805 . . . . 0.0 109.272 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.674 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . -172.91 61.63 0.14 Allowed Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 58.91 41.9 96.47 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 50.2 p-10 -60.66 72.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -1.083 . . . . 0.0 110.977 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 80' ' ' GLY . 3.0 mp -47.6 -28.25 2.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.88 172.15 23.53 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.43 ' HH2' ' O ' ' A' ' 129' ' ' GLY . 49.3 m95 -44.52 138.62 3.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -1.189 . . . . 0.0 110.144 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.49 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -144.06 149.75 37.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.515 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 36' ' ' ASN . 3.3 t -120.62 151.22 39.74 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.28 1.038 . . . . 0.0 110.78 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -57.92 -15.62 9.37 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.38 -14.94 69.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 t -157.88 61.05 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.233 -1.157 . . . . 0.0 110.187 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.405 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.8 mmm -137.63 39.93 2.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.613 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.9 t 59.03 169.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' HG2' ' A' ' 95' ' ' GLN . . . -84.98 -67.13 1.42 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD2' HG12 ' A' ' 91' ' ' VAL . 3.0 Cg_exo -61.08 -43.58 29.05 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.599 1.315 . . . . 0.0 110.76 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CB ' ' HB ' ' A' ' 91' ' ' VAL . 2.6 t80 -54.57 -45.74 73.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.569 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . 2.1 pt20 -84.21 -40.79 17.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.425 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.544 ' N ' ' HG3' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -44.44 -34.16 1.94 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.128 -0.982 . . . . 0.0 110.433 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -82.49 -78.79 0.2 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 0.0 110.416 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.079 ' HB1' HG21 ' A' ' 127' ' ' VAL . . . -38.14 -70.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.953 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 95' ' ' GLN . 28.7 m-85 -41.63 -56.32 2.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.234 -0.916 . . . . 0.0 110.589 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -67.57 -14.63 63.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 110.377 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 112' ' ' THR . 3.2 mt -109.65 161.66 23.26 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 110.524 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.56 170.35 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.699 1.368 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.996 HG22 ' C ' ' A' ' 127' ' ' VAL . 0.5 OUTLIER -98.54 137.71 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.599 ' HB3' ' CG ' ' A' ' 109' ' ' PRO . 0.4 OUTLIER 164.38 -52.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.216 -0.928 . . . . 0.0 111.637 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 126' ' ' MET . . . 44.24 -173.26 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 O-C-N 120.881 -1.137 . . . . 0.0 111.436 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.584 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 30.2 ttp 87.23 -106.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 122.85 0.46 . . . . 0.0 110.905 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.469 ' C ' ' HD3' ' A' ' 109' ' ' PRO . 15.5 t0 -79.32 45.36 0.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.606 -1.309 . . . . 0.0 111.259 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 10.1 tttt 49.63 47.78 5.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 111.594 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 2.4 Cg_endo -62.56 -54.22 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.258 1.136 . . . . 0.0 109.762 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.497 ' O ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -41.72 175.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 122.276 1.036 . . . . 0.0 111.643 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -26.3 45.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.585 HG21 HD13 ' A' ' 101' ' ' LEU . 7.8 t -85.45 -156.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.02 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.7 m-20 -121.43 138.78 28.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.06 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.6 Cg_endo -54.49 -59.51 0.85 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.328 1.172 . . . . 0.0 111.579 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.606 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.9 Cg_endo -57.76 72.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.433 1.228 . . . . 0.0 110.928 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.2 m -89.92 144.82 8.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 120.899 -1.126 . . . . 0.0 109.423 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 2.1 ttmt -98.6 142.45 30.16 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.181 -0.95 . . . . 0.0 110.243 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.544 ' H ' ' HE2' ' A' ' 123' ' ' HIS . 2.9 t 178.06 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.464 -0.772 . . . . 0.0 110.183 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.26 -66.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.953 . . . . 0.0 110.615 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.05 25.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.109 -0.994 . . . . 0.0 110.787 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . 154.97 -148.81 19.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 9.3 m-85 -106.05 139.27 40.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.307 -1.113 . . . . 0.0 109.859 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' HE2' ' H ' ' A' ' 118' ' ' THR . 1.0 OUTLIER -135.03 139.07 44.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.074 -1.016 . . . . 0.0 109.893 -179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.06 HG23 ' CB ' ' A' ' 114' ' ' PRO . 8.6 mt -89.61 102.8 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.239 -0.913 . . . . 0.0 110.447 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.776 HD12 HG21 ' A' ' 116' ' ' VAL . 17.4 mt -89.98 127.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 109.284 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.645 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 4.3 ttp -123.04 101.7 7.57 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.313 -0.867 . . . . 0.0 109.293 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.079 HG21 ' HB1' ' A' ' 98' ' ' ALA . 15.9 t -89.32 121.54 39.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.734 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -150.76 107.47 3.53 Favored 'General case' 0 C--O 1.195 -1.802 0 O-C-N 121.027 -1.046 . . . . 0.0 109.625 -178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.508 ' HA3' ' HB2' ' A' ' 39' ' ' LYS . . . 144.21 -32.07 1.79 Allowed Glycine 0 C--N 1.267 -3.278 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.646 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -33.07 153.89 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.987 0.899 . . . . 0.0 111.96 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 130' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.636 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.209 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.2 t -122.23 -30.36 4.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -1.158 . . . . 0.0 110.308 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 53.07 70.38 0.94 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -42.44 30.12 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.681 1.358 . . . . 0.0 110.37 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.31 82.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.48 34.93 3.62 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.72 93.84 0.36 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 179.45 53.44 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.952 ' O ' HG22 ' A' ' 86' ' ' THR . 91.0 m-20 -140.08 -47.5 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -1.154 . . . . 0.0 110.028 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -129.41 149.02 51.37 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.497 -0.752 . . . . 0.0 109.435 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.649 ' HB ' HG13 ' A' ' 127' ' ' VAL . 2.1 m -150.5 150.52 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 5.4 tptm -88.85 93.37 9.56 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 116.835 -1.946 . . . . 0.0 109.409 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG23 HG23 ' A' ' 125' ' ' ILE . 7.9 p -89.69 147.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-O 121.905 0.859 . . . . 0.0 112.234 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 125' ' ' ILE . 21.3 mtt180 -137.28 149.94 47.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.595 ' CD2' HD11 ' A' ' 82' ' ' LEU . 1.4 p80 -134.5 143.01 47.22 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.289 -1.507 . . . . 0.0 113.451 -177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 68' ' ' ALA . 5.9 mt -130.13 134.28 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.776 HD22 ' ND1' ' A' ' 123' ' ' HIS . 7.2 mt -122.54 151.2 41.61 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.383 -1.448 . . . . 0.0 112.038 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' ND1' ' A' ' 48' ' ' HIS . 55.9 m -125.99 -9.92 6.57 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 120.833 -1.167 . . . . 0.0 110.473 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER 67.37 -59.29 0.4 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 109.206 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -99.11 -17.56 18.14 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.708 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.8 m80 60.75 24.94 14.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.689 0.757 . . . . 0.0 111.54 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' H ' ' HG3' ' A' ' 47' ' ' LYS . . . -72.52 -21.88 79.27 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -120.37 -5.99 9.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.731 -0.864 . . . . 0.0 109.55 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.708 HD13 ' CE1' ' A' ' 48' ' ' HIS . 3.7 tp -49.59 -34.97 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.54 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -75.86 -49.94 16.51 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 3.4 tt0 -52.37 -29.7 25.25 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -77.68 -33.49 53.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.86 ' HE3' ' HG2' ' A' ' 114' ' ' PRO . 1.5 mtp -77.81 -40.34 40.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.296 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -67.74 -59.58 3.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.818 . . . . 0.0 109.358 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HD2' ' CE ' ' A' ' 62' ' ' MET . 0.4 OUTLIER -42.53 -60.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.048 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 54' ' ' ALA . 97.9 mt -47.78 -38.22 15.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.534 -0.728 . . . . 0.0 109.631 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 60' ' ' SER . 1.7 tttt -76.1 -68.07 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.584 -0.697 . . . . 0.0 109.937 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.584 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -38.54 -44.64 0.97 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 110.172 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.13 28.05 0.67 Allowed Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.556 ' CE ' ' HD2' ' A' ' 57' ' ' LYS . 1.9 tpp -89.15 176.17 7.08 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.852 -1.381 . . . . 0.0 109.251 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.572 ' CB ' ' HB2' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -43.48 148.82 0.3 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 110.758 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -91.42 -42.77 10.13 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 69' ' ' ALA . 14.9 p-10 -90.81 -36.19 14.38 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.736 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.848 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 60.7 mm-40 -49.75 -54.65 17.72 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.002 -1.686 . . . . 0.0 106.772 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.165 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -50.83 -79.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -35.43 -33.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.286 0.565 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.848 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -47.04 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.78 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.34 -41.38 10.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 116.575 -2.05 . . . . 0.0 111.833 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.165 ' CE2' HG12 ' A' ' 67' ' ' VAL . 3.8 m-30 -41.45 -29.89 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 44' ' ' LEU . 9.2 t -80.73 -138.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 74' ' ' ASP . 23.7 mm-40 -146.21 19.29 1.39 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.5 -1.375 . . . . 0.0 110.193 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 4.2 t70 162.51 -88.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 121.515 0.674 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 76' ' ' ALA . 37.3 tptt -55.04 157.1 3.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 110.508 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ARG . . . -161.29 -119.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.421 -0.8 . . . . 0.0 109.796 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.54 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 1.7 ttt180 70.27 3.35 4.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.902 -1.124 . . . . 0.0 110.879 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.551 ' NE2' ' HD2' ' A' ' 41' ' ' ARG . 2.6 tm0? 159.59 -53.58 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 68' ' ' ALA . . . 174.96 35.32 0.04 OUTLIER Glycine 0 C--N 1.298 -1.549 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.821 ' O ' HD12 ' A' ' 82' ' ' LEU . . . 76.17 40.72 28.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.462 ' HB2' ' OE1' ' A' ' 78' ' ' GLN . 8.9 t0 -60.11 76.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.305 -1.115 . . . . 0.0 110.577 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 80' ' ' GLY . 6.0 mp -46.88 -24.03 0.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 110.069 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 105.64 172.6 23.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.597 ' CH2' ' O ' ' A' ' 129' ' ' GLY . 42.5 m95 -40.62 150.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.469 -1.018 . . . . 0.0 110.096 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.507 ' CG ' ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -147.31 135.28 21.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.211 -0.931 . . . . 0.0 110.174 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -129.68 150.09 51.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.191 -0.943 . . . . 0.0 110.457 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.04 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.345 -0.847 . . . . 0.0 110.098 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.58 -62.15 0.32 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.85 -18.9 60.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -1.118 . . . . 0.0 109.78 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.507 ' SD ' ' CG ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -60.95 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.914 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.496 HG23 ' HD2' ' A' ' 93' ' ' PRO . 16.4 m -126.19 -30.9 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.074 -1.017 . . . . 0.0 110.444 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.07 -75.32 0.28 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.496 ' HD2' HG23 ' A' ' 91' ' ' VAL . 2.9 Cg_endo -61.43 -33.58 88.11 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.771 1.406 . . . . 0.0 110.111 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.652 ' HE1' HG21 ' A' ' 40' ' ' VAL . 8.1 t80 -65.28 -56.4 12.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 1.5 tt0 -55.65 -45.58 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.093 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' GLN . 3.4 mt-10 -43.06 -54.33 4.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 110.037 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 100' ' ' ALA . . . -86.35 -72.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.596 ' HB2' HD13 ' A' ' 125' ' ' ILE . . . -37.5 -67.15 0.2 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.654 . . . . 0.0 110.798 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -44.14 -26.96 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.009 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -97.14 -19.52 18.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.985 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD22 ' CG2' ' A' ' 110' ' ' VAL . 16.2 mt -64.84 114.09 13.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' HG3' ' CE2' ' A' ' 111' ' ' PHE . 2.4 Cg_endo -59.43 140.26 93.4 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 N-CA-C 108.836 -1.255 . . . . 0.0 108.836 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.904 HG23 ' HA ' ' A' ' 128' ' ' GLU . 1.1 p -45.93 145.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.73 -1.231 . . . . 0.0 109.148 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 103' ' ' VAL . 0.8 OUTLIER 160.3 -70.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.326 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.59 ' CA ' ' HB2' ' A' ' 126' ' ' MET . . . 86.48 177.86 49.55 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.219 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 105' ' ' GLY . 2.4 tmm? 74.58 -108.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.837 -0.802 . . . . 0.0 110.629 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' OD1' ' CD ' ' A' ' 114' ' ' PRO . 18.6 t70 -177.5 59.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.274 -1.517 . . . . 0.0 111.678 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 11.0 ttmm -157.95 -65.96 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.898 -1.126 . . . . 0.0 110.967 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 2.8 Cg_endo -58.94 -44.05 38.43 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 122.796 0.892 . . . . 0.0 110.756 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 111' ' ' PHE . 1.4 p -53.14 -162.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.361 -0.837 . . . . 0.0 110.907 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.687 ' H ' HG22 ' A' ' 110' ' ' VAL . 22.4 m-85 -117.24 -78.2 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.062 -1.023 . . . . 0.0 110.927 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.563 ' CG2' HD21 ' A' ' 101' ' ' LEU . 1.8 t -64.48 -175.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.231 -0.918 . . . . 0.0 110.884 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 112' ' ' THR . 4.5 p30 -80.06 136.6 53.82 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.748 . . . . 0.0 109.544 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 1.0 ' CB ' HG23 ' A' ' 124' ' ' ILE . 2.8 Cg_endo -56.3 -59.39 0.7 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.437 1.23 . . . . 0.0 112.385 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.632 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.7 Cg_endo -56.1 71.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.433 1.422 . . . . 0.0 110.845 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.99 HG13 ' O ' ' A' ' 114' ' ' PRO . 2.8 m -89.95 150.1 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.957 -1.089 . . . . 0.0 109.675 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 0.5 OUTLIER -101.12 141.61 33.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.029 -1.044 . . . . 0.0 111.225 -179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 117' ' ' LYS . 1.2 t 174.14 31.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 110.173 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -178.67 -70.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.062 -1.024 . . . . 0.0 111.035 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.16 36.93 2.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.075 -1.016 . . . . 0.0 111.188 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.62 ' O ' ' CE1' ' A' ' 123' ' ' HIS . . . 122.52 -155.4 17.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.649 ' HB2' ' CE1' ' A' ' 48' ' ' HIS . 2.9 m-85 -89.9 137.71 32.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.217 -1.167 . . . . 0.0 108.801 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.776 ' ND1' HD22 ' A' ' 44' ' ' LEU . 2.6 m-70 -129.57 141.37 50.98 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.04 -1.038 . . . . 0.0 109.734 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.0 HG23 ' CB ' ' A' ' 114' ' ' PRO . 27.6 mt -89.36 106.89 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.679 -1.263 . . . . 0.0 108.144 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.658 HG23 HG23 ' A' ' 40' ' ' VAL . 11.4 mt -89.59 126.44 42.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.773 0.797 . . . . 0.0 110.435 -178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.59 ' HB2' ' CA ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -122.51 116.66 24.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.708 -0.62 . . . . 0.0 109.429 -179.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.649 HG13 ' HB ' ' A' ' 38' ' ' VAL . 53.7 t -89.87 148.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.877 . . . . 0.0 109.579 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.904 ' HA ' HG23 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -145.75 89.95 1.95 Allowed 'General case' 0 C--O 1.204 -1.316 0 CA-C-O 123.038 1.399 . . . . 0.0 111.139 179.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.597 ' O ' ' CH2' ' A' ' 84' ' ' TRP . . . 90.67 106.29 1.32 Allowed Glycine 0 C--N 1.277 -2.722 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 3.8 ttt180 -125.47 170.07 11.77 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.359 -1.083 . . . . 0.0 109.909 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.424 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -75.3 -71.45 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.207 -1.172 . . . . 0.0 110.26 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.98 75.24 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.03 -63.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.74 1.389 . . . . 0.0 110.427 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.6 mttp 44.5 -150.28 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.0 110.324 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.07 -171.02 5.09 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.34 -2.85 29.46 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' ASN . . . -108.78 166.71 12.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.988 ' O ' HG22 ' A' ' 86' ' ' THR . 20.7 t30 178.51 -45.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -1.123 . . . . 0.0 110.008 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -143.51 150.3 38.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.009 ' CG2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -150.11 150.52 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 0.2 OUTLIER -89.8 93.49 9.46 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 119.955 -1.716 . . . . 0.0 108.002 179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.009 HG13 ' CG2' ' A' ' 38' ' ' VAL . 2.7 m -98.13 150.13 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 122.083 0.944 . . . . 0.0 113.0 -177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.15 150.27 51.48 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.523 ' CE1' ' HB3' ' A' ' 73' ' ' GLU . 4.1 p80 -127.22 128.6 46.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.201 -1.562 . . . . 0.0 113.608 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.974 HD12 ' NE ' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -126.06 112.84 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.399 -0.813 . . . . 0.0 110.175 178.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.748 HD12 ' OE1' ' A' ' 73' ' ' GLU . 2.8 mt -93.58 149.28 21.36 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.615 -1.303 . . . . 0.0 111.79 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' LYS . 24.8 p -90.98 -21.23 21.4 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 120.442 -1.412 . . . . 0.0 108.804 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 45' ' ' CYS . 8.3 tt0 66.26 -55.82 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.76 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 45' ' ' CYS . 3.6 pttt -115.72 9.08 15.1 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.583 -0.698 . . . . 0.0 109.467 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 13.8 m80 57.49 27.19 13.65 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.735 0.779 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.66 -28.19 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -106.42 -4.22 20.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.023 -1.281 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 45' ' ' CYS . 6.4 tp -48.42 -32.65 4.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 118.496 -1.282 . . . . 0.0 107.875 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -80.52 -48.5 12.68 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 23.5 tt0 -53.64 -29.76 39.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.508 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -74.25 -35.07 63.81 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.55 ' CE ' ' HG2' ' A' ' 114' ' ' PRO . 12.7 mtt -77.59 -58.61 3.18 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.395 0.617 . . . . 0.0 109.839 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 2.4 mt-10 -51.27 -67.07 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 110.018 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 62' ' ' MET . 0.8 OUTLIER -39.72 -69.59 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.409 179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.945 HD12 ' CE ' ' A' ' 62' ' ' MET . 0.5 OUTLIER -41.94 -31.94 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 110.625 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -80.77 -29.71 36.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.977 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.535 ' N ' ' HG3' ' A' ' 59' ' ' LYS . 5.6 m -78.69 -46.48 18.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.489 -0.757 . . . . 0.0 109.321 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.72 40.24 0.54 Allowed Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.828 -1.177 . . . . 0.0 110.215 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.958 ' HE2' HG11 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -81.78 -157.22 0.18 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.975 -1.309 . . . . 0.0 109.341 179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' N ' ' HG2' ' A' ' 62' ' ' MET . 0.0 OUTLIER -71.59 150.97 44.19 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.226 -0.921 . . . . 0.0 109.162 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.543 ' CD1' ' HG3' ' A' ' 78' ' ' GLN . 1.1 m-85 -90.44 -29.13 18.16 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 73.6 m-20 -90.3 -37.59 13.96 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.457 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.734 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 17.2 mm-40 -54.78 -62.89 1.36 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.205 -1.559 . . . . 0.0 107.155 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.087 HG12 ' CE2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -47.8 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.717 ' H ' HG23 ' A' ' 67' ' ' VAL . . . -38.55 -45.21 1.04 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.925 -0.485 . . . . 0.0 110.051 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -43.03 -61.44 1.3 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.357 -0.839 . . . . 0.0 109.119 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 70' ' ' GLN . 7.5 tp60 -91.02 -55.83 3.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.724 1.25 . . . . 0.0 109.479 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 1.087 ' CE2' HG12 ' A' ' 67' ' ' VAL . 2.8 m-30 -43.81 -29.08 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.321 -177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.919 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 32.2 t -76.34 173.21 11.7 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.495 -1.378 . . . . 0.0 110.755 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.748 ' OE1' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -68.65 66.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 123.587 1.66 . . . . 0.0 106.718 178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' SER . 25.3 t0 60.44 19.48 9.18 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.073 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 13.3 tptt -130.54 -98.33 0.33 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.504 -0.748 . . . . 0.0 110.078 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.783 ' HB3' ' N ' ' A' ' 80' ' ' GLY . . . 177.11 127.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.07 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.974 ' NE ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -72.86 -33.01 65.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.373 -1.455 . . . . 0.0 109.51 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.543 ' N ' ' HG3' ' A' ' 77' ' ' ARG . 38.8 mm-40 -100.84 -54.57 2.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.901 -1.124 . . . . 0.0 108.77 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.99 -24.02 75.91 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.787 -2.125 . . . . 0.0 107.787 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.783 ' N ' ' HB3' ' A' ' 76' ' ' ALA . . . -103.64 5.66 47.97 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 83' ' ' GLY . 27.9 t0 -37.99 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.682 -0.893 . . . . 0.0 110.024 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 81' ' ' ASP . 7.9 mp -39.86 -27.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.525 -0.735 . . . . 0.0 110.093 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.91 -179.88 45.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.606 ' CZ3' ' O ' ' A' ' 129' ' ' GLY . 57.7 m95 -40.95 140.22 0.77 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.616 -0.932 . . . . 0.0 110.01 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 1.4 mmt -145.17 132.04 20.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.179 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.988 HG22 ' O ' ' A' ' 36' ' ' ASN . 1.2 p -118.72 150.12 40.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.369 -0.832 . . . . 0.0 110.44 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -53.22 -35.84 60.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.493 -0.755 . . . . 0.0 110.219 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.29 -28.42 4.49 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.56 98.21 2.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -1.134 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.597 ' C ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -152.1 -81.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.154 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 92' ' ' GLY . 0.4 OUTLIER 176.43 -82.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 0.0 110.198 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.74 ' N ' HG22 ' A' ' 91' ' ' VAL . . . -173.02 -85.63 0.06 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 118' ' ' THR . 3.1 Cg_exo -60.5 -54.12 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.628 1.331 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 93' ' ' PRO . 3.3 t80 -44.54 -47.43 10.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.869 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 99' ' ' PHE . 4.5 tm0? -69.25 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.107 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -48.06 -29.83 3.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.456 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.607 ' O ' HD12 ' A' ' 101' ' ' LEU . . . -71.24 -74.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.75 ' HB2' ' CG2' ' A' ' 125' ' ' ILE . . . -73.06 -56.53 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 110.87 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 95' ' ' GLN . 2.7 t80 -37.88 -54.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.84 . . . . 0.0 111.399 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.17 9.01 11.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.893 . . . . 0.0 110.946 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.821 ' HB3' HG11 ' A' ' 110' ' ' VAL . 18.2 mt -122.35 149.01 53.95 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 120.977 -1.077 . . . . 0.0 111.168 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.932 ' HD2' HG21 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -63.07 151.5 84.41 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.86 1.453 . . . . 0.0 111.32 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.913 ' HA ' HG13 ' A' ' 127' ' ' VAL . 2.6 t -52.55 158.36 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.606 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 109' ' ' PRO . 0.6 OUTLIER 167.09 -97.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.301 -0.875 . . . . 0.0 110.929 179.766 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.576 ' CA ' ' HA ' ' A' ' 126' ' ' MET . . . 75.65 -173.94 52.95 Favored Glycine 0 N--CA 1.495 2.632 0 O-C-N 120.768 -1.208 . . . . 0.0 111.307 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.566 ' HE3' ' H ' ' A' ' 107' ' ' ASP . 2.5 ttp 69.21 -163.63 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.633 -0.922 . . . . 0.0 110.645 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' H ' ' HE3' ' A' ' 106' ' ' MET . 57.3 t0 -75.97 8.26 3.31 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.959 -1.088 . . . . 0.0 111.42 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 4.3 tttp -141.28 54.18 4.13 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.129 -0.982 . . . . 0.0 108.811 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 108' ' ' LYS . 3.2 Cg_exo -65.85 -175.38 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.79 1.416 . . . . 0.0 110.938 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.932 HG21 ' HD2' ' A' ' 102' ' ' PRO . 1.4 p -72.41 -162.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.37 -0.831 . . . . 0.0 110.673 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' H ' HG22 ' A' ' 110' ' ' VAL . 95.9 m-85 -41.29 -39.89 1.51 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.432 -0.793 . . . . 0.0 110.306 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -72.33 139.22 47.82 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.429 -0.795 . . . . 0.0 111.138 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -76.84 160.41 76.7 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.619 ' CB ' ' HD3' ' A' ' 115' ' ' PRO . 3.7 Cg_exo -59.61 -54.94 2.02 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.443 1.233 . . . . 0.0 111.863 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.619 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.2 Cg_exo -65.35 69.17 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 120.838 1.025 . . . . 0.0 111.651 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 123' ' ' HIS . 20.3 m -89.88 150.41 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.749 -1.22 . . . . 0.0 109.431 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -113.68 147.64 37.8 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.096 -1.003 . . . . 0.0 110.697 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.619 HG22 ' HB2' ' A' ' 93' ' ' PRO . 66.9 p -146.26 -63.84 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.764 . . . . 0.0 110.034 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 119' ' ' LYS . 1.3 tppp? -154.06 32.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.93 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.503 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -159.78 -57.59 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.883 . . . . 0.0 110.233 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -176.27 -156.09 14.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 7.0 m-30 -91.67 94.65 9.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.224 -1.162 . . . . 0.0 110.167 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.858 ' O ' HG22 ' A' ' 116' ' ' VAL . 12.9 p80 -98.39 148.22 23.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.145 -0.972 . . . . 0.0 110.545 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 HG21 ' A' ' 43' ' ' ILE . 20.2 mt -89.71 115.62 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.649 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.75 ' CG2' ' HB2' ' A' ' 98' ' ' ALA . 12.3 mt -89.74 118.45 35.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.677 0.751 . . . . 0.0 109.638 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -114.27 99.85 7.91 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 103' ' ' VAL . 1.4 p -89.28 120.33 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.651 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 4.5 tm-20 -150.33 100.88 2.93 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.068 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.606 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 116.73 81.67 0.88 Allowed Glycine 0 C--N 1.273 -2.917 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -125.19 172.72 9.3 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.615 -179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 130' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.153 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 m 47.95 74.69 0.16 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -1.153 . . . . 0.0 110.149 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.04 76.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 2.9 Cg_endo -62.14 -163.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.634 1.334 . . . . 0.0 110.543 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER 63.97 117.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.27 -125.41 1.49 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 27.14 8.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.35 32.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 55.32 95.86 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.321 -1.105 . . . . 0.0 110.062 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.798 ' HB3' ' HG3' ' A' ' 131' ' ' LYS . . . -147.86 147.3 29.63 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.733 -0.604 . . . . 0.0 109.545 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.936 ' HB ' HG13 ' A' ' 127' ' ' VAL . 19.6 m -151.07 150.89 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.582 -0.699 . . . . 0.0 109.422 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.665 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.8 tptm -88.4 106.76 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.741 -1.849 . . . . 0.0 108.785 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 HG23 ' A' ' 38' ' ' VAL . 16.4 m -104.85 147.5 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.153 0.978 . . . . 0.0 112.448 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 77' ' ' ARG . 3.8 mtt-85 -138.53 150.11 46.04 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.708 ' NE2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -148.64 134.5 18.99 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.138 -1.825 . . . . 0.0 114.318 -177.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 HD11 ' A' ' 58' ' ' LEU . 55.9 mt -127.95 111.07 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.159 HD22 ' CE1' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -113.91 150.08 34.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.417 -1.427 . . . . 0.0 110.815 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.999 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -125.79 113.26 17.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.615 -1.303 . . . . 0.0 110.017 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.8 tt0 -65.74 -23.08 66.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.479 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -103.66 -6.55 21.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.768 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 45' ' ' CYS . 3.3 m-70 58.0 14.26 2.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.493 -0.754 . . . . 0.0 110.558 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -83.37 -33.59 22.36 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -108.09 -17.89 13.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.44 -1.035 . . . . 0.0 109.693 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.672 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -46.98 -32.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 55' ' ' MET . 0.0 OUTLIER -77.74 -51.06 11.16 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.711 -0.618 . . . . 0.0 109.65 178.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 1.6 tt0 -57.12 -29.78 63.84 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 58' ' ' LEU . . . -59.34 -32.75 70.38 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER -82.11 -48.05 11.82 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' CA ' ' OE1' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -69.34 -61.55 1.74 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.427 -0.796 . . . . 0.0 109.665 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.68 ' HG3' ' HG3' ' A' ' 62' ' ' MET . 4.2 tttt -43.27 -62.29 1.1 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.259 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.855 HD11 HD12 ' A' ' 43' ' ' ILE . 69.5 mt -49.9 -39.55 40.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.798 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -70.37 -76.07 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.159 -0.963 . . . . 0.0 110.841 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -33.88 -32.9 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.543 . . . . 0.0 111.066 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 59' ' ' LYS . . . 121.85 6.19 8.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.68 ' HG3' ' HG3' ' A' ' 57' ' ' LYS . 54.6 mmm -55.49 -169.27 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.591 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -71.22 137.15 48.43 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.267 -0.896 . . . . 0.0 111.321 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.546 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 57.1 m-85 -90.21 -32.5 16.57 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 46.7 t30 -87.18 -33.73 19.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.844 -0.535 . . . . 0.0 111.387 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 11.0 mm-40 -70.25 -45.92 65.48 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.074 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 71' ' ' TYR . 12.2 m -67.68 -51.03 55.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.653 ' N ' HG23 ' A' ' 67' ' ' VAL . . . -55.62 -30.46 60.98 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 120.851 -1.156 . . . . 0.0 108.016 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -51.52 -74.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.604 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -91.39 -45.56 8.5 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.161 -1.015 . . . . 0.0 113.377 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB2' ' O ' ' A' ' 67' ' ' VAL . 3.3 m-30 -47.34 -30.61 3.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.301 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.613 ' HA ' ' N ' ' A' ' 44' ' ' LEU . 66.3 m -68.69 -11.0 59.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.348 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 44' ' ' LEU . 4.4 tm-20 30.13 45.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.848 0.832 . . . . 0.0 111.049 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER 170.92 -67.18 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.479 0.657 . . . . 0.0 109.606 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 72' ' ' SER . 4.6 tptt -126.51 -132.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.47 -0.769 . . . . 0.0 109.316 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.905 ' HB3' ' N ' ' A' ' 80' ' ' GLY . . . -167.13 140.15 3.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.981 -1.074 . . . . 0.0 110.296 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.778 HH11 HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -65.63 -31.26 72.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.25 -0.906 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 77' ' ' ARG . 4.7 mp0 -117.1 -64.99 1.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 108.749 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.45 -16.85 37.69 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.905 ' N ' ' HB3' ' A' ' 76' ' ' ALA . . . -121.01 2.4 11.69 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' OD2' ' NH1' ' A' ' 41' ' ' ARG . 62.9 t0 -41.2 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 110.382 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' NE2' ' A' ' 42' ' ' HIS . 12.9 mt -42.04 -29.71 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 84' ' ' TRP . . . 87.23 -171.82 42.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.588 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 27.4 m95 -41.61 137.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.022 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 5.2 tpt -146.52 149.01 32.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.995 -1.066 . . . . 0.0 110.873 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.5 t -135.05 151.23 50.59 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.279 1.038 . . . . 0.0 110.902 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -49.96 166.58 0.06 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.318 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.09 -66.96 0.3 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -17.11 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -1.097 . . . . 0.0 110.238 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.6 -148.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.121 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' A' ' 94' ' ' PHE . 2.5 p -126.84 -144.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.787 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.811 ' N ' HG13 ' A' ' 91' ' ' VAL . . . -99.42 -73.84 1.1 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.234 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.1 Cg_exo -59.03 -52.59 4.79 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.703 1.37 . . . . 0.0 111.388 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.845 ' HB3' HG12 ' A' ' 91' ' ' VAL . 30.8 t80 -44.78 -45.26 9.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.273 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HG2' ' CB ' ' A' ' 99' ' ' PHE . 3.8 tm0? -77.42 -35.24 54.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.181 -0.95 . . . . 0.0 109.84 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 2.1 mt-10 -61.45 -29.97 70.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.335 -0.853 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 101' ' ' LEU . . . -87.77 -72.4 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.837 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB1' ' CG2' ' A' ' 127' ' ' VAL . . . -61.69 -69.57 0.24 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.839 . . . . 0.0 111.046 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.465 ' CB ' ' HG2' ' A' ' 95' ' ' GLN . 0.3 OUTLIER -43.67 -30.8 0.67 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.274 -0.891 . . . . 0.0 110.986 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 96' ' ' GLU . . . -83.21 -45.21 14.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.061 -1.024 . . . . 0.0 110.524 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.747 HD22 ' HD2' ' A' ' 111' ' ' PHE . 19.8 mt -86.99 161.6 46.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 110.687 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.618 ' HD2' HG21 ' A' ' 110' ' ' VAL . 2.7 Cg_endo -63.58 178.05 1.46 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.864 1.455 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 127' ' ' VAL . 14.3 m -59.04 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 O-C-N 121.097 -1.002 . . . . 0.0 110.139 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' MET . 0.3 OUTLIER 163.84 -149.12 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 121.776 0.798 . . . . 0.0 112.058 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' O ' ' CE ' ' A' ' 106' ' ' MET . . . 81.97 178.51 52.44 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.589 ' CE ' ' O ' ' A' ' 105' ' ' GLY . 0.0 OUTLIER 77.41 -30.01 0.17 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.573 -0.957 . . . . 0.0 113.306 178.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' HG2' ' A' ' 106' ' ' MET . 5.3 t0 175.4 102.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.73 -1.231 . . . . 0.0 109.553 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 109' ' ' PRO . 20.2 tptp 61.02 65.39 1.98 Allowed Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 5.8 Cg_exo -62.84 -154.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.02 1.537 . . . . 0.0 111.404 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.622 HG22 ' N ' ' A' ' 111' ' ' PHE . 3.2 p -101.13 170.32 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.495 -0.753 . . . . 0.0 111.14 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.747 ' HD2' HD22 ' A' ' 101' ' ' LEU . 29.0 m-85 18.64 -81.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.281 0.562 . . . . 0.0 112.489 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.559 ' N ' ' O ' ' A' ' 110' ' ' VAL . 7.3 t -70.31 -169.0 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.326 -0.859 . . . . 0.0 111.051 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 1.1 m-20 -109.79 165.95 11.69 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.558 -0.713 . . . . 0.0 109.675 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.861 ' O ' HG13 ' A' ' 116' ' ' VAL . 2.8 Cg_endo -58.37 -56.97 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.469 1.247 . . . . 0.0 111.948 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.63 ' HD2' ' CD ' ' A' ' 114' ' ' PRO . 2.5 Cg_endo -60.38 82.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.31 1.163 . . . . 0.0 110.666 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -89.86 149.92 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.035 -1.04 . . . . 0.0 110.145 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.39 141.54 35.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 119' ' ' LYS . 15.9 p -140.79 -61.73 0.49 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.179 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' N ' ' OG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -165.27 36.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 110.139 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.6 -51.68 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -176.06 -130.32 1.32 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -115.63 114.07 24.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -1.178 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 1.159 ' CE1' HD22 ' A' ' 44' ' ' LEU . 8.7 m-70 -107.31 140.2 40.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.724 HG23 ' CB ' ' A' ' 114' ' ' PRO . 83.8 mt -89.84 99.12 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.944 . . . . 0.0 109.235 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.825 HD11 ' CD2' ' A' ' 94' ' ' PHE . 12.8 mt -89.91 149.58 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.333 -0.854 . . . . 0.0 111.193 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -144.67 107.92 4.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.936 HG13 ' HB ' ' A' ' 38' ' ' VAL . 24.0 t -89.6 133.77 30.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.665 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 41.2 tp10 -150.27 92.88 1.92 Allowed 'General case' 0 C--O 1.195 -1.798 0 C-N-CA 118.088 -1.445 . . . . 0.0 111.528 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.579 ' O ' ' CZ3' ' A' ' 84' ' ' TRP . . . 108.04 95.78 2.41 Favored Glycine 0 C--N 1.272 -2.985 0 O-C-N 120.189 -1.569 . . . . 0.0 109.543 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.694 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 15.3 mtm105 -116.38 170.53 8.47 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.434 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.798 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.25 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' CA ' ' HD3' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.467 -1.453 . . . . 15.25 109.467 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.522 ' N ' ' HD3' ' A' ' 32' ' ' LYS . 84.8 p -74.29 66.0 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -1.128 . . . . 14.16 110.163 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 79.57 -157.34 42.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.384 -1.486 . . . . 12.77 109.384 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.25 112.95 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.707 1.372 . . . . 12.08 110.227 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -170.67 -43.0 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.219 -0.926 . . . . 12.15 110.375 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' N ' ' HE3' ' A' ' 32' ' ' LYS . . . 72.36 95.73 0.08 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.901 -1.279 . . . . 8.03 109.901 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' ' NZ ' ' A' ' 32' ' ' LYS . . . 58.25 152.84 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.874 -1.291 . . . . 6.27 109.874 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 36' ' ' ASN . . . -53.05 137.61 36.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.46 -1.456 . . . . 4.19 109.46 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 99' ' ' PHE . 83.8 m-20 -143.71 -41.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 2.49 110.605 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 130' ' ' ARG . . . -89.86 130.52 36.08 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.204 -0.935 . . . . 0.73 109.869 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.581 HG12 ' HB3' ' A' ' 130' ' ' ARG . 1.4 m -150.54 150.55 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.86 -0.793 . . . . 0.88 108.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 10.9 tptp -88.8 94.63 9.99 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 117.164 -1.814 . . . . 1.71 108.777 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 82' ' ' LEU . 10.0 p -91.71 150.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.345 1.069 . . . . 1.44 113.074 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB3' ' NH2' ' A' ' 77' ' ' ARG . 2.3 mtt180 -132.18 150.2 52.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.473 -1.677 . . . . 1.89 106.473 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.859 ' CD2' HD12 ' A' ' 82' ' ' LEU . 2.3 p80 -146.55 111.61 5.39 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 115.739 -2.384 . . . . 3.2 116.255 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.761 ' HB ' ' HD2' ' A' ' 77' ' ' ARG . 0.1 OUTLIER -102.6 123.77 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 N-CA-C 108.58 -0.896 . . . . 0.85 108.58 176.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.078 HD12 ' N ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -119.06 143.8 46.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.564 -1.335 . . . . 1.77 108.579 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 1.078 ' N ' HD12 ' A' ' 44' ' ' LEU . 61.7 m -124.01 129.84 51.58 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.852 -1.155 . . . . 1.67 110.199 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' OE2' ' OE1' ' A' ' 73' ' ' GLU . 1.5 tt0 -80.17 -38.68 30.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 2.6 109.195 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' HIS . 9.1 mttt -88.68 -7.71 55.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.441 -0.787 . . . . 2.04 109.602 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.696 ' CD2' ' CD2' ' A' ' 122' ' ' TYR . 0.7 OUTLIER 57.25 15.45 2.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.417 -0.802 . . . . 1.64 110.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.05 -44.17 4.2 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.934 -1.667 . . . . 0.87 108.934 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HG3' ' HA ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -79.23 -17.44 54.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -1.069 . . . . 1.71 110.147 179.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 48' ' ' HIS . 4.3 tp -48.41 -34.85 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 118.782 -1.167 . . . . 0.84 108.278 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.578 ' HA ' ' HB2' ' A' ' 55' ' ' MET . 0.0 OUTLIER -81.38 -45.97 15.34 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.509 -0.923 . . . . 2.15 108.509 178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 1.8 tt0 -53.66 -29.52 38.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.251 -1.759 . . . . 1.79 106.251 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 58' ' ' LEU . . . -78.09 -29.93 49.34 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.976 -1.12 . . . . 0.55 107.976 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.584 ' HE2' ' HD3' ' A' ' 115' ' ' PRO . 1.5 mtt -76.22 -44.52 37.24 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.789 -0.764 . . . . 0.98 109.512 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.442 ' HG3' ' HE1' ' A' ' 52' ' ' MET . 0.5 OUTLIER -68.83 -60.53 2.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 1.93 109.939 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' CE ' ' HG2' ' A' ' 62' ' ' MET . 3.5 mttp -44.09 -68.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 1.21 109.458 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 54' ' ' ALA . 1.2 mp -43.47 -35.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.97 109.701 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -76.05 -75.38 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.36 -0.838 . . . . 2.13 110.264 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -39.99 -38.22 0.68 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.516 -0.74 . . . . 1.0 110.213 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.53 30.51 2.2 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.514 -1.434 . . . . 0.89 109.514 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.546 ' HG2' ' CE ' ' A' ' 57' ' ' LYS . 2.3 tpp -77.94 -149.62 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.126 -1.22 . . . . 2.28 109.46 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.752 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.5 mtt180 -68.15 126.46 29.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.086 -1.009 . . . . 1.89 110.49 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -90.38 -31.83 16.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.127 -0.983 . . . . 2.07 108.753 178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.45 -33.7 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.837 . . . . 1.88 110.56 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm-40 -66.82 -53.17 35.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.973 -1.079 . . . . 2.39 108.173 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 63' ' ' ARG . 30.2 m -59.37 -53.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.347 -1.353 . . . . 0.58 107.347 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 77' ' ' ARG . . . -50.21 -40.68 48.03 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.126 -0.983 . . . . 0.64 108.412 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 66' ' ' GLU . . . -52.66 -72.19 0.06 Allowed 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.301 -0.96 . . . . 0.56 109.315 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.625 ' NE2' ' HA ' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -91.47 -43.64 9.59 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.028 -1.469 . . . . 2.28 113.556 -179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.662 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 3.4 m-30 -48.8 -29.53 4.69 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.181 -1.407 . . . . 1.1 108.174 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 47.3 t -74.68 -2.48 26.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.623 -0.673 . . . . 1.59 109.909 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' GLN . 2.1 tm-20 25.8 47.58 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.375 0.607 . . . . 3.94 110.755 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 1.3 t70 162.99 121.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.215 0.531 . . . . 3.53 110.164 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 74' ' ' ASP . 7.7 tptt 39.48 36.22 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 3.04 111.016 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' ALA . . . 40.73 -156.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.865 . . . . 2.07 110.244 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.769 ' CB ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.23 -94.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.821 -1.175 . . . . 8.13 111.742 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.637 ' NE2' ' NH1' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -51.98 -55.39 20.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.837 -1.789 . . . . 2.83 108.606 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.35 -24.5 16.64 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 106.68 -2.568 . . . . 3.69 106.68 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 77' ' ' ARG . . . -86.53 -49.35 4.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.043 -1.223 . . . . 1.84 110.043 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.694 ' N ' ' O ' ' A' ' 77' ' ' ARG . 18.4 t0 33.84 82.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.829 -0.806 . . . . 2.11 110.631 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.859 HD12 ' CD2' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -37.51 -29.53 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.932 . . . . 1.56 110.487 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 88.65 -179.4 45.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.162 -1.175 . . . . 0.77 110.162 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CE3' ' HB1' ' A' ' 37' ' ' ALA . 44.8 m95 -48.39 136.89 11.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.48 -1.012 . . . . 0.96 110.17 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -138.25 141.8 39.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.165 -0.96 . . . . 1.66 110.428 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 36' ' ' ASN . 0.6 OUTLIER -119.59 145.55 46.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.558 -0.714 . . . . 1.27 110.259 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' A' ' 99' ' ' PHE . 2.3 ttp180 -63.3 73.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 2.75 110.271 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -146.79 -52.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.103 -1.599 . . . . 1.24 109.103 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.99 -1.65 28.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -1.104 . . . . 1.64 109.985 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.42 ' SD ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -66.67 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 1.86 110.37 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 92' ' ' GLY . 2.2 t -114.48 -166.08 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.339 -0.85 . . . . 1.8 109.632 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 91' ' ' VAL . . . -83.45 -73.29 1.25 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.697 -1.361 . . . . 0.83 109.697 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 3.0 Cg_endo -61.65 -48.03 10.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.661 1.348 . . . . 0.89 110.822 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 93' ' ' PRO . 6.6 t80 -42.1 -39.66 2.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 1.58 110.516 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.496 ' HG2' ' HB2' ' A' ' 99' ' ' PHE . 1.1 tt0 -90.01 -47.01 8.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 2.15 110.62 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -39.83 -30.0 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.362 -0.836 . . . . 2.61 110.892 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 101' ' ' LEU . . . -89.74 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.131 -0.98 . . . . 0.81 110.775 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' HB2' HG21 ' A' ' 125' ' ' ILE . . . -37.76 -67.58 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.641 -0.662 . . . . 0.83 110.935 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 36' ' ' ASN . 1.4 m-85 -41.99 -65.07 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.248 -0.908 . . . . 1.81 110.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.98 -16.61 61.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 1.29 110.292 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 97' ' ' ALA . 24.2 mt -97.66 155.8 36.79 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 1.77 110.254 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.29 149.09 91.95 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.718 1.378 . . . . 1.14 110.872 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 127' ' ' VAL . 5.3 t -50.61 174.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.837 . . . . 1.48 109.64 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.549 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 2.3 m 73.33 167.43 0.31 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.312 -0.868 . . . . 2.44 111.08 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 106' ' ' MET . . . -176.3 -101.06 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.889 -1.684 . . . . 1.05 108.889 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.496 ' HG2' ' N ' ' A' ' 107' ' ' ASP . 57.8 ttp 55.04 -95.48 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -1.186 . . . . 1.64 110.827 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' A' ' 106' ' ' MET . 12.8 t0 -160.21 47.46 0.25 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.049 -1.032 . . . . 2.89 110.479 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.594 ' CB ' ' CD ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -175.59 -59.99 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.21 -0.931 . . . . 4.27 110.112 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.0 Cg_exo -57.37 -154.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.32 1.168 . . . . 2.6 109.947 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 111' ' ' PHE . 3.3 p 38.17 -158.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.496 -0.753 . . . . 2.33 110.079 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.72 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.7 m-85 -129.58 -63.66 0.92 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.675 -1.266 . . . . 1.94 111.153 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 111' ' ' PHE . 10.7 t -54.48 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.368 -0.833 . . . . 0.97 110.959 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -96.93 143.88 26.88 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.545 -0.722 . . . . 2.31 109.589 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.995 ' CB ' HG23 ' A' ' 124' ' ' ILE . 3.4 Cg_exo -59.45 -54.44 2.54 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.525 1.276 . . . . 0.67 112.107 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 114' ' ' PRO . 3.1 Cg_exo -63.05 74.45 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.071 1.181 . . . . 0.62 110.629 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 114' ' ' PRO . 3.2 m -90.89 150.12 3.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.315 -0.865 . . . . 0.6 110.33 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -101.85 142.57 32.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 2.08 110.179 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.612 HG23 ' NE2' ' A' ' 123' ' ' HIS . 62.4 p -135.25 -38.63 0.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 1.49 110.228 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -171.76 -34.49 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 4.09 110.135 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.83 -54.94 3.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.228 -0.92 . . . . 2.86 110.103 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -175.13 -153.27 10.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.243 -1.543 . . . . 0.84 109.243 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.696 ' CD2' ' CD2' ' A' ' 48' ' ' HIS . 20.9 m-30 -90.31 134.41 34.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -1.179 . . . . 1.67 110.014 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 116' ' ' VAL . 26.5 p80 -144.07 150.14 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.76 110.113 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.995 HG23 ' CB ' ' A' ' 114' ' ' PRO . 31.5 mt -89.52 130.82 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.395 -0.815 . . . . 0.45 110.518 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.521 HD11 ' HE1' ' A' ' 123' ' ' HIS . 5.0 mt -111.62 123.69 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.449 -0.782 . . . . 0.78 110.09 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.501 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 1.1 ttp -123.13 109.53 14.14 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.239 -0.913 . . . . 1.19 109.27 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' CG1' HG22 ' A' ' 103' ' ' VAL . 41.4 t -89.68 150.22 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.03 109.334 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.636 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -147.15 89.72 1.82 Allowed 'General case' 0 C--O 1.204 -1.321 0 CA-C-O 122.851 1.31 . . . . 2.3 111.846 -179.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 38' ' ' VAL . . . 89.25 122.17 2.09 Favored Glycine 0 C--N 1.277 -2.697 0 O-C-N 120.829 -1.169 . . . . 1.16 111.163 177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -136.06 174.88 10.12 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.626 -0.926 . . . . 2.24 110.213 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 14.3 mtpt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.965 -1.017 . . . . 3.75 110.221 -179.899 . . . . . . . . 1 1 . 1 stop_ save_